UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-K

(Mark One)

þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2013

2016

or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

      ��          

For the transition period fromto

Commission file number: 0-26272

001-36849

NATURAL HEALTH TRENDS CORP.

(Exact name of registrant as specified in its charter) 

Delaware   

59-2705336

Delaware59-2705336
(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

4514 Cole Avenue

609 Deep Valley Drive
Suite 1400

Dallas, Texas 75205

395

Rolling Hills Estates, California 90274
(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:(972) 241-4080

(310) 541-0888

Securities registered pursuant to Section 12(b) of the Act:

None

Title of each className of each exchange on which registered
Common Stock, par value $0.001 per shareThe NASDAQ Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.001 par value

(Title of each class)

None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No 

þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No 

þ

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No

¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No

¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

¨

Accelerated filer 

þ

Non-accelerated filer ¨ (Do not check if a smaller reporting company)

Smaller reporting company 

¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No 

þ

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the closing price of such common equity on June 28, 2013: $6,903,264

30, 2016: $202,402,875

At February 28, 2014,March 7, 2017, the number of shares outstanding of the registrant’s common stock was 11,448,57111,341,890 shares.

DOCUMENTS INCORPORATED BY REFERENCE

None.



 
Portions of the registrant’s definitive proxy statement to be filed with the United States Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year end to which this report relates are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated.




NATURAL HEALTH TRENDS CORP.
Annual Report onForm 10-K
December 31, 2013

2016

TABLE OF CONTENTS

  

Page

 

20

20

20

20

   

 

21

22

23

29

30

51

51

52

   

 

53

55

58

59

60

   

 

60

   

61





FORWARD-LOOKING STATEMENTS
 

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K, in particular “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Item 1. Business,” include “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used in this report, the words or phrases “will likely result,” “expect,” “intend,” “will continue,” “anticipate,” “estimate,” “project,” “believe” and similar expressions are intended to identify “forward-looking statements” within the meaning of the Exchange Act. These statements represent our expectations or beliefs concerning, among other things, future revenue, earnings, growth strategies, new products and initiatives, future operations and operating results, and future business and market opportunities.

Forward-looking statements in this report speak only as of the date hereof, and forward lookingforward-looking statements in documents incorporated by reference speak only as of the date of those documents. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on certain assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein.

For a summary of certain risks related to our business, see “Item 1A. Risk Factors” in this report. Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our financial statements and the related notes.

Unless otherwise noted, the terms “we,” “our,” “us,” and “Company,” refer to Natural Health Trends Corp. and its subsidiaries.Referencessubsidiaries. References to “dollars” and “$” are to United States dollars.



Part I
 

Part I

Item 1. BUSINESS


Overview of Business

Natural Health Trends Corp. is an international direct-selling and e-commerce company headquartered in Dallas, Texas.Rolling Hills Estates, California. Subsidiaries controlled by the Companyus sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to a network of consumers or business builders that either uses the products themselves or resells them to consumers.

Our wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of ItalyEurope. We also operate in Russia and Slovenia. In June and December 2013, we opened marketing centers in Almaty, Kazakhstan and Odessa, Ukraine, respectively, through our engagement with our Russiana local service provider. See Note 10 of the Notes to Consolidated Financial Statements in “Item 8. Financial Statements and Supplementary Data” of this report for further information about our net sales by geographic area.

Most of our order volume, particularly in our Hong Kong subsidiary, is for personal consumption through existing members’ referrals. The Kazakhstan and Ukraine centers opened for sales and distribution purposes in September 2013 and February 2014, respectively.

We seekexception is our Chinese entity, where we sell directly to sell our products into many markets, primarilyconsumers through our direct selling marketing operations.an e-commerce retail platform. Our objectives are to enrich the lives of the users of our products and enable our distributorsmembers to benefit financially from the sale of our products.

We were originally incorporated as a Florida corporation in 1988. We merged into one of our subsidiaries and re-incorporated in Delaware effective June 29, 2005.

Our common stock is quotedcurrently traded on the NASDAQ Capital Market under the trading symbol “NHTC” on the OTCQB tier of the OTC Market, a centralized electronic quotation service run by the OTC Markets Group, Inc.

“NHTC.”

Available Information

We maintain executive offices at 4514 Cole Avenue,609 Deep Valley Drive, Suite 1400, Dallas, Texas 75205395, Rolling Hills Estates, California 90274 and our telephone number is (972) 241-4080.(310) 541-0888. Our website is located atwww.naturalhealthtrendscorp.com. www.naturalhealthtrendscorp.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to such reports are available, free of charge, on our website as soon as reasonably practicable after we file electronically such material with, or furnish it to, the United States Securities and Exchange Commission, or SEC. Our Code of Ethics for Senior Financial Officers can also be found on our website. The information provided on our website should not be considered part of this report. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1–800–SEC–0330. The SEC maintains an internet website athttp://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

Our Principal Products

We offer a line of “NHT Global” branded products in threefive distinct categories includingcategories: wellness, skincareherbal, beauty, lifestyle, and lifestyle.home, our newest category. These three product categories, along with the business opportunity we offer in most of our markets, provide our members a platform to further their goal of achieving and maintaining healthy, quality lifestyles complete with product supplementation and the opportunity for financial rewards.

NHT Global Essentials, the wellness and nutritional supplementation



The following table summarizes our product line, includes:

offering by category:
Product CategoryDescriptionProducts
 

Wellness
Products formulated and designed to meet specific wellness goals of our customers. Includes targeted nutrition such as joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health.Liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, minerals
Premium Noni Juice™ is a reconstituted morinda citrifolia fruit juice, made from organic noni puree. Noni is a fruit native in the Samoan Islands of the South Pacific. Marketed as a refreshing and energizing beverage, its natural flavor has been enhanced with white grape concentrate, concord grape concentrate, pineapple juice puree and other natural flavors.

Juice, Triotein
®, Cluster X2®, Children’s Chewable MultiVitamin, ReStor Silver®, ReStorVital®, HerBalance®, Trifusion Max, Glucosamine 2200, FibeRich®, Energin, Enhanced Essential Probiotics®, Omega 3 Essential Fatty Acids, Memory Burst®, StemRenu®, OcuFocus, FE Enzyme Toothpaste

 

Triotein™is a lactose-free whey protein powder that provides amino acid substrates needed to stimulate the body’s production of an anti-oxidant, intracellular glutathione peroxidase,

Herbal
Products formulated incorporating ingredients commonly found in an effort to optimize the body’s ability to increase immunity.

traditional Chinese medicine
Herbal supplements
LivaPro®, Cordyceps Mycelia CS-4, Purus

 

Cluster X2™ is a product created for increased and more efficient cell hydration, improved cellular function and communication and release of cellular toxins.


 

Trifusion Max™ is a beverage with a unique blend

Beauty
Products to help improve skin health and bring an appearance of exotic fruitsyouthful vibrancy. This product line includes anti-aging and berries rich in antioxidants, lycopene,hydrating cleansers, creams, lotions, serums and more.  Its main ingredients are Acai berry, Goji berry,toners to moisturize, protect and improve the Mangosteen fruit, and the Gac fruit; each containing phytonutrients.  Phytonutrients are compounds having antioxidative properties found naturally in plant-based foods such as fruit and vegetables.  Trifusion Max also contains calcium as well for improved health benefits.

appearance of skin.

 

Glucosamine 2200™ is a great source of daily glucosamine to assist with jointFacial skin care and cartilage health and reduce inflammation and swelling in the joints, a primary cause of pain. The consumption of Glucosamine 2200 can directly stimulate cartilage cells to produce more collagen and proteoglycan of the articular cartilage and help prevent loss of synovial fluid to support normal functionality of the joints.

body care

 

FibeRich™ is a dietary supplement high in dietary fiber to assist with proper digestive health and more. Every teaspoon of FibeRich contains more than 6 grams of dietary fiber helping to ease bowel movements and remove toxic substances from our bodies. FibeRich also contains 8 billion compound high-density probiotics including L. rhamnosus, L. acidophilus, B. longum and B. bifidum. These probiotics protect the digestive tract and can help the body to absorb vitamins, minerals and nutrients. 

Energin™ is a dietary supplement to help increase metabolism and energy and improve brain function.  The key ingredient in Energin is Korean ginseng, which helps to promote a healthy physical, as well as active mental lifestyle. Studies show that Korean ginseng helps stimulate the formation of blood vessels and improves blood circulation in the brain, thereby improving memory and cognitive abilities.

Essential Probiotics™ helps maintain the ecological balance of intestinal micro flora, helps peristalsis in the intestinal tract and supports overall intestinal health. Essential Probiotics is a great-tasting powder which dissolves easily and is conveniently packaged in a foil stick pack for portability. One pouch taken daily following a meal is all that is required to restore a healthy balance to the intestinal tract.

ReStor™ is a patent-pending liquid dietary supplement targeted to help the body replace a critical enzyme called Ca2+ATPase, which naturally declines as we age. This enzyme is important for optimal cellular function and has been known to assist with improved sleep function and efficiency, reduced joint and muscular pain and soreness, improved bladder function and, increased muscle endurance and strength.

HerBalance™is a daily supplement rich in Gamma linolenic acid, isoflavones, vitamins and herbal extracts to improve menopausal symptoms, increase energy and support healthy blood circulation in women.

LivaPro is an excellent combination of traditional Chinese herbals and modern scientific technology. It consists of eight Chinese herbal ingredients including Ganoderma, Lycii Fructus, Ligustrum lucidum, Pueraria, and more. It is all natural and great for supporting healthy liver function.

Cordyceps Mycelia CS-4 is one of NHT Global’s formulations centered around traditional Chinese herbal benefits. The unique combination of Cordyceps Mycelia and Agaricus Blazei help improve kidney function and improve quality of life.

NHT Global Beauty, the skincare product line, includes:

Skindulgence™

Skindulgence®30-Minute Non-Surgical Facelift System, is a skin care system that includes a daily cleanser and moisturizer, as well as a specialty mask to lift and reduce the appearance of fine lines and wrinkles in just 30 minutes and after just one use. The 30-Minute Non-Surgical Facelift is designed to help tone and firm facial muscles as it dries and tightens on the skin.

Time Restore™series is comprised of the Time Restore Essence and Time Restore Eye Cream and is specifically targeted toward anti-aging benefitsEssence, BioCell Mask, 24K Renaissance Rejuvenation Serum, Valesce®, Soothe, Floraeda Hydrating Series, NHT Homme®, Complete Renewal 8 Shampoo, Conditioner and long-term wrinkle reduction. Skindulgence Time Restore products combine the Skindulgence herbal aromatherapy technology and dermatology technology such as Adenosine, Argireline, Matrixyle3000, Polylift and Regu-Age to create and sustain healthier, more beautiful, younger looking skin.

Hair Mask

 

BioCell™ is a patented skincare treatment product providing hydration and skin brightening. The patented bio-cellulose mask material helps BioCell’s essence gel penetrate deep into the skin, locking in moisture and resulting in a more even skin tone, skin clarity and providing the nutrition a user’s skin needs to maintain a youthful glow.


 

24K Renaissance Skin Rejuvenation Serum™facilitates moisture absorption

Lifestyle
Products uniquely formulated to improve overall quality of life and storage to bring your skinsupport active, physical and healthy hydration. Formulated with real 24K gold flakes, NHT Global has found that ingredients EGFlifestyles including weight management, intimacy support and TRF combined with Hyaluronate form an all-natural bionic protective layer to a user’s skin’s surface increasing water retention and ultimately diminishing the appearance of fine lines and wrinkles and helping restore elasticity.

energy enhancing supplements.

 

Soothe™is an all-over body cream idealSupplements and topical gels for use in extreme and harsh weather conditions. When used daily it softens, smoothes and helps alleviate dryness and redness associated with chapped, chafed skin.

improved vitality

NHT Global Lifestyle, the lifestyle enhancing product line, includes:

 

Alura™

Alura® Lux by NHT Global, is an intimacy enhancing cream for women.

Valura Lux, LaVie Vibrant Energy drink, Twin Slim Diet Jelly®, NaturalGlo

 

Valura™ is topical male intimacy enhancing gel to improve and stimulate male sexual performance and desire.

 

La Vie™ is an energy-boosting dietary supplement with

Home
Products designed to create a proprietary herbal blendclean and natural flavors formulated to increase energyliving environment for the homeHome and vitality and assist with mental clarity and focus.

car appliances
PurAir Air Purifier, AquaPur Water Purifier

In addition, some of our subsidiaries offer products specific to their local markets.

NHT Global


We continuously sourcessource unique, proprietary and immediate impact products to offer to our members and customers. ProductOur product development is an ongoing process at NHT Global that is fueled by marketplace trends, and new scientific findings, members’ input, research and research.

vendor proposals.

Working closely with raw material manufacturers and leading domestic and international contract manufacturers, NHT Global’sour mission is to co-develop and bring to market the highest quality products. Our manufacturers are primarily located in the United States, as well as a few in Asia.OurSouth Korea, Hong Kong and China. Our raw materials (including botanical ingredients) are sourced from reputable suppliers around the world. In addition, raw material Certificates of Analysis are reviewed in our effort to assure that the appropriate testing has been performed and are within ingredient specification requirements.

Operations of the Business

Operating Strategy

Our objective is to help our members succeed in achieving their life objectives; be it personal health, beauty, happiness or financial security. The Company consists ofOur professionals who focus on assisting our members in attaining their goals.


We believe that, since early 2010, we have completely changed our corporate identity and are building a competitive business model applicable to the markets in which we operate based on six key competencies:

Our field leaders are experienced and culturally coherent. They work effectively with the Company’s management, implementing our strategies and providing continuous feedback to improve the Company’s services. Most of them have been with the Company for eight years or more and are fiercely loyal to the Company.

The Company has implemented a commission structure that makes it as easy as possible to join the Company’s business, while giving existing members a chance to start making money as quickly as possible in a number of different ways.

We have developed and rolled out a comprehensive training system that provides a complete career path appropriate for our members. Our training material covers the needs of all of our members, be they prospects, new recruits, product evangelists, sales leaders or dream builders.

The continuously improving mentality and methodology we have instilled in our field leaders and personnel have not only distinguished us as an organization, but have also given us a constant flow of information as to how we can do better to service our members.

We have developed a year-round, multi-faceted promotional plan that targets different segments of our membership and has proven most effective in the last few years.

Last, but perhaps most importantly, a discipline and capability has been established to continue launching high-quality consumer products that are designed to facilitate the accomplishment of our corporate objective.

 

Our field leaders are experienced and culturally coherent. They work effectively with our management, implementing our strategies and providing continuous feedback to improve our services.

A discipline and capability has been established to continue launching high-quality consumer products that are designed to facilitate the accomplishment of our corporate objectives.

We have developed and rolled out a comprehensive training system that provides a complete career path appropriate for our members. Our training material covers the needs of our members, be they prospects, new recruits, product evangelists, sales leaders or dream builders.

We have developed a year-round, multi-faceted promotional plan that targets different segments of our membership and has proven most effective in the last few years.

We have implemented a commission structure that makes it as easy as possible to join our business, while giving existing members a chance to start making money as quickly as possible in multiple ways.

The continuously improving mentality and methodology in our customer services have not only distinguished us as an organization, but have also given us a constant flow of information as to how we can do better to service our members.

Sourcing of Products

Our corporate staff works with research and development personnel of our manufacturers and other prospective vendors to create product concepts and develop the product ideas into actual products. We then may enter into supply agreements with the vendors pursuant to which we obtain rights to sell the products under private labels (or trademarks) that are owned by us. Because our current main products all came to us originally as proposals from our vendors, we have incurred minimal “out-of-pocket” research and development costs through December 31, 2013. In addition, some of our local markets introduce their own products from time to time and these products are sometimes adopted by our other markets.

We or certain of our subsidiaries generally purchase finished goods from manufacturers and sell them to our distributorsmembers for their resale or personal consumption. Two Harbors Trading Company (forPremium Noni Juice™) and 40Js LLC (forAlura™) are our most significant vendors, accounting for a majority of our product purchases. We believe that in the event we are unable to source products from our current or alternate suppliers, our revenue, income and cash flow could be adversely and materially impacted. We have a contract with Two Harbors Trading Company that has annualone of our suppliers through February 2019 with automatic renewal rights and a contract with 40Js LLC through July 2016.

rights.

Marketing and Distribution

We distribute our products internationally primarily through a network marketing system, which is a form of person-to-person direct selling.  Under this system, distributors purchasemembers primarily refer our products to prospective consumers or they may buy at wholesale prices for personal consumption or for resale to consumers and for personal consumption.consumers.  The concept of network marketing is based on the strength of personal recommendations that frequently come from friends, neighbors, relatives, and close acquaintances.  We believe that network marketing is an effective way to distribute our products because it allows person-to-person product education and testimonials as well as higher levels of customer service, all of which are not as readily available through other distribution channels. In some markets, like China, we distribute our products directly to consumers using an e-commerce platform. In those markets, we refer to these consumers as “members” rather than distributors. In this document, we generically use the term “distributor”“member” to refer to distributorsmembers who purchase for their own consumption or for resale, or both, as well as to members who only sign up to consume our products.

Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per weekly sales period. Bonus volume points are essentially a percentage of a product’s wholesale price.

Our distributorsmembers are independent full-time or part-time contractors who purchase products directly from our subsidiaries via the internet for their own personal consumption or for resale to retail consumers (other than in China and certain other markets) or for their own personal consumption.consumers. Purchasers of our products in China and certain other markets may purchase only for their own personal consumption and not for resale.


The following table sets forth the number of active distributorsmembers by market foras of the time periodsdates indicated. We consider a distributormember “active” if they have placed at least one product order with us during the preceding year.

  

December 31,

 
  

2012

  

2013

 
         

North America

  1,310   1,720 

Hong Kong

  14,130   20,190 

Taiwan

  1,350   1,710 

South Korea

  270   510 

Japan

  150   150 

Russia and Kazakhstan

  3,100   2,970 

Europe

  370   270 

Total

  20,680   27,520 

NHT Global distributors Members may not necessarily reside in the market for which they sign up as a member.

 December 31,
 2016 2015
North America3,720
 2,870
Hong Kong (including those members residing in China)1
108,570
 100,820
Taiwan4,030
 3,280
South Korea290
 420
Japan100
 100
Singapore80
 
Russia, Kazakhstan and Ukraine2
940
 1,460
Europe1,230
 410
Total118,960
 109,360
1Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. See “Item 1A. Risk Factors”.
2We discontinued our Ukraine operations during the second quarter of 2015.

Members must agree to the terms and conditions of our distributormember agreement posted on our website and generally pay an annual enrollment fee. The distributormember agreement sets forth our policies and procedures, and we may elect to terminate a distributormember for non-compliance.

We pay commissions to eligible NHT Global distributorsmembers based on product purchases by such distributors’members’ down-line distributorsmembers during a given commission period. To be eligible to receive commissions, distributorsmembers in some countries may be required to make nominal monthly or other periodic purchases of products. See “Working with DistributorsMembers.

Distributors

Members generally place orders through the internet and pay by credit card prior to shipment. Accordingly, we carry minimal accounts receivable and credit losses are historically minimal.

negligible.
 

We sponsor promotional meetings and motivational training events for current and potential NHT Global distributors.members. These events are designed to inform prospective and existing distributorsmembers about both existing and new product lines, selling techniquesour latest marketing and promotional plans, and new services improvements. These events also serve as a venue for recognition of distributormember accomplishments. DistributorsMembers typically share their direct selling experiences in using our products and developing their individual selling styles and their recruiting methodsbusiness at these promotional or training events. Prospective distributors are educated about the structure, dynamics and benefits of the direct selling industry. We are continually developing or updating our marketing strategies and programs to motivate our distributors. These programs are designed to increase distributors' monthly product sales and the recruiting of new distributors in their down-lines.

members.

Management Information Systems

The NHT Global

Our business uses a proprietary web-based system to process orders and to communicate bonus volume activity and commissions to distributors. Other than this proprietary system, we have not fully automated and integrated other critical business processes such as inventory management.members. We have automated a substantial amount of our financial reporting processes through implementation of Oracle’s E-Business Suite.

Suite, and have integrated other critical business processes such as inventory management in our most significant markets.

Employees

At December 31, 2013,2016, we employed 99143 total full-time employees worldwide, of which 1325 were located in the United States, 56North America, 101 in HongGreater China (Hong Kong, China, and China, 14Taiwan), five in Taiwan, nineRussia, two in Commonwealth of Independent States (Russia, Kazakhstan and Ukraine), threeSingapore, two in Malaysia, four in South Korea, three in Europe, and one in Japan.


Seasonality

From quarter to quarter, we are somewhat impacted by seasonal factors and trends such as major cultural events and vacation patterns. For example, most Asian markets celebrate their respective local New Year in the first quarter, whichquarter. This generally has a significant negative impact on that quarter.the services of our third-party providers, and can negatively impact our net sales. We believe that direct selling isnet sales can also generallybe negatively impacted during the third quarter, when many individuals, includingof our distributors,members traditionally take time off for vacations. In addition, the national holidays in Hong Kong, China and Taiwan in early October tend to have a significantan adverse effect on sales in those markets.

Our spending, as well as to some extent revenue, is materially affected by the major events planned at different times of the year. A major promotional event could significantly increase the reported expenses during the quarter in which the event actually takes place, while the revenue that might be generated by the event may not occur in the same reporting period.


Intellectual Property

Most of our products are packaged under a "private label"“private label” arrangement. We have obtained or applied for trademark registration for certain names, logos and various product names in several countries in which we are doing business or considering expanding. We also rely on common law trademark rights to protect our unregistered trademarks. These common law trademark rights do not provide us with the same level of protection as afforded by a United States federal trademark. Common law trademark rights are limited to the geographic area in which the trademark is actually utilized, while a United States federal registration of a trademark enables the registrant to discontinue the unauthorized use of the trademark by a third party anywhere in the United States even if the registrant has never used the trademark in the geographic area where the trademark is being used; provided, however, that the unauthorized third party user has not, prior to the registration date, perfected its common law rights in the trademark within that geographic area.

We have a foreign holding and operating company structure for our non-United States businesses, which involves the division of our United States and non-United States operations. Under this structure, we and some of our United States subsidiariesentities have granted an exclusive license to some of our non-United States subsidiaries to use outside of the United States all of their intangible property, including trademarks, trade secrets and other proprietary information.


Working with Distributors

Members

Sponsorship

Sponsoring

Enrolling new distributorsmembers creates multiple levels in theour direct selling structure of NHT Global.structure. The persons that a distributor sponsorsmember enrolls within the network are referred to as "sponsored" distributors,“sponsored” members, who may purchase solely for their own personal consumption, for resale, or both. Persons newly recruitedenrolled are assigned by sponsoring distributors into network positions that can be “under” other distributors,members, and thus they can be called “down-line” distributors.members. If down-line distributorsmembers also sponsorenroll new distributors,members, they create additional levels within the structure, but their down-line distributorsmembers remain in the same down-line network as theirthe original sponsoring distributor.

member that introduced them to our business.
 

While we provide product samples, brochures and other sales materials, distributorsmembers are primarily responsible for recruitingenrolling and educating their new distributorsmembers with respect to products, the compensation plan and how to build a successful distributorshipmembership network.

Distributors

Members are not required to sponsorenroll other distributorsmembers as their down-line, and we do not pay any commissions for sponsoringenrolling new distributors.members. However, because of the financial incentives provided to those who succeed in building a distributormember network that consumes and resells products, we believe that many of our distributorsmembers attempt, with varying degrees of effort and success, to sponsorenroll additional distributors.members. Because they are seeking new opportunities for income, people are often attracted to become distributorsmembers after using our products or after attending introductory seminars. Once a person becomes a distributor,member, he or she is able to purchase products directly from us at wholesale prices via the internet. The distributormember is also entitled to sponsorenroll other distributorsmembers in order to build a network of distributorsmembers and product users.


Compensation Plans

NHT Global employs

We employ what is commonly referred to as a binary compensation plan, enhanced with certain unilevel features. Under the NHT Globalour compensation plan, distributorsmembers are paid weekly commissions by our subsidiary, in which they are enrolled for product purchases by their down-line distributormember network across all geographic markets, exceptmarkets. Our China where we maintainsubsidiary maintains an e-commerce retail platform and dodoes not pay any commissions. This “seamless” compensation plan enables a distributormember located in one country to sponsor other distributorsmembers located in other countries. Currently, there are basically two ways in which NHT Global distributorsmembers can earn income:

Through retail markups on sales of products purchased by distributors at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market); and

Through commissions paid on product purchases made by their down-line distributors.


Through commissions paid on product purchases made by their down-line members; and

Through retail markups on sales of products purchased by members at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market).
Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per sales period. Bonus volume points are essentially a percentage of a product’s wholesale price. As the distributor’smember’s business expands, the distributormember receives higher commissions from purchases made by an expanding down-line network. To be eligible to receive commissions, a distributormember may be required to make nominal monthly or other periodic purchases of our products. Certain of our subsidiaries do not require these nominal purchases for a distributormember to be eligible to receive commissions. In determining commissions, the number of levels of down-line distributorsmembers included within the distributor'smember’s commissionable group increases as the number of distributorshipsmemberships directly below the distributormember increases. Under our current compensation plan, certainsome of our commission payout may be limited to a hard cap in terms ofdollar amount per week or a specific percentage of the total product sales. In some markets, commissions may be further limited.

In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors,members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors. Distributorsmembers. Members can also earn income, trips and other prizes in specific time-limited promotions and contests we hold from time to time.

From time to time

Occasionally, we make modifications and enhancements to our compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time weWe may also enter into agreements for business or market development, which maycould result in additional compensation to specific distributors.

Distributormembers.

Member Support

We are committed to providing a high level of support services tailored to the needs of our distributorsmembers in each marketplacemarket we are serving. We attempt to meet the needs and build the loyalty of distributorsmembers by providing personalized distributormember services and by maintaining a generous product return policy (see “Product Warranties and Returns”). We believe that maximizing a distributor’smember’s efforts by providing effective distributormember support has been, and could continue to be, important to our success.


Through product training meetings, annualregular conventions, web-based messages, distributormember focus groups, regular telephone conference calls and other personal contacts with distributors,members, we seek to understand and satisfy the needs of our distributors.members. Via our websites, we provide product fulfillment and tracking services that result in user-friendly and timely product distribution.

 

To help maintain communication with our distributors,members, we offer the following support programs:

Teleconferences – we hold teleconferences with company management and associate field leadership on various subjects such as technical product discussions, distributor organization building and management techniques.

Internet –we maintain a website atwww.nhtglobal.com. On this website, the user can read company news, learn more about various products, sign up to be a distributor, place orders, and track the fulfillment and delivery of their orders.

Product Literature – we offer a variety of literature to distributors, including product catalogs, informational brochures, pamphlets and posters for individual products.

Broadcast E-mail and Text Messages – we send announcements via e-mail and/or text messages to all active distributors.

Social Media tools – in some countries we maintain country-specific social media sites to foster a community environment around our product offering and business opportunity.


Teleconferences – we hold teleconferences with associate field leadership on various subjects such as technical product discussions, member organization building and management techniques.

Internet – we maintain a website at www.nhtglobal.com. On this website, the user can read company news, learn more about various products, sign up to be a member, place orders, and track the fulfillment and delivery of their orders.
Product Literature – we offer a variety of literature to members, including product catalogs, informational brochures, pamphlets and posters for individual products, which are both printed and available online.
Broadcast E-mail and Text Messages – we send announcements via e-mail and/or text messages to members who opt in to receive this form of communication.

Social Media Tools – in some countries we maintain country-specific social media sites to foster a community environment around our product offering and business opportunity.

Technology and Internet Initiatives

We believe that the internet is important to our business as more consumers communicate online and purchase products over the internet as opposed to traditional retail and direct sales channels. As a result, we have committed significant resources to our e-commerce capabilities and the abilities of our distributorsmembers to take advantage of the internet. Substantially all of our sales take place via the internet. NHT Global offersWe offer a global web page that allows a distributormember to have a personalized replicating website through which he or she can sell products in all of the countries in which we do business. Links to these websites can be found at our main website for distributorsmembers atwww.nhtglobal.com. www.nhtglobal.com. The information provided on these websites should not be considered part of this report.

Rules Affecting Distributors

Members

Our distributormember policies and procedures establish the rules that distributorsmembers must follow in each market. We also monitor distributormember activity in an attempt to provide our distributorsmembers with a “level playing field” so that one distributormember may not be disadvantaged by the activities of another. We require our distributorsmembers to present products and business opportunities in an ethical and professional manner. DistributorsMembers further agree that their presentations to customers must be consistent with, and limited to, the product claims and representations made in our literature.

We require

Our policies and procedures state that we produce or pre-approve all sales aids used by distributorsmembers such as presentations videotapes, audiotapes, brochures and promotional clothing. Further, distributorsmembers may not use any form of media advertising to promote products unless it is pre-approved by us. Products may be promoted only by personal contact or by literature produced or approved by us. DistributorsMembers are not entitled to use our trademarks or other intellectual property without our prior consent.

Our compliance and member services department reviews reports of alleged distributormember misbehavior. If we determine that a distributormember has violated our distributormember policies or procedures, we may terminate the distributor’smember’s rights completely. Alternatively, we may impose sanctions, such as warnings, probation, withdrawal or denial of an award, suspension of privileges of the distributorship,membership, fines, withholding commissions, until specified conditions are satisfied or other appropriate injunctive relief. Our distributorsmembers are independent contractors, not employees, and may act independently of us. Further, our distributorsmembers may resign or terminate their distributorshipmembership at any time without notice. See “Item 1A. Risk Factors.”


Government Regulations

Direct Selling Activities

Direct selling, or multi-level marketing, activities are regulated by various federal, state and local governmental agencies in the United States and other countries. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants for recruiting additional participants irrespective of product sales, use high-pressure recruiting methods and/or do not involve legitimate products.schemes. The laws and regulations in our current markets often:

impose cancellation/product return, inventory buy-backs and cooling-off rights for consumers and distributors;

require us or our distributors to register with governmental agencies;

impose reporting requirements; and

impose upon us requirements, such as requiring distributors to maintain levels of retail sales to qualify to receive commissions, to ensure that distributors are being compensated for sales of products and not for recruiting new distributors.

 

impose cancellation/product return, inventory buy-backs and cooling-off rights for consumers and members;

require us or our members to obtain a license from, or register with, governmental agencies;

impose reporting requirements; and

impose upon us requirements, such as requiring members to maintain levels of retail sales to qualify to receive commissions, to ensure that members are being compensated for sales of products and not for recruiting new members.
The laws and regulations governing direct selling are modified from time to time, and, like other direct selling companies, we aremay be subject from time to time to government reviews, examinations or investigations in our various markets related to our direct selling activities. This can require us to make changes to our business model and aspects of our global compensation plan in the markets impacted by such changes and investigations.

examinations.

Based on advice of our engaged outside professionals in existing markets, the nature and scope of inquiries from government regulatory authorities and our history of operations in those markets to date, we believe our method of distribution complies in all material respects with the laws and regulations related to direct selling of the countries in which we currently operate.

As a result of restrictions in China on direct selling activities, we are not conducting direct selling in China. Consumers and members purchase the Company’s products via our Hong Kong-based web site or our e-commerce platform in China. The regulatory environment in China is complex. Because we operate a direct selling model outside of China, our operations in China have attracted constant and significant regulatory and media scrutiny.


At the end of 2005, China adopted new direct selling and anti-pyramiding regulations that are restrictive and contain various limitations, including a restriction on the ability to pay multi-level compensation to independent distributors. Regulationsmembers. We are subject to discretionary interpretation by municipal and provincial level regulators. Interpretations of what constitutes permissible activities by regulators can vary from province to province and can change from time to time because of the lack of clearly defined rules regardingnot conducting direct selling activities.

Because of thein China. Rather, consumers and members purchase our products via our Hong Kong-based website or our e-commerce retail platform in China. The regulatory environment in China is complex, and our operations in China can receive regulatory and media attention.

The Chinese government’s significant concerns about direct selling activities and its adoption of direct selling and anti-pyramiding regulations, itgovernment scrutinizes very closely activities of direct selling companies. Our business continues to be subject to reviewsregulations and investigationsexaminations by municipal and provincial level regulators. At times, investigations and related actions by government regulators have caused an obstruction toimpacted our members’ activities in certain locations, and have resulted in a few cases of enforcement actions. In each of these cases, we helped our members with their defense in the legality of their conduct. So far, no material changes to our business model have been required. We expect to receive continued guidance and direction as we work with regulators to address our business model and any changes that need to be made to comply with the direct selling regulations.

To augment

We believe that neither our businessHong Kong-based website nor our e-commerce platform in China our Chinese subsidiary appliedrequire a direct selling license in China, which we currently do not hold. We have previously sought to obtain a direct selling license, and in August 2015 initiated the process for submitting a new preliminary application for a direct selling license first in 2005, providedChina. If we are able to obtain a revised versiondirect selling license in June 2006, and then updated againChina, we believe that the incentives inherent in the direct selling model in China would incrementally benefit our applicationexisting business. Increased sales in November 2007. AfterChina that could be derived from obtaining a direct selling license may be partially offset by the approval from the municipal and the provincial authorities, the application did not progress furtherhigher fixed costs associated with the central government.  Eventually, the information containedestablishment and maintenance of required service centers and branch offices. We are unable to predict whether and when we will be successful in our most recent application became staleobtaining a direct selling license to operate in China, and if we withdrew the license application in February 2009 with the intention of filing an updated application in the future.

are successful, when we will be permitted to conduct direct selling operations and whether such operations would be profitable.

Regulation of Our Products

Our products and related promotional and marketing activities are subject to extensive governmental regulation by numerous governmental agencies and authorities in the United States, including theU.S.the U.S. Food and Drug Administration (the “FDA”), the Federal Trade Commission (the “FTC”), the Consumer Product Safety Commission, the United States Department of Agriculture, State Attorneys General and other state regulatory agencies.  In our foreign markets, the products are generally regulated by similar government agencies.


Our personal care products are subject to various laws and regulations that regulate cosmetic products and set forth regulations for determining whether a product can be marketed as a “cosmetic” or requires further approval as an over-the-counter (OTC) drug. In the United States, regulation of cosmetics is under the jurisdiction of the FDA.  The Food, Drug and Cosmetic Act defines cosmetics by their intended use, as “articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body . . . for cleansing, beautifying, promoting attractiveness, or altering the appearance.”  Among the products included in this definition are skin moisturizers, eye and facial makeup preparations, perfumes, lipsticks, fingernail polishes, shampoos, permanent waves, hair colors, toothpastes and deodorants, as well as any material intended for use as a component of a cosmetic product.  Conversely, a product will not be considered a cosmetic, but may be considered a drug if it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or is intended to affect the structure or any function of the body. A product’s intended use can be inferred from marketing or product claims.  The other markets in which we operate have similar regulations.  In Japan, the Ministry of Health, Labour and Welfare regulates the sale and distribution of cosmetics and requires us to have an import business license and to register each personal care product imported into Japan.  In Taiwan, all “medicated” cosmetic products require registration.  In China, personal care products are placed into one of two categories, “general” and “drug.”  Products in both categories require submission of formulas and other information with the health authorities, and drug products require human clinical studies.  The product registration process in China for these products can take from nine to more than 18 months or longer.  Such regulations in any given market can limit our ability to import products and can delay product launches as we go through the registration and approval process for those products.  The sale of cosmetic products is regulated in the European Union under the European Union Cosmetics Directive, which requires a uniform application for foreign companies making personal care product sales.

 

The markets in which we operate all have varied regulations that distinguish foods and nutritional health supplements from “drugs” or “pharmaceutical products.”  Because of the varied regulations, some products or ingredients that are recognized as a “food” in certain markets may be treated as a “pharmaceutical” in other markets.  These regulations may require us to either modify a product or refrain from selling the product in a given market. As a result, we must oftenregularly modify the ingredients and/or the levels of ingredients in our products for certain markets.  In some circumstances, the regulations in foreign markets may require us to obtain regulatory approval prior to introduction of a new product or limit our uses of certain ingredients altogether. Because of negative publicity associated with some supplements, thereThere has been an increased movement in the United States and other markets to expand the regulation of dietary supplements, whichsupplements. This could impose additional restrictions or requirements in the future.  In general, theBecause of this increased regulatory environment is becoming more complexfocus, our internal review efforts have been enhanced in order to comply with increasingly strictour understanding of current regulations.
FDA regulations each year.

Effective June 2008, the FDA established regulations to require current good manufacturing practices (cGMP) for dietary supplements.  The regulations ensure that dietary supplements are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled. The regulations include requirements for establishing quality control procedures for us and our vendors and suppliers, designing and constructing manufacturing plants, and testing ingredients and finished products.  The regulations also include requirements for record keeping and handling consumer product complaints.  If dietary supplements contain contaminants or do not contain the type or quantity of dietary ingredient they are represented to contain, the FDA would consider those products to be adulterated or misbranded.  

Our business is subject to additional FDA regulations, such as those implementing an adverse event reporting system (“AER’s”) effective December 2007,, which requires us to document and track adverse events and report serious adverse events, which are events involving hospitalization or death, associated with consumers’ use of our products.  

Most of our major markets also regulate advertising and product claims regarding the efficacy of products. This is particularly true with respect to our dietary supplements because we typically market them as foods or health foods. For example, in the United States, we are unable to claim that any of our nutritional supplements will diagnose, cure, mitigate, treat or prevent disease. In the United States, the Dietary Supplement Health and Education Act, however, permits substantiated, truthful and non-misleading statements of nutritional support to be made in labeling, such as statements describing general well-being resulting from consumption of a dietary ingredient or the role of a nutrient or dietary ingredient in affecting or maintaining a structure or a function of the body. Most of the other markets in which we operate have not adopted similar legislation, although we may be subject to more restrictive limitations on the claims we can make about our products in these markets.

Other Regulatory Issues

As a United States entity operating through subsidiaries in foreign jurisdictions, we are subject to foreign exchange control, transfer pricing and custom laws that regulate the flow of funds between our subsidiaries and us for product purchases, management services and contractual obligations, such as the payment of distributormember commissions. As is the case with most companies that operate in our product categories, we might receive inquiries from time to time from government regulatory authorities regarding the nature of our business and other issues, such as compliance with local direct selling, transfer pricing, customs, taxation, foreign exchange control, securities and other laws.


Product Warranties and Returns

NHT Global

Our refund policies and procedures closely follow industry and country-specific standards, which vary greatly by country. For example, in the United States, the Direct Selling Association recommends that direct sellers permit returns during the twelve-month period following the sale, while in Hong Kong the standard return policy is 14 days following the sale. Our return policies typically conform to local laws or the recommendation of the local direct selling association. In most cases, distributorsmembers who timely return unopened product that is in resalable condition may receive a refund. The amount of the refund may be dependent on the country in which the sale occurred, the timeliness of the return, and any applicable re-stocking fee. NHT Global must be notified of the return in writing and such written requests would be considered a termination notice of the distributorship. From time to time, wemembership. We may alter our return policy in response to special circumstances.

 
Significant Customers

Sales are made to our members and no single customer accounted for 10% or more of our net sales. However, our business model can result in a concentration of sales to several different members and their network of members. Although no single member accounted for 10% or more of net sales, the loss of a key member or that member’s network could have an adverse effect on our net sales and financial results.

Our Industry

We are engaged in the direct selling industry, selling wellness, herbal, beauty, lifestyle enhancement products, cosmetics, personal care and dietary supplements.home products. More specifically, we are engaged in what is called network marketing or multi-level marketing. This type of organizational structure and approach to marketing and sales include companies selling lifestyle enhancement products, cosmetics and dietary supplements, or selling other types of consumer products. Generally, direct selling is based upon an organizational structure in which independent distributors ofmembers purchasing a company’s products are compensated for sales made directly to consumers.

NHT Global distributors

Our members are compensated based on sales generated by distributorsmembers they have recruitedenrolled and all subsequent distributors recruitedmembers enrolled by their "down-line"“down-line” network of distributors.members. The experience of the direct selling industry has been that once a sizeable network of distributorsmembers is established, new and alternative products and services can be offered to those distributorsmembers for sale to consumers and additional distributors.

members.

Competition

We compete

The network marketing industry is very diverse, with a significant number of other retailers that are engaged in similar lines of business, including sellers of health-related products and othergiant multinational corporations as well as smaller, local operators. Big network marketing companies such asinclude Nu Skin Enterprises, Inc., USANA Health Sciences, Inc., Mannatech, Inc., Reliv’ International, Inc, and Herbalife, Ltd. Many of our competitorsLtd, which have much greater name recognition and financial resources than we do and also have many more distributors. Amembers. They are publicly traded and therefore serve as informational benchmarks, but we don’t overlap with them in terms of marketplace or product range. On the other hand, many medium- and small-sized privately held Chinese, Taiwanese and Hong Kong companies are fierce competitors and are much closer to directly competing with us. Also, a number of our former employees and distributorsmembers now work for competitors, and sometimes try to use relationships and knowledge obtained with us to compete with us.

Our ability to compete with other network marketing companies depends, in significant part, on our success in attracting and retaining distributors.members.  There can be no assurance that our programs for attracting and retaining distributorsmembers will be successful.  The pool of individuals interested in network marketing is limited in each market and is reduced to the extent other network marketing companies successfully attract these individuals into their businesses.  Although we believe that we offer an attractive opportunity for our distributors,members, there can be no assurance that other network marketing companies will not be able to recruit our existing distributorsmembers or deplete the pool of potential distributorsmembers in a given market.

The direct selling channel tends to sell products at a higher price compared to traditional retailers, which poses a degree of competitive risk. There is no assurance that we would continue to compete effectively against retail stores, internet-based retailers or other direct sellers.

Item 1A. RISK FACTORS


We are exposed to a variety of risks that are present in our business and industry. The following are some of the more significant factors that could affect our business, results of operations and financial condition.

We may experience substantial negative cash flows, which may have a significant adverse effect on our business and could threaten our solvency.

We experienced substantial negative cash flows during the years ended December 31, 2008 and 2009, primarily due to declines in our revenues greater than the decreases in expenditures we could manage.  If we again experience negative cash flows, any resulting decreasing cash balance could impair our ability to support our operations and, eventually, threaten our solvency, which would have a material adverse effect on our business, results of operations and financial condition, as well as our stock price.  Negative cash flows and the related adverse market perception associated therewith may have negatively affected, and may in the future negatively affect, our ability to attract new distributors and/or sell our products.  There can be no assurance that we will be successful in maintaining an adequate level of cash resources and we could be forced to act more aggressively in the area of expense reduction in order to conserve cash resources as we look for alternative solutions.

If we experience negative cash flows, we may need to seek additional debt or equity financing, which may not be available on acceptable terms or at all.  If available, it could have a highly dilutive effect on the holdings of existing stockholders.

Unless we are able to at least maintain revenues, control expenses and achieve positive cash flows, our ability to support our obligations could be impaired and our liquidity could be adversely affected and our solvency and our ability to repay our debts when they come due could be threatened.  We may need to seek additional debt or equity financing on acceptable terms in order to improve our liquidity.  However, we may not be able to obtain additional debt or equity financing on satisfactory terms, or at all, and any new financing could have a dilutive effect to our existing stockholders.

 

The anti-dilution provisions of warrants to purchase 1,375,952 shares of our common stock would, if triggered, cause substantial dilution and may, therefore, make it particularly difficult to obtain new equity financing.  The warrants were originally issued under a Securities Purchase Agreement dated October 19, 2007.  The warrants have an exercise price of $3.52 per share, subject to certain anti-dilution provisions that reduce the exercise price and increase the number of shares underlying the warrants if we issue common stock or equivalent securities below the exercise price for the warrants (with certain transactions exempted).  These warrants expire on April 21, 2015.

We could be adversely affected by management changes or an inability to attract and retain key management, directors and consultants.

We incur a low level of overhead and are run by a small number of executives, who rely on a small group of employees. Our future success depends to a significant degree on the skills, experience and efforts of our top management and directors.  We also depend on the ability of our executive officers and other members of senior management to work effectively as a team.  The loss of one or more of our executive officers, members of our senior management or directors could have a material adverse effect on our business, results of operations and financial condition.  Moreover, as our business evolves, we may require additional or different management members, directors or consultants, and there can be no assurance that we will be able to locate, attract and retain them if and when they are needed.



Because our Hong Kong operations account for a majoritysubstantial portion of our overall business, and mostsubstantially all of our Hong Kong business is derived from the sale of products to members in China, any material adverse change in our business relating to either Hong Kong or China would likely have a material adverse impact on our overall business.

In 20122016, 2015 and 2013,2014, approximately 70%92%, 93% and 77%89% of our revenue, respectively, was generated in Hong Kong. MostSubstantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. This geographic concentration in our business means that events or conditions that could negatively impact this geographic region or our operations in this region would have a greater adverse impact upon our overall business and financial results than would be the case with a company having greater geographic diversification.


Our operations in China are subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations of those laws or government actions otherwise directed at us could have a material adverse impact on our business and the value of our company.

In contrast to our operations in other parts of the world, we have not implemented a direct sales model in China. The Chinese government permits direct selling only by organizations that have a license, thatwhich we do not have,are in the process of applying for, and has also adopted anti-multilevel marketing legislation. We operate an e-commerce direct selling model in Hong Kong and recognize the revenue derived from sales to both Hong Kong and Chinese members as being generated in Hong Kong. Products purchased by members in China are delivered by us to one or more third parties that act as the importers of record under agreements to pay applicable duties.  In addition, through a Chinese entity, we sell products in China using an e-commerce retail model. The Chinese entity operates separately from the Hong Kong entity, althoughand a Chinese member may elect to participate separately or in both.

We

After consulting with outside professionals, we believe that theour e-commerce direct selling model in Hong Kong does not violate any applicable laws and regulations in China, regarding direct selling and multi-level marketing are not specifically applicable toeven though it is used for the internet purchase of our Hong Kong based e-commerce activity, andproducts by members in China. We also believe that our Chinese entity, including its e-commerce retail platform, is operating in compliance with applicable Chinese laws. However, there can be no assurance that the Chinese authorities will agree with our interpretations of applicable laws and regulations or that China will not adopt new laws or regulations. Should the Chinese government determine that our e-commerce activity violatesactivities violate China’s direct selling or anti-multilevel marketing legislation, or should new laws or regulations be adopted, there could be a material adverse effect on our business, financial condition and results of operations.

Because of

The Chinese government scrutinizes the Chinese government’s significant concerns about direct selling activities, it scrutinizes very closely activities of direct selling companies. Our business continues to be subject to regulations and examinations by municipal and provincial level regulators. At times, investigations and related actions by government regulators have impacted our members’ activities in certain locations and have resulted in a few cases where we have paid substantial fines.of enforcement actions. In each of these cases, we have been allowed to recommence operations afterhelped our members with their defense of the government’s investigation,legality of their conduct, and no material changes to our business model were requiredrequired.
However, our business operations and the value of our company can be adversely affected by Chinese government scrutiny of our operations, even if that scrutiny does not result in connection with these finesinvestigations of our operations. For example, one or more parties encouraged the Beijing City governmental authorities to conduct an investigation of our business, which resulted in a meeting in January 2016 involving members of our Beijing office staff, Beijing City governmental officials, and impediments.

two complainants. Even though the Beijing City governmental officials advised our staff and the complainants at that meeting that there was insufficient evidence to warrant an investigation of us, gross mischaracterizations of the meeting immediately appeared in several “news reports.” Similarly, a subsequent meeting between several Guangzhou City government officials and members of our Guangzhou office staff that resulted in our providing routine information about our operations to the government officials was also grossly mischaracterized in an online posting made immediately following the meeting. Although we attemptremain in regular contact with Chinese government officials and take other steps to work closely with both national and local Chinese governmental agencies in conductingaddress the risks posed by these events, our business and the value of our effortscompany remain vulnerable to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violationsChinese government scrutiny of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, and activities by individual distributors that may violate laws notwithstanding our strict policies prohibiting such activities. Any determination that our operations, whether or activities, or the activities of our individual distributors or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on our future ability to obtain business licenses or expand into new locations, changes to our business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm our business, financial condition and results of operations.

initiated by third parties.


Various other factors could harm our business in Hong Kong and China, such as worsening economic conditions in Hong Kong or China, adverse local publicity or other events that may be out of our control.  For example, we were advised to voluntarily suspend marketing activities in China during the third quarter of 2007 when the Chinese government was expected to impose a more intense enforcement program against illegal chain sales activities.  We did not want to run the risk of being inadvertently entangled in the government enforcement actions and voluntarily withdrew all marketing activities from China during that period.  It may be necessary or advisable to repeat this or similar actions from time to time in the future, and such periods of reduced activity could have a material adverse effect on our business.



Although we attempt to work closely with both national and local Chinese governmental agencies in conducting our business, our efforts to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violations of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, and activities by individual members that may violate laws notwithstanding our strict policies prohibiting such activities. Any determination that our operations or activities, or the activities of our individual members or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on our future ability to obtain business licenses or expand into new locations, changes to our business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm our business, financial condition and results of operations. 

Our failure to maintain and expand our distributormember relationships could adversely affect our business.

We distribute our products through independent distributors,members, and we depend upon them directly for all of our sales in most of our markets. Accordingly, our success depends in significant part upon our ability to attract, retain and motivate a large base of distributors.members. Our direct selling organization is headed by a relatively small number of key distributors.members. The loss of a significant number of distributors, especiallymembers, or the loss of one or more key distributors,members, could materially and adversely affect sales of our products and could impair our ability to attract new distributors.members. Moreover, the replacement of distributorsmembers could be difficult because, in our efforts to attract and retain distributors,members, we compete with other direct selling organizations, including but not limited to those in the personal care, cosmetic product and nutritional supplement industries. Our distributorsmembers may terminate their services with us at any time and, in fact, like most direct selling organizations, we have a high rate of attrition.


The number of active distributorsmembers or their productivity may not increase and could decline in the future.  We cannot accurately predict any fluctuation in the number and productivity of distributorsmembers because we primarily rely upon existing distributorsmembers to sponsorenroll and train new distributorsmembers and to motivate new and existing distributors.members. Operating results could be adversely affected if our existing and new business opportunities and products do not generate sufficient economic incentive or interest to retain existing distributorsmembers and to attract new distributors.

members.

The number and productivity of our distributorsmembers could be harmed by several factors, including:

adverse publicity or negative perceptions regarding us, our products, our method of distribution or our competitors;


adverse publicity or negative perceptions regarding us, our products, our method of distribution or our competitors;

lack of interest in, or the technical failure of, existing or new products;

lack of interest in, or the technical failure of, existing or new products;

lack of interest in our existing compensation plan for distributors or in enhancements or other changes to that compensation plan;

our actions to enforce our policies and procedures;

regulatory actions or charges or private actions against us or others in our industry;

general economic and business conditions;

changes in management or the loss of one or more key distributor leaders;

entry of new competitors, or new products or compensation plan enhancements by existing competitors, in our markets; and

potential saturation or maturity levels in a given country or market which could negatively impact our ability to attract and retain distributors in such market.

The high level of competition in our industryexisting compensation plan for members or in enhancements or other changes to that compensation plan;


our actions to enforce our policies and procedures;

regulatory actions or charges or private actions against us or others in our industry;

general economic and business conditions;

changes in management or the loss of one or more key member leaders;

entry of new competitors, or new products or compensation plan enhancements by existing competitors, in our markets; and

potential saturation or maturity levels in a given country or market which could negatively impact our ability to attract and retain members in such market.


We are currently being sued in three lawsuits alleging, among other things, that we made materially false and misleading statements regarding the legality of our business operations in China.

We, together with our executive officers, have been named as defendants in three complaints (one of which also names our directors as defendants) relating to alleged materially false and misleading statements regarding the legality of our business operations in China, among other things. These complaints seek an indeterminate amount of damages, and one of the complaints also seeks various equitable remedies. Notwithstanding potentially applicable insurance coverage, these complaints, or others filed alleging similar facts, could result in monetary or other penalties that may adversely affect our business.

Theoperating results and financial condition. Moreover, the negative publicity stemming from these complaints and the allegations they make could harm our business of marketing personal care, cosmetic, nutritional supplements, and lifestyle enhancement products is highly competitive.  This market segment includes numerous manufacturers, distributors, marketers, and retailers that actively compete foroperations. Accordingly, any adverse determination against us in these suits, or even the business of consumers bothallegations contained in the United Statessuits regardless of whether they are ultimately found to be without merit, could harm our business, operations and abroad.  The market is highly sensitivefinancial condition.


We are currently involved in, and may in the future face, litigation claims and governmental proceedings and inquiries that could harm our business.
We are currently, and have in the past, been a party to lawsuits, claims and governmental proceedings and inquiries.  Prosecuting and defending these matters may require significant expense and attention of our management.  There can be no assurance that we will be able to successfully defend or resolve any such litigation, claims or governmental proceedings or inquiries, or that the introduction of new products, which may rapidly capture a significant share of the market.  Sales of similar products by competitors may materiallymoney, time and effort spent in defending these matters will not adversely affect our business, financial condition and results of operations.

We


Although our members are subject to significant competition for the recruitment of distributors from other direct selling organizations, including thoseindependent contractors, improper member actions that market similar products.  Many ofviolate laws or regulations could harm our competitorsbusiness.
Our members are substantially larger thanindependent contractors and, accordingly, we are offernot in a wider array of products, have far greater financial resourcesposition to directly provide the same direction, motivation and many more active distributors thanoversight as we have.  Our ability to remain competitive depends, in significant part, onwould if members were our success in recruiting and retaining distributors with our products, attractive compensation plan and other incentives.  We believe that we have an attractive product line and that our compensation and incentive programs provide our distributors with significant earning potential.  However, we cannot be sure that our programs for recruitment and retention of distributors would be successful.

Some of our competitors have employed or otherwise contracted for the services of our former officers, employees, consultants, and distributors, who may try to use information and contacts obtained while under contract with us for competitive advantage.  While we seek to protect our information through contractual and other means,own employees.  As a result, there can be no assurance that weour members will timely learn of such activity, have the resources to attempt to stop it,participate in our marketing strategies or have adequate remedies available to us.


An increase in the amount of compensation paid to distributors would reduce profitability.

A significant expense is the payment of compensation toplans, accept our distributors, which represented approximately 42% and 46% of net sales during 2012 and 2013, respectively.  We compensate our distributors by paying commissions, bonuses, and certain awards and prizes.  Factors impacting the overall commission payout include the growth and depth of the distributor network, the distributor retention rate, the level of promotions, local promotional programs and business development agreements.  Any increase in compensation payments to distributors as a percentage of net sales will reduce our profitability.

Our compensation plan includes a cap that may be enforced on distributor compensation paid out as a percentage of product sales.  There can be no assurance that enforcement of this cap will ensure profitability (which depends on many other factors).  Moreover, enforcement of this cap could cause key distributors affected by the cap to leave and join other companies.

Failureintroduction of new products, or comply with our member policies and procedures.  Extensive federal, state, local and foreign laws regulate our business, our products and our network marketing program.  Because we have expanded into foreign countries, our policies and procedures for our members differ due to the different legal requirements of each country in which we do business.  While we have implemented member policies and procedures designed to govern member conduct and to protect the goodwill associated with our trademarks and trade names, it can be difficult to enforce these policies and procedures because of the large number of members and their independent status.  

Given the size and diversity of our member force, we experience problems with members from time to time, especially with respect to our members in foreign markets. For example, if our members engage in illegal activities in China, those actions could be attributed to us. Chinese laws regarding how and when members may assemble and the activities that they may conduct, or the conditions under which the activities may be conducted, are subject to interpretations and enforcement that sometimes vary from province to province, among different levels of government, and from time to time. Members can be accused of violating one or more of the laws regulating these activities, notwithstanding training that we attempt to provide. Enforcement measures regarding these violations, which can include arrests, raise the uncertainty and perceived risk associated with conducting this business, especially among those who are aware of the enforcement actions but not the specific activities leading to the enforcement action. We believe that this has led some existing members in China - who are signed up as members in Hong Kong - to leave the business or curtail their selling activities and has led some potential members to choose not to participate. Among other things, we are managing this risk with more training and public relations efforts that are designed, among other things, to distinguish our company from businesses that make no attempt to comply with the law. This environment creates uncertainty about the future of doing this type of business in China generally and under our business model, specifically.

In addition, members often desire to enter a market before we have received approval to do business in order to gain distributoran advantage in the marketplace.  Improper member activity in new geographic markets could result in adverse publicity and market acceptance could harm our business.

An important component of our business iscan be particularly harmful to our ability to develop newultimately enter these markets.  Violations by our members of applicable law or of our policies and procedures in dealing with customers could reflect negatively on our products and operations, and harm our business reputation.  In addition, it is possible that create enthusiasm amonga judicial or administrative body could hold us civilly or criminally accountable based on vicarious liability because of the actions of our distributor force.members.  If we fail to introduce new products on a timely basis,any of the above or related events involving our distributor productivitymembers occur, our business, financial condition, or results of operations could be harmed.  In addition, if any new products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, this would harm our results of operations.  Factors that could affect our ability to continue to introduce new products include, among others, limited capital and human resources, government regulations, proprietary protections of competitors that may limit our ability to offer comparable products and any failure to anticipate changes in consumer tastes and buying preferences.

materially adversely affected.


Direct-selling laws and regulations may prohibit or severely restrict our direct sales efforts and cause our revenue and profitability to decline, and regulators could adopt new regulations that harm our business.

Our direct selling system is subject to extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints.  These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants for recruiting additional participants irrespective of product sales, use high pressure recruiting methods and/or do not involve legitimate products.

They also seek to ensure that claims regarding the ability of participants to earn money are truthful and substantiated.

Complying with these widely varying and sometimes inconsistent rules and regulations can be difficult and may require the devotion of significant resources on our part.  There can be no assurance that we or our distributorsmembers are in compliance with all of these regulations.  Our failure or our distributors’members’ failure to comply with these regulations or new regulations could lead to the imposition of significant penalties or claims and could negatively impact our business.  If we are unable to continue business in existing markets or commence operations in new markets because of these laws, our revenue and profitability may decline.

We are also subject to the risk that new laws or regulations might be implemented or that current laws or regulations might change, which could require us to change or modify the way we conduct our business in certain markets.  This could be particularly detrimental to us if we have to change or modify the way we conduct business in markets that represent a significant percentage of our revenue.  For example,

The high level of competition in our industry could adversely affect our business.
The business of marketing personal care, cosmetic, nutritional supplements, and lifestyle enhancement products is highly competitive.  This market segment includes numerous manufacturers, members, marketers, and retailers that actively compete for the Federal Trade Commission (the “FTC”) released a proposed New Business Opportunity Rulebusiness of consumers both in April 2006.  As initially drafted, the proposed rule would have required pre-sale disclosures for all business opportunities,United States and abroad.  The market is highly sensitive to the introduction of new products, which may rapidly capture a significant share of the market.  Sales of similar products by competitors may materially and adversely affect our business, financial condition and results of operations.
We are subject to significant competition for the recruitment of members from other direct selling organizations, including those that market similar products.  Many of our competitors are substantially larger than we are, offer a wider array of products, have included network marketing compensation plans such as ours.  However, in November 2011, the FTC issued a final rule that does not apply to multi-level marketingfar greater financial resources and many more active members than we have.  Even more numerous are those medium- and small-sized, all privately held Chinese, Taiwanese and Hong Kong companies that do not representare fierce competitors and are much closer to directly competing with us. Our ability to remain competitive depends, in significant part, on our success in recruiting and retaining members with our products, attractive compensation plan and other incentives.  We believe that theywe have an attractive product line and that our compensation and incentive programs provide our members with significant earning potential.  However, we cannot be sure that our programs for recruitment and retention of members will be successful.
Some of our competitors have employed or another designated person will do any of the following:  (a) provide locationsotherwise contracted for the operationservices of equipment, displays, vending machinesour former officers, employees, consultants, and members, who may try to use information and contacts obtained while under contract with us for competitive advantage.  While we seek to protect our information through contractual and other means, there can be no assurance that we will timely learn of such activity, have the resources to attempt to stop it, or similar devices owned, leased, controlled or paid for by the purchaser of the opportunity; (b) provide outlets, accounts, or customers (including but not limitedhave adequate remedies available to internet outlets, accounts, or customers) for the purchaser’s goods or services (advertising and general advice about business development and training is not considered as “providing locations, outlets, accounts, or customers”); or (c) buy back any or all of the goods or services that the purchaser makes or provides.  As we understand the final regulation, the Company does not make any of these representations and therefore is not covered by the final rule, which took effect on March 1, 2012.

us.

Challenges by third parties to the formlegality of our business modeloperations could harm our business.


We are also subject to the risk of private party challenges to the legality of our operations, including our direct selling system.  The regulatory requirements concerning direct selling systems generally do not include “bright line” rules and are inherently fact-based and subject to judicial or administrative interpretation. An adverse judicial or administrative determination against us with respect to our direct selling system, or in proceedings not involving us directly but which challenge the legality of other direct selling marketing systems, could have a material adverse effect on our business.  There is also risk that challenges and settlements involving other parties could provide incentives for similar actions by distributorsmembers against us and other direct selling companies.  Moreover, challenges to our business system and operations in important markets may come from short sellers, hedge funds, other investors, bloggers and other investors.reporters.  Other companies in our industry have recently faced such challenges.  Any challenges regarding us or others in our industry could harm our business if such challenges result in the investigation of our business model and operations or the imposition of any fines or damages on our business, create adverse publicity, increase scrutiny or investigations of us or our industry, detrimentally affect our efforts to recruit or motivate distributorsmembers and attract customers, or interpret laws in a manner inconsistent with our current business practices.



An increase in the amount of compensation paid to members would reduce profitability.
 
A significant expense is the payment of compensation to our members, which represented approximately 44%, 48% and 46% of net sales during 2016, 2015 and 2014, respectively.  We compensate our members by paying commissions, bonuses, and certain awards and prizes.  Factors impacting the overall commission payout include the growth and depth of the member network, the member retention rate, the level of promotions, local promotional programs and business development agreements.  Any increase in compensation payments to members as a percentage of net sales will reduce our profitability.  

Our compensation plan includes a cap that may be enforced on member compensation paid out on a weekly dollar limit or as a percentage of product sales. There can be no assurance that enforcement of this cap will ensure profitability (which depends on many other factors).  Moreover, enforcement of this cap could cause key members affected by the cap to leave and join other companies.
Currency exchange rate fluctuations could lower our revenue and net income.
In 2016, 98% of our revenue was recorded by subsidiaries located outside of North America.  Revenue transactions and related commission payments, as well as other incurred expenses, are typically denominated in the local currency.  Accordingly, our international subsidiaries use the local currency as their functional currency.  The results of operations of our international subsidiaries are exposed to foreign currency exchange rate fluctuations during consolidation since we translate into U.S. dollars using the average exchanges rates for the period.  As exchange rates vary, revenue and other operating results may differ materially from our expectations.  Additionally, we may record significant gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of inter-company balances.  
Our most significant foreign exchange exposure, the Hong Kong dollar, is for now pegged to the U.S. dollar.  We also purchase a significant majority of inventories in U.S. dollars.  Our foreign currency exchange rate exposure to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble, Kazakhstani tenge, Singaporean dollar, Malaysian ringgit, Canadian dollar and European euro represented approximately 7%, 6% and 10% of our revenue in 2016, 2015 and 2014, respectively.  Our foreign currency exchange rate exposure may increase in the near future as we develop opportunities in Southeast Asia, Canada, Central America, South America and Europe.  Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar.  Finally, we also experience indirect exchange rate exposure due to the concentration of our sales in China and the recent performance of the Chinese yuan. Following the 2015 devaluation of the Chinese yuan, the Chinese yuan experienced depreciation against the Hong Kong dollar of 7% for the year ended December 31, 2016, the cumulative effect of which has been to erode our Chinese members’ purchasing power and, we believe, to adversely affect our product sales.

Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition.  Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.
Changes in tax or duty laws, and unanticipated tax or duty liabilities, could adversely affect our net income.
In the course of doing business we may be subject to various taxes, such as sales and use, value-added, and franchise. We are also subject to income taxes in the United States and numerous foreign jurisdictions. We earn a substantial portion of our income in foreign jurisdictions. If our capital or financing needs in the United States (including the repurchase of our stock and payment of dividends in the United States) require us to repatriate earnings from foreign jurisdictions, our effective income tax rates for the affected periods could be negatively impacted. Economic and political conditions make tax rules in any jurisdiction, including the United States, subject to significant change. There have been proposals to reform U.S. and foreign tax laws that could significantly impact how U.S. multinational corporations are taxed on foreign earnings. Although we cannot predict whether or in what form these proposals will pass, several of the proposals considered, if enacted into law, could have an adverse impact on our income tax expense and cash flows.
Our principal domicile is the United States. Under tax treaties, we are eligible to receive foreign tax credits in the United States for taxes paid abroad. Taxes paid to foreign taxing authorities may exceed the credits available to us, resulting in the payment of a higher overall effective tax rate on our worldwide operations.
Our effective income tax rate in the future could be adversely affected by a number of factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws, the outcome of income tax audits in various jurisdictions around the world, and any repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.

We may also be subject to examinations of our tax returns and other tax matters by the Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes, which is subject to significant discretion. There can be no assurance as to the outcome of these examinations. If our effective tax rates were to increase, particularly in the U.S., or if the ultimate determination of taxes owed is for an amount in excess of amounts previously accrued, our financial results or operations could be adversely affected.
In addition, our operations are subject to regulations designed to ensure that appropriate levels of customs duties are assessed on the importation of our products. The failure to properly calculate, report and pay such duties when we are subject to them could have a material adverse effect on our financial condition and results of operations. Any change in the laws or regulations regarding such duties, or any interpretation thereof, could result in an increase in the cost of doing business.

Transfer pricing regulations affect our business and results of operations.
In many countries, including the United States, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned by our United States or local entities and are taxed accordingly. We have adopted transfer pricing agreements with our subsidiaries to regulate inter-company transfers, which agreements are subject to transfer pricing laws that regulate the flow of funds between the subsidiaries and the parent corporation for product purchases, management services, and contractual obligations, such as the payment of member compensation. We believe that we operate in compliance with all applicable transfer pricing laws, and we intend to continue to operate in compliance with such laws. However, there can be no assurance that we will continue to be found to be operating in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may require changes in our operating procedures or otherwise may have a material adverse effect on our financial results or operations.

Our products and related activities are subject to extensive government regulation, which could delay, limit or prevent the sale of some of our products in some markets. 

The formulation, manufacturing, packaging, labeling, importation, advertising, distribution, sale and storage of certain of our products are subject to extensive regulation by various federal agencies, including the Food and Drug Administration (the “FDA”), the FTC, the Consumer Product Safety Commission and the United States Department of Agriculture and by various agencies of the states, localities and foreign countries in which our products are manufactured, distributed and sold.  For example, the FDA requires us and our suppliers to meet relevant current good manufacturing practice (cGMP) regulations for the preparation, packing and storage of foods and over-the-counter (OTC) drugs.  We are also now required to report serious adverse events associated with consumer use of certain of our products.  Other laws and regulations govern or restrict the claims that may be made about our products and the information that must be included and excluded on labels.

In markets outside the United States, prior to commencing operations or marketing new products, we may be required to obtain approvals, licenses, or certifications from a ministry of health or a comparable agency. Moreover, a foreign jurisdiction may pass laws that would prohibit the use of certain ingredients in their particular market.  Compliance with these regulations can create delays and added expense in introducing new products to certain markets.

Failure by our distributorsmembers or us to comply with those regulations could lead to the imposition of significant penalties or claims and could materially and adversely affect our business.  If we are not able to satisfy the various regulations, then we would have to cease sales of that product in that market.  In addition, the adoption of new regulations or changes in the interpretation of existing regulations may result in significant compliance costs or discontinuation of product sales and may adversely affect the marketing of our products, resulting in significant loss of revenues.

We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, could have on our business.  These potential effects could include, however, requirements for the reformulation of certain products to meet new standards, the recall or discontinuance of certain products, additional recordkeeping and reporting requirements, expanded documentation of the properties of certain products, expanded or different labeling, or additional scientific substantiation.  Any or all of these requirements could have a material adverse effect on our business, financial condition, or results of operations.



Failure of new products to gain member and market acceptance could harm our business.
An important component of our business is our ability to develop new products that create enthusiasm among our member force.  If we fail to introduce new products on a timely basis, our member productivity could be harmed.  In addition, if any new products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, this would harm our results of operations.  Factors that could affect our ability to continue to introduce new products include, among others, limited capital and human resources, government regulations, proprietary protections of competitors that may limit our ability to offer comparable products and any failure to anticipate changes in consumer tastes and buying preferences.
New regulations governing the marketing and sale of nutritional supplements could harm our business.

There has been an increasing movement in the United States and other markets to increase the regulation of dietary supplements, which could impose additional restrictions or requirements in the future.  In the United States, for example, some legislators and industry critics continue to push for increased regulatory authority by the FDA over nutritional supplements.  Our business could be harmed if more restrictive legislation is successfully introduced and adopted in the future.  In particular, the adoption of legislation requiring FDA approval of supplements or ingredients could delay or inhibit our ability to introduce new supplements.  We face similar pressures in our other markets.  In the United States effective December 1, 2009, the FTC approved revisions to its Guides Concerning the Use of Endorsements and Testimonials in Advertising (“Guides”) that require disclosure of material connections between an endorser and the company they are endorsing and do not allow marketing using atypical results.require the disclosure of typical results when these are different from those reported by the endorser.  The requirements and restrictions of the revised Guides may diminish the impact of our marketing efforts and negatively impact our sales results.  If we or our distributorsmembers fail to comply with these Guides, the FTC could bring an enforcement action against us and we could be fined and/or forced to alter our operations.  Our operations also could be harmed if new laws or regulations are enacted that restrict our ability to market or distribute nutritional supplements or impose additional burdens or requirements on nutritional supplement companies or require us to reformulate our products.

 

Regulations governing the production and marketing of our personal care products could harm our business.

Our personal care products are subject to various domestic and foreign laws and regulations that regulate cosmetic products and set forth regulations for determining whether a product can be marketed as a “cosmetic” or requires further approval as an over-the-counter drug.  A determination that our cosmetic products impact the structure or function of the human body, or improper marketing claims by our distributors,members, may lead to a determination that such products require pre-market approval as a drug.  Such regulations in any given market can limit our ability to import products and can delay product launches as we go through the registration and approval process for those products.  Furthermore, if we fail to comply with these regulations, we could face enforcement action against us and we could be fined, forced to alter or stop selling our products and/or required to adjust our operations.  Our operations also could be harmed if new laws or regulations are enacted that restrict our ability to market or distribute our personal care products or impose additional burdens or requirements on the contents of our personal care products or require us to reformulate our products.


If we are found not to be in compliance with good manufacturing practices our operations could be harmed.

FDA regulations

Regulations on good manufacturing practices and adverse event reporting requirements for the nutritional supplement industry are in effect and require good manufacturing processes for us and our vendors, including stringent vendor qualifications, ingredient identification, manufacturing controls and record keeping.   We are also now required to report serious adverse events associated with consumer use of our products.  Our operations could be harmed if regulatory authorities make determinations that we or our vendors are not in compliance with the new regulations.  A finding of noncompliance may result in administrative warnings, penalties or actions impacting our ability to continue selling certain of our products.  In addition, compliance with these regulations has increased and may further increase the cost of manufacturing certain of our products as we work with our vendors to assure they are qualified and in compliance.

Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm our business.

Our failure to comply with FTC or state regulations, or with regulations in foreign markets that cover our product claims and advertising, including direct claims and advertising by us, as well as claims and advertising by distributorsmembers for which we may be held responsible, may result in enforcement actions and imposition of penalties or otherwise materially and adversely affect the distribution and sale of our products.  DistributorMember activities in our existing markets that violate applicable governmental laws or regulations could result in governmental or private actions against us in markets where we operate.  Given the size of our distributormember force, we cannot ensure that our distributors wouldmembers will comply with applicable legal requirements.

Although our distributors are independent contractors, improper distributor actions that violate laws or regulations could harm our business.

Our distributors are independent contractors and, accordingly, we are not in a position to directly provide the same direction, motivation and oversight as we would if distributors were our own employees.  As a result, there can be no assurance that our distributors will participate in our marketing strategies or plans, accept our introduction of new products, or comply with our distributor policies and procedures.  Extensive federal, state and local laws regulate our business, our products and our network marketing program.  Because we have expanded into foreign countries, our policies and procedures for our distributors differ due to the different legal requirements of each country in which we do business.  While we have implemented distributor policies and procedures designed to govern distributor conduct and to protect the goodwill associated with our trademarks and trade names, it can be difficult to enforce these policies and procedures because of the large number of distributors and their independent status.  Given the size and diversity of our distributor force, we experience problems with distributors from time to time, especially with respect to our distributors in foreign markets.  Distributors often desire to enter a market, before we have received approval to do business, to gain an advantage in the marketplace.  Improper distributor activity in new geographic markets could result in adverse publicity and can be particularly harmful to our ability to ultimately enter these markets.  Violations by our distributors of applicable law or of our policies and procedures in dealing with customers could reflect negatively on our products and operations, and harm our business reputation.  In addition, it is possible that a court could hold us civilly or criminally accountable based on vicarious liability because of the actions of our distributors.  If any of these events occur, our business, financial condition, or results of operations could be materially adversely affected.


Adverse publicity associated with our products, ingredients or network marketing program, or those of similar companies, could harm our financial condition and operating results.

Adverse publicity concerning any actual or claimed failure by us or our distributorsmembers to comply with applicable laws and regulations regarding product claims and advertising, good manufacturing practices, the regulation of our network marketing program, the licensing of our products for sale in our target markets or other aspects of our business, whether or not resulting in enforcement actions or the imposition of penalties, could have an adverse effect on our goodwill and could negatively affect our ability to attract, motivate and retain distributors,members, which would negatively impact our ability to generate revenue.  We cannot ensure that all distributorsmembers will comply with applicable legal requirements relating to the advertising, labeling, licensing or distribution of our products.

 

In addition, our distributors’members’ and consumers’ perception of the safety and quality of our products and ingredients, as well as similar products and ingredients distributed by other companies, can be significantly influenced by national media attention, publicized scientific research or findings, widespread product liability claims and other publicity concerning our products or ingredients or similar products and ingredients distributed by other companies.  Adverse publicity, whether or not accurate or resulting from consumers’ use or misuse of our products, that associates consumption of our products or ingredients or any similar products or ingredients with illness or other adverse effects, questions the benefits of our or similar products or claims that any such products are ineffective, inappropriately labeled or have inaccurate instructions as to their use, could negatively impact our reputation or the market demand for our products.


We are subject to risks relating to product concentration and lack of revenue diversification.
Although we have a limited product line.

We offer a limited numberin recent years expanded our line of products, under our NHT Global brand.  Our Premium Noni Juice™ and Alura™ products each account for a significant portionwe derive more than 10% of our total revenue and, together, account for a majorityfrom each of our total revenue.Premium Noni Juice and Enhanced Essential Probiotics® products. Further, we currently source each such product from a single supplier. If demand for these products decreases significantly, government regulation restricts thetheir sale, of these products, we are unable to adequately source (we currently source each from single suppliers) or deliver thesethe products, or we cease offering any of theseare unable to offer the products for any reason without a suitable replacement,replacements, our business, financial condition and results of operations could be materially and adversely affected.

Our future success will also depend on our ability to reduce our dependence on these few products by developing and introducing new products and product or feature enhancements in a timely manner. Even if we are able to develop and commercially introduce new products and enhancements, they may not achieve market acceptance and the revenue generated from these new products and enhancements may not offset the costs, which could substantially impair our business, financial condition and results of operations.

We rely on a limited number of independent third parties to manufacture and supply our products.

All of our products are manufactured by a limited number of independent third parties.  There is no assurance that our current manufacturers will continue to reliably supply products to us at the level of quality we require.  If a key manufacturer suffers liquidity problems or experiences operationsoperational or other problems assisting with our products, our results could suffer.  In the event any of our third-party manufacturers become unable or unwilling to continue to provide the products in required volumes and quality levels at acceptable prices, we will be required to identify and obtain acceptable replacement manufacturing sources or replacement products.  There is no assurance that we will be able to obtain alternative manufacturing sources or products or be able to do so on a timely basis.  An extended interruption in the supply of certain of our products may result in a substantial loss of revenue.  In addition, any actual or perceived degradation of product quality as a result of our reliance on third party manufacturers may have an adverse effect on revenue or result in increased product returns.

Growth may be impeded by the political and economic risks of entering and operating foreign markets.

Our ability to achieve future growth is dependent, in part, on our ability to continue our international expansion efforts.  However, there can be no assurance that we would be able to grow in our existing international markets, enter new international markets on a timely basis, or that new markets would be profitable.  We must overcome significant regulatory and legal barriers before we can begin marketing in any foreign market.


Also, it is difficult to assess the extent to which our products and sales techniques would be accepted or successful in any given country.  In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures and legal systems from those elsewhere.  We may be required to reformulate certain of our products before commencing sales in a given country.  Once we have entered a market, we must adhere to the regulatory and legal requirements of that market.  No assurance can be given that we would be able to successfully reformulate our products in any of our current or potential international markets to meet local regulatory requirements or attract local customers.  The failure to do so could have a material adverse effect on our business, financial condition, and results of operations.  There can be no assurance that we would be able to obtain and retain necessary permits and approvals.

In many markets, other direct selling companies already have significant market penetration, the effect of which could be to desensitize the local distributormember population to a new opportunity or to make it more difficult for us to recruit qualified distributors.members. There can be no assurance that, even if we are able to commence operations in foreign countries, there would be a sufficiently large population of potential distributorsmembers inclined to participate in a direct selling system offered by us.  We believe our future success could depend in part on our ability to seamlessly integrate our business methods, including distributormember compensation plan, across all markets in which our products are sold.  There can be no assurance that we would be able to further develop and maintain a seamless compensation program.

 

Currency exchange rate fluctuations could lower our revenue and net income.

In 2012 and 2013, approximately 95% of our revenue was recorded by subsidiaries located outside of North America.  Revenue transactions and related commission payments, as well as other incurred expenses, are typically denominated in the local currency.  Accordingly, our international subsidiaries use the local currency as their functional currency.  The results of operations of our international subsidiaries are exposed to foreign currency exchange rate fluctuations during consolidation since we translate into U.S. dollars using the average exchanges rates for the period.  As exchange rates vary, revenue and other operating results may differ materially from our expectations.  Additionally, we may record significant gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of inter-company balances.

We believe that our foreign currency exchange rate exposure is somewhat limited since the Hong Kong dollar is pegged to the U.S. dollar.  We also purchase a significant majority of inventories in U.S. dollars.  Our foreign currency exchange rate exposure, mainly to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble and European euro, represented approximately 25% and 18% of our revenue in 2012 and 2013, respectively.  Our foreign currency exchange rate exposure may increase in the near future as our Greater China, Russia and European subsidiaries expand operations and we develop new markets.  Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar.

Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition.  Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.

Transfer pricing, duties and other tax regulations affect our business.

In many countries, including the United States, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned by our United States or local entities and are taxed accordingly.  In addition, our operations are subject to regulations designed to ensure that appropriate levels of customs duties are assessed on the importation of our products.

Our principal domicile is the United States.  Under tax treaties, we are eligible to receive foreign tax credits in the United States for taxes paid abroad.  Taxes paid to foreign taxing authorities may exceed the credits available to us, resulting in the payment of a higher overall effective tax rate on our worldwide operations.

We have adopted transfer pricing agreements with our subsidiaries to regulate inter-company transfers, which agreements are subject to transfer pricing laws that regulate the flow of funds between the subsidiaries and the parent corporation for product purchases, management services, and contractual obligations, such as the payment of distributor compensation. We believe that we operate in compliance with all applicable transfer pricing laws, and we intend to continue to operate in compliance with such laws.  However, there can be no assurance that we will continue to be found to be operating in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may require changes in our operating procedures or otherwise may have a material adverse effect on our financial results or operations.

Failure to properly pay business taxes or customs duties, including those in China, could have a material adverse effect.

In the course of doing business we may be subject to various taxes, such as sales and use, value-added, franchise, income, and import duties.  The failure to properly calculate, report and pay such taxes or duties when we are subject to them could have a material adverse effect on our financial condition and results of operations.  Moreover, any change in the law or regulations regarding such taxes or duties, or any interpretation thereof, could result in an increase in the cost of doing business.

We may be held responsible for certain taxes or assessments relating to the activities of our distributors,members, which could harm our financial condition and operating results.

Our distributorsmembers are subject to taxation, and in some instances, legislation or governmental agencies impose an obligation on us to collect the taxes, such as value added taxes, and to maintain appropriate records.  In addition, we are subject to the risk in some jurisdictions of being responsible for social security and similar taxes with respect to our distributors.

We may face litigation that could harm our business.

We have been a party to lawsuits and other proceedings in the past.  Prosecuting and defending potential litigation and other governmental proceedings may require significant expense and attention of our management.  There can be no assurance that the significant money, time and effort spent will not adversely affect our business, financial condition and results of operations.

members.
 

We may be unable to protect or use our intellectual property rights.

We rely on trade secret, copyright and trademark laws and confidentiality agreements with employees and third parties, all of which offer only limited protection of our confidential information and trademarks.  Moreover, the laws of some countries in which we market our products may afford little or no effective protection of our intellectual property rights.  The unauthorized copying, use or other misappropriation of our confidential information, trademarks and other intellectual property could enable third parties to benefit from such property without paying us for it.  This could have a material adverse effect on our business, operating results and financial condition.  If we resort to legal proceedings to enforce our intellectual property rights, the proceedings could be burdensome, expensive and result in inadequate remedies.  It is also possible that our use of our intellectual property rights could be found to infringe on prior rights of others and, in that event, we could be compelled to stop or modify the infringing use, which could be burdensome and expensive.

We do not have a comprehensive product liability insurance program and product liability claims could hurt our business.

Currently, we do not have a comprehensive product liability insurance program, although the insurance carried by our suppliers may cover certain product liability claims against us.  As a marketer of dietary supplements, cosmetics and other products that are ingested by consumers or applied to their bodies, we may become subjected to various product liability claims, including that:

our products contain contaminants or unsafe ingredients;

our products include inadequate instructions as to their uses; or

our products include inadequate warnings concerning side effects and interactions with other substances.

our products contain contaminants or unsafe ingredients;

our products include inadequate instructions as to their uses; or

our products include inadequate warnings concerning side effects and interactions with other substances.
If our suppliers’ product liability insurance fails to cover product liability claims or other product liability claims, or any product liability claims exceeds the amount of coverage provided by such policies or if we are unsuccessful in any third party claim against the manufacturer or if we are unsuccessful in collecting any judgment that may be recovered by us against the manufacturer, we could be required to pay substantial monetary damages which could materially harm our business, financial condition and results of operations. As a result, we may become required to pay high premiums and accept high deductibles in order to secure adequate insurance coverage in the future.  Especially since we do not have direct product liability insurance, it is possible that product liability claims and the resulting adverse publicity could negatively affect our business.


Our internal controls and accounting methods may require modification.

We continue to review and develop controls and procedures sufficient to accurately report our financial performance on a timely basis.  If we do not develop and implement effective controls and procedures, we may not be able to report our financial performance on a timely basis and our business and stock price would be adversely affected.

If we fail to achieve and maintain an effective system of internal controls in the future, we may not be able to accurately report our financial results or prevent fraud.  As a result, investors may lose confidence in our financial reporting.

The Sarbanes-Oxley Act of 2002 requires that we report annually on the effectiveness of our internal control over financial reporting.  Among other things, we must perform systems and processes evaluation and testing.  We must also conduct an assessment of our internal controls to allow management to report on our assessment of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act.  We are required to provide management’s assessment of internal controls in conjunction with the filing of this report.our Annual Report on Form 10-K.  As disclosed under Item 9A“Item 9A. Controls and Procedures” of this report, our management concludedhas delivered its report concluding that our internal control over financial reporting was effective at December 31, 2013.2016, and our independent registered public accounting firm has also delivered its attestation to the report.  In the future, our continued assessment, or the assessment by our independent registered public accounting firm, could reveal significant deficiencies or material weaknesses in our internal controls, which may need to be disclosed in future Annual Reports on Form 10-K.  We believe, at the current time, that we are taking appropriate steps to mitigate these risks.  However, disclosures of this type can cause investors to lose confidence in our financial reporting and may negatively affect the price of our common stock.  Moreover, effective internal controls are necessary to produce reliable financial reports and to prevent fraud.  Deficiencies in our internal controls over financial reporting may negatively impact our business and operations.


We rely on and are subject to risks associated with our reliance upon information technology systems.

Our success is dependent on the accuracy, reliability, and proper use of information processing systems and management information technology.  Our information technology systems are designed and selected to facilitate order entry and customer billing, maintain distributormember records, accurately track purchases and distributormember compensation payments, manage accounting operations, generate reports, and provide customer service and technical support.  Any interruption in these systems could have a material adverse effect on our business, financial condition, and results of operations.

 

Although we believe that the members of our software development team have the qualifications, know-how and experience to perform the necessary software development and other information technology services, there can be no assurance that there will not be delays or interruptions in these services.  An interruption or delay in availability of these services could, if it lasted long enough, prevent us from accepting orders, cause distributorsmembers to leave our business, or otherwise materially adversely affect our business.

System failures and attacks could harm our business.

Because of our diverse geographic operations and our internationally applicable distributormember compensation plans, our business is highly dependent on the efficient functioning of our information technology systems and operations, which are vulnerable to damage or interruption from fires, earthquakes, telecommunications failures, computer viruses and worms, hacking, denial of service attacks, software defects and other events.  They are also subject to break-ins, sabotage, acts of vandalism and similar misconduct, as well as human error.  Despite precautions implemented by our information technology staff, problems could result in interruptions in services and materially and adversely affect our business, financial condition and results of operations.

Moreover, hackers could attack our system seeking to retrieve personal or confidential information of ours or of third parties, such as credit card information used to purchase our products on-line.  Although we take steps to prevent such loss of information, there can be no assurance that our system will not be successfully hacked.  Laws in the United States and other jurisdictions where we do business require prompt notice of any such loss of information.  Failure to comply with those reporting obligations could result in material penalties.  In addition, if our system were hacked, we could incur material costs in investigating the incidents and could be liable for damages.  Any such damages may or may not be covered by insurance.


Terrorist attacks, cyber-attacks, acts of war, epidemics or other communicable diseases or any other natural disasters may seriously harm our business.

Terrorist attacks, cyber-attacks, or acts of war or natural disasters may cause damage or disruption to us, our employees, our facilities and our distributorsmembers and customers, which could impact our revenues, expenses and financial condition.  The potential for future terrorist attacks, the national and international responses to terrorist attacks, and other acts of war or hostility, such as challenges to Chinese sovereignty claims in the South China Sea or Chinese objection to the Taiwan independence movement and itsthe resultant tension in the Taiwan Strait, could materially and adversely affect our business, results of operations, and financial condition in ways that we currently cannot predict.  Additionally, natural disasters less severe than the Indian Ocean tsunami that occurred in December 2004 may adversely affect our business, financial condition and results of operations.

Because our systems, software and data reside on third-party servers, our access could be temporarily or permanently interrupted.

Beginning in 2012, most of our systems, software and data reside in the “cloud” on third-party servers to which we have contractual access.  Cyber-attacks or hacking on these servers unrelated to us, or system or hardware failures experienced by the third party vendor, could result in disclosure of or damage to our systems, software and data.  Moreover, any delay or failure in payment of the third party vendors, disputes with such vendors, or business interruption or failure of the third party vendors could result in loss of or interruption in access to our systems, software or data.  It is possible that our systems, software and data could in the future be moved to servers of different third parties or to our own servers.  Any such move could result in temporary or permanent loss of access to our systems, software or data.  Any protracted loss of such access would materially and adversely affect our business, financial condition and results of operations.


We may experience substantial negative cash flows, which may have a significant adverse effect on our business and could threaten our solvency.
We experienced substantial negative cash flows during the years ended December 31, 2009 and 2008, primarily due to declines in our revenues greater than the decreases in expenditures we could manage.  If we again experience negative cash flows, any resulting decreasing cash balance could impair our ability to support our operations and, eventually, threaten our solvency, which would have a material adverse effect on our business, results of operations and financial condition, as well as our stock price.  Negative cash flows and the related adverse market perception associated therewith may have negatively affected, and may in the future negatively affect, our ability to attract new members and/or sell our products.  There can be no assurance that we will be successful in maintaining an adequate level of cash resources and we could be forced to act more aggressively in the area of expense reduction in order to conserve cash resources as we look for alternative solutions.
If we experience negative cash flows, we may need to seek additional debt or equity financing, which may not be available on acceptable terms or at all.  If available, it could have a highly dilutive effect on the holdings of existing stockholders.
Unless we are able to maintain revenues, control expenses and achieve positive cash flows, our ability to support our obligations could be impaired and our liquidity could be adversely affected and our solvency and our ability to repay our debts when they come due could be threatened.  We may need to seek additional debt or equity financing on acceptable terms in order to improve our liquidity.  However, we may not be able to obtain additional debt or equity financing on satisfactory terms, or at all, and any new financing could have a dilutive effect to our existing stockholders.
Disappointing quarterly revenue or operating results could cause the price of our common stock to fall.

Our quarterly revenue and operating results are difficult to predict and may fluctuate significantly from quarter to quarter.  If our quarterly revenue or operating results fall below the expectations of investors or securities analysts, the price of our common stock could fall substantially.

Our common stock is particularly subject to volatility because of the industry in which we operate.

The market prices of securities of direct selling companies have been extremely volatile, and have experienced fluctuations that have often been unrelated or disproportionate to the operating performance of such companies.  These broad market fluctuations could adversely affect the market price of our common stock.

 

Trading

Our common stock continues to experience wide fluctuations in trading volumes and prices. This may make it more difficult for holders of our common stock may be volatileto sell shares when they want and sporadic, which could depress the market price of our common stock and make it difficult for our stockholders to resell their shares.

There is currently a limitedat prices they find attractive.

The public market for our common stock andhas historically been very volatile. Notwithstanding the volumetransition in trading of our common stock traded on any day may vary significantly from one day to another. Our common stock is currently quoted on the OTCQB tier of the OTC Market. TradingMarket to the NASDAQ Capital Market in February 2015, our stock quoted on the OTC Market’s OTCQB is often thin and characterized bycontinues to experience wide fluctuations in trading prices due to manyvolumes and prices. There are a number of factors that may have littlecontribute to do with our operations or business prospects. The availability of buyers and sellers represented by this volatility, could leadincluding the following:

active participation of speculative traders in our stock (including short sellers);

market rumors regarding our business operations;

government scrutiny of our business;

adverse publicity related to our business or industry; and

fluctuations in our operating results.

This market volatility for our stock may make it more difficult for holders of our stock to sell shares when they want and at prices they find attractive. There can be no assurance that a larger or more liquid market pricewill be developed or maintained for our common stock that is unrelated to operating performance. Moreover, the OTC Market’s OTCQB is not a stock exchange, and trading of securities quoted on the OTC Market’s OTCQB is often more sporadic than the trading of securities listed on a stock exchange like NASDAQ. There is no assurance that there will be a sufficient market in our stock, in which case it could be difficult for our stockholders to resell their shares.

The exercise of our warrants may result in substantial dilution and may depress the market price of our common stock.

As of February 28, 2014, we had outstanding 11,448,571 shares of common stock and also (i) 123,693 shares of Series A preferred stock convertible into the same number of shares of common stock and (ii) warrants issued in our October 2007 private placement exercisable for 1,375,952 shares of common stock at an exercise price of $3.52 per share. If these convertible securities are exercised or converted, and the shares of common stock issued upon such exercise or conversion are sold, our common stockholders may experience substantial dilution and the market price of our shares of common stock could decline.  Further, the perception that such convertible securities might be exercised or converted could adversely affect the market price of our shares of common stock.  In addition, holders of our warrants are likely to exercise them when, in all likelihood, we could obtain additional capital on terms more favorable to us than those provided by the warrants.  The anti-dilution provisions of warrants to purchase 1,375,952 shares of our common stock would, if triggered, cause substantial dilution and may, therefore, make it particularly difficult to obtain new equity financing.

Future sales by us or our existing stockholders could depress the market price of our common stock.

If we or our existing stockholders sell a large number of shares of our common stock, the market price of our common stock could decline significantly.  Further, even the perception in the public market that we or our existing stockholders might sell shares of common stock could depress the market price of theour common stock.

Item 1B.

UNRESOLVED STAFF COMMENTS

Not applicable.

Item 1B. UNRESOLVED STAFF COMMENTS

None.

Item 2.  

PROPERTIES

Item 2. PROPERTIES
We lease approximately 3,8004,900 square feet of office space in Dallas, TexasRolling Hills Estates, California for our corporate headquarters. Outside the United States,headquarters with terms expiring in September 2025. In addition, we lease 2,400 and 1,600 square feet of retail space in Monterey Park, California and Vancouver, British Columbia, respectively, to help further develop the market for our products in North America. The Monterey Park and Vancouver locations have terms expiring in August 2020 and February 2021, respectively. We also maintain an office in Dallas, Texas.

Outside of North America, we lease 7,300 square feet of office space in Hong Kong with terms expiring in February 2018, nine branch offices throughout China, and additional office space in Japan, Taiwan, South Korea, Singapore, Malaysia, Vietnam and South Korea.the Cayman Islands. We also lease a multi-purposedmulti-purpose facility and factory in Zhongshan, China intended toand 11 service stations throughout the city of Guangzhou, China that serve or will in the future serve the needs of our Chinese consumers. We contract with third parties for fulfillment and distribution operations in mostall of our international markets. Through our Russiana local service provider, we maintain marketing and distributormember centers in Almaty, Kazakhstan and Odessa, Ukraine.Moscow, Russia. We believe that our existing office space is in good condition, and is suitable and adequate for the conduct of our business.


Item 3. 

LEGAL PROCEEDINGS

None.

Item 3. LEGAL PROCEEDINGS

Securities Class Action

In January 2016, two putative securities class action complaints were filed against us and our top executives in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. On March 29, 2016, the court consolidated these actions, appointed two Lead Plaintiffs, Messrs. Dao and Juan, and appointed the Rosen Law Firm and Levi & Korsinsky LLP as co-Lead Counsel for the purported class. Plaintiffs filed a consolidated complaint on April 29, 2016. The consolidated complaint purports to assert claims on behalf of all persons who purchased or otherwise acquired our common stock between March 6, 2015 and March 15, 2016 under (i) Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder against Natural Health Trends Corp., Chris T. Sharng, and Timothy S. Davidson, and (ii) Section 20(a) of the Securities Exchange Act of 1934 against Chris T. Sharng, Timothy S. Davidson, and George K. Broady. The consolidated complaint alleges, inter alia, that we made materially false and misleading statements regarding the legality of our business operations in China, including running an allegedly illegal multi-level marketing business. The consolidated complaint seeks an indeterminate amount of damages, plus interest and costs. We filed a motion to dismiss the consolidated complaint on June 15, 2016 and a reply in support of our motion to dismiss on August 22 2016. On December 5, 2016, the Court denied our motion to dismiss. On February 17, 2017, we filed an answer to the consolidated complaint. We believe that these claims are without merit and intend to vigorously defend against them.

Shareholder Derivative Claims

In February 2016, a purported shareholder derivative complaint was filed in the Superior Court of the State of California, County of Los Angeles: Zhou v. Sharng. In March 2016, a purported shareholder derivative complaint was filed in the United States District Court for the Central District of California: Kleinfeldt v. Sharng (collectively the “Derivative Complaints”). The Derivative Complaints purport to assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and corporate waste against certain of our officers and directors. The Derivative Complaints also purport to assert fiduciary duty claims based on alleged insider selling and conspiring to enter into several stock repurchase agreements, which allegedly harmed us and our assets. The Derivative Complaints allege, inter alia, that we made materially false and misleading statements regarding the legality of our business operations in China, including running an allegedly illegal multi-level marketing business, and that certain officers and directors sold common stock on the basis of this allegedly material, adverse non-public information. The Derivative Complaints seek an indeterminate amount of damages, plus interest and costs, as well as various equitable remedies. On February 1, 2017, pursuant to a stipulation among the parties, the Los Angeles Superior Court entered a stay of the Zhou action pending conclusion of the related federal class action in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. A nearly identical stipulated stay was entered in the Kleinfeldt case on February 28, 2017. We believe that these claims are without merit and intend to vigorously defend against them.

Item 4.

MINE SAFETY DISCLOSURES

Item 4. MINE SAFETY DISCLOSURES

Not applicable.




Part II
 

Part II

Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES


Market Information

Our common stock is currently traded on the NASDAQ Capital Market (“Nasdaq”) under the symbol “NHTC.” Prior to February 17, 2015, our common stock was quoted under the trading symbol “NHTC” on the OTCQB tier of the OTC Market. The following table sets forth the range of the high and low bid quotations of our common stock as reported by Nasdaq and the OTC Markets Group, Inc. The bid quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

  

2012

  

2013

 
  

High

  

Low

  

High

  

Low

 
                 

First quarter

 $1.68  $0.65  $1.44  $1.01 

Second quarter

  1.49   1.15   1.30   0.80 

Third quarter

  1.49   0.91   2.20   0.93 

Fourth quarter

  1.32   0.51   3.40   1.86 

 2016 2015
 High Low High Low
First quarter$36.19
 $17.75
 $18.29
 $10.49
Second quarter38.25
 26.24
 44.18
 17.78
Third quarter34.30
 25.89
 43.33
 21.91
Fourth quarter29.95
 21.44
 53.72
 32.96
On February 28, 2014,March 7, 2017, the last reported closing price of our common stock on the OTCQBas reported by Nasdaq was $4.66$27.95 per share.

Holders of Record

At February 28, 2014,March 7, 2017, there were approximately 170125 record holders of our common stock (although we believe that the number of beneficial owners of our common stock is substantially greater).


Dividends

No dividends

The following tables summarize all cash dividend activity during 2016 and 2015 (in thousands, except per share data), all of which dividend payments were ever declared or paid onmade to holders of our common stock prior to the end of fiscal 2013. At December 31, 2013, we had accrued unpaid dividends of $98,000 with respect to the outstanding shares of Series A preferred stock, but such dividends had not been declared and we were under no obligation to pay such accrued dividends except in certain extraordinary circumstances. On March 7, 2014,stock:
Declaration Date Per Share Amount Payment Date
October 23, 2016 (special) $0.35
 $3,941
 November 25, 2016
October 23, 2016 0.08
 901
 November 25, 2016
July 19, 2016 0.07
 787
 August 26, 2016
April 21, 2016 0.06
 686
 May 20, 2016
March 1, 2016 0.05
 576
 March 24, 2016
Total $0.61
 $6,891
  

Declaration Date Per Share Amount Payment Date
October 21, 2015 $0.05
 $598
 November 20, 2015
July 28, 2015 0.04
 489
 August 28, 2015
May 4, 2015 0.03
 372
 May 29, 2015
February 27, 2015 0.02
 250
 March 27, 2015
Total $0.14
 $1,709
  

Additionally, on January 24, 2017, the Board of Directors declared a dividend on each share of outstanding Series A preferred stock in the amount of $0.81507 per share representing the accrued unpaid dividends from May 4, 2007 through March 7, 2014. Simultaneously, the Board of Directors also declared acash dividend of $0.005$0.09 and a special cash dividend of $0.35 on each share of common stock outstanding. All suchSuch dividends are payable in cashwere paid on April 8, 2014March 3, 2017 to stockholders of record on March 28, 2014.February 21, 2017. Payment of any future dividends on shares of our Series A preferred stock and common stock will be at the discretion of our Board of Directors.

Equity Compensation Plan Information

The following




Stock Performance Graph

Set forth below is a line graph and table sets forth information regarding all compensation plans under which Company equity securities are authorized for issuance ascomparing the performance of our common stock to the S&P 500 Index and to a market-weighted index of publicly traded peers from the period from December 31, 2013:

Plan Category

 

Number of securities to

be issued upon exercise

of outstanding options,

warrants and rights

(a)

  

Weighted-average

exercise price of

outstanding options,

warrants and rights

(b)

  

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

(c)

 
             

Equity compensation plans approved by security holders

    $   1,083 

Equity compensation plans not approved by security holders

 

  

  

 

Total

 

  

   1,083 

2011 through December 31, 2016. The graph assumes $100 was invested in our common stock, the S&P 500 Index and the index of publicly traded peers on December 31, 2011 and that all dividends were reinvested. The publicly traded companies in the peer group consist of Nature's Sunshine Products, Nu Skin Enterprises Inc., USANA Health Sciences Inc., and Herbalife Ltd. The graph represents past performance and should not be considered to be an indication of future performance.

 Period NHTC S&P 500 Peer Group
December 31, 2011 $100
 $100
 $100
December 31, 2012 155
 116
 74
December 31, 2013 492
 154
 224
December 31, 2014 1,766
 175
 135
December 31, 2015 5,194
 177
 167
December 31, 2016 3,944
 198
 161

 


Purchases of Equity Securities by the Issuer and Affiliated Purchasers

A summary of the Company’s purchases, as Trustee, of shares of its common stock during the quarter ended December 31, 2013 is as follows:

Period

 

Total Number of Shares Purchased(a)

  

Average Price Paid Per Share

  

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(b)

  

Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs(c)

 
                 

October 1–31, 2013

  2,800  $2.00   75,165   69,265 

November 1—30, 2013

  2,100   3.31   77,265   67,165 

December 1—31, 2013

  2,100   3.46   79,365   65,065 

(a)     The shares were purchased in open market transactions under the Distributor and Employee Plans described in footnote (b) below.

(b)     On August 13, 2012, the Company disclosed in its Quarterly Report on Form 10-Q that its Board of Directors had, on that day, authorized the Company, acting as trustee for certain of its distributors, to execute a Rule 10b5-1 plan to purchase up to $60,000 of its common stock (less commissions and other transaction costs) in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions (the “Distributor Plan”) and that, on that same date, the Company’s Board of Directors further authorized the Company, acting as trustee for certain of its employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions (the “Employee Plan”).  The Company may terminate the plans at any time.  The distributors for whom the Company will purchase the stock as trustee under the Distributor Plan will receive the stock as compensation under a special incentive plan offered to certain distributors who are not citizens or residents of the United States. The employees for whom the Company will purchase stock as trustee under the Employee Plan will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution. Any stock that is purchased under the Employee Plan that is forfeited by an employee whose employment terminates will be delivered to the Company and held by it as treasury stock.

(c)     The Company, as Trustee, completed its purchases under the Distributor Plan in October 2012, and began purchasing under the Employee Plan in December 2012. Under the initial 10b5-1 plan executed by the Company, as Trustee, with the Board’s authorization, the Company, as Trustee, would not purchase more than 2,800 shares per month. That 10b5-1 plan for the Employee Plan shares was replaced by a new 10b5-1 plan effective November 11, 2013. The Company, as Trustee, will not purchase more than 2,100 shares per month under the new 10b5-1 plan. The current 10b5-1 plan for the Employee Plan shares will expire on November 11, 2014, unless terminated earlier, and the Company, as Trustee, intends at or after that time to enter into a new 10b5-1 plan or plans to complete the Employee Plan purchases authorized by the Board.

Item 6. SELECTED FINANCIAL DATA

Not applicable under smaller reporting company disclosure rules.


The following selected consolidated financial data, which have been derived from our audited consolidated financial statements, are not necessarily indicative of the results of future operations and should be read in conjunction with “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations”, and the consolidated financial statements and accompanying notes included elsewhere in this Annual Report on Form 10-K (in thousands, except per share data).
 Year Ended December 31
 2016 2015 2014 2013 2012
Consolidated Statements of Operations Data:         
Net sales$287,728
 $264,860
 $124,590
 $52,527
 $37,514
Cost of sales54,903
 54,098
 26,981
 12,551
 9,685
Gross profit232,825
 210,762
 97,609
 39,976
 27,829
Operating expenses:         
Commissions expense125,050
 126,598
 56,997
 24,053
 15,724
Selling, general and administrative expenses43,245
 36,024
 19,687
 11,634
 9,415
Depreciation and amortization394
 263
 105
 66
 45
Total operating expenses168,689
 162,885
 76,789
 35,753
 25,184
Income from operations64,136
 47,877
 20,820
 4,223
 2,645
Other expense, net(59) (84) (184) (32) (39)
Income before income taxes64,077
 47,793
 20,636
 4,191
 2,606
Income tax provision (benefit)8,991
 552
 266
 102
 (24)
Net income55,086
 47,241
 20,370
 4,089
 2,630
Preferred stock dividends
 
 (10) (15) (17)
Net income available to common stockholders$55,086
 $47,241
 $20,360
 $4,074
 $2,613
Income per common share:         
Basic$4.84
 $3.84
 $1.67
 $0.36
 $0.24
Diluted$4.83
 $3.82
 $1.61
 $0.36
 $0.23
Weighted-average number of common shares outstanding:         
Basic11,382
 12,302
 12,131
 11,154
 10,944
Diluted11,407
 12,372
 12,600
 11,331
 11,234
Cash dividends declared per common share$0.61
 $0.14
 $0.03
 $
 $
          
Consolidated Balance Sheets Data:         
Cash and cash equivalents$125,921
 $104,914
 $44,816
 $14,550
 $4,207
Inventories, net11,257
 10,455
 3,760
 1,828
 867
Working capital84,090
 56,199
 25,253
 3,598
 (325)
Long-term incentive8,190
 5,770
 1,665
 
 
Total assets148,051
 124,152
 52,540
 19,827
 8,219
Total stockholders’ equity82,439
 56,809
 26,450
 6,077
 1,909
          
Consolidated Statements of Cash Flows Data:         
Net cash provided by (used in):         
Operating activities$53,174
 $81,326
 $30,613
 $10,686
 $2,214
Investing activities(905) (3,738) (339) (292) 397
Financing activities(30,595) (17,471) (189) (52) (3)
Repurchase of common stock(23,704) (16,071) (4,661) (52) (3)
Income taxes paid, net of refunds8,791
 707
 60
 71
 34

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


Business Overview

We are an international direct-selling and e-commerce company. Subsidiaries controlled by us sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to an independent distributor network that either uses the products themselves or resells them to consumers. Our wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of ItalyEurope. We also operate in Russia and Slovenia. In June and December 2013, we opened marketing centers in Almaty, Kazakhstan and Odessa, Ukraine, respectively, through our engagement with our Russiana local service provider. The Kazakhstan and Ukraine centers also opened for sales and distribution purposes in September 2013 and February 2014, respectively.

Our distributor network operates in a seamless manner from market to market, except for the Chinese market, where we sell to consumers through an e-commerce platform. We believe that each of our operating segments should be aggregated into a single reportable segment as they have similar economic characteristics. Additionally, we believe that eachSee Note 10 of the operating segments are similarNotes to Consolidated Financial Statements in the nature“Item 8. Financial Statements and Supplementary Data” of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment. Our e-commerce retail business in China does not require a direct selling license and allowsthis report for discounts on volume purchases. There is no separate segment manager who is held accountablefurther information about our net sales by our chief operating decision-makers, or anyone else, for operations, operating results and planning for the Chinese market on a stand-alone basis. Accordingly, we consider ourselves to be in a single reporting segment and operating unit structure.

geographic area.

As of December 31, 2013,2016, we were conducting business through 27,520118,960 active distributors.members, compared to 109,360 in 2015 and 54,360 in 2014. We consider a distributormember “active” if they have placed at least one product order with us during the preceding year. Currently we do not intend to devote material resources to opening any additional foreign markets in the near future. Our priority is to focus our resources in our most promising markets, which we consider to be Greater China and certain Commonwealth of Independent States (“CIS”) countries namely Russia, Ukrainewhere our existing members have the connections to recruit prospects and Kazakhstan.

sell our products, such as Southeast Asia. We have also begun investing some resources in Central and South America.

We generate about 95%98% of our net sales from subsidiaries located outside North America, with sales inof our Hong Kong subsidiary representing 77%92% of net sales in the latest fiscal year. Because of the size of our foreign operations, operating results can be impacted negatively or positively by factors such as foreign currency fluctuations, and economic, political and business conditions around the world. In addition, our business is subject to various laws and regulations, in particular, regulations related to direct selling activities that create certainuncertain risks for our business, including improper claims or activities by our distributorsmembers and potential inability to obtain necessary product registrations.

For further information regarding some of the risks associated with the conduct of our business in China, see “Item 1A. Risk Factors,” and more specifically under the captions “Risk Factors - Because our Hong Kong operations account for a substantial portion of our overall business...” and “Risk Factors - Our operations in China are subject to compliance with a myriad of applicable laws and regulations...”.

China has been and continues to be our most important business development project. In June 2004, NHT Global obtained a general business licenseWe operate an e-commerce direct selling model in Hong Kong that generates revenue derived from the sale of products to members in Hong Kong and elsewhere, including China. Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. Direct selling is prohibitedThrough a separate Chinese entity, we operate an e-commerce retail platform in China withoutChina. We believe that neither of these activities require a direct selling license thatin China, which we do not have. In December 2005, we submittedcurrently hold. We have previously sought to obtain a direct selling license, and in August 2015 initiated the process for submitting a new preliminary application for a direct selling license. In June 2006,license in China. If we submitted a revised application package in accordance with new requirements issued by the Chinese government. In June 2007, we launched a new e-commerce retail platform in China that does not requireare able to obtain a direct selling license and is separate from our current worldwide platform. Wein China, we believe this model, which offers discounts based on volume purchases, will encourage repeat purchases of our products for personal consumptionthat the incentives inherent in the Chinese market. The platform is designed to be in compliance with our understanding of current laws and regulations in China. In November 2007, we filed a new, revised direct selling application incorporatingmodel in China would incrementally benefit our existing business. Increased sales in China that could be derived from obtaining a name change, our new e-commerce model and other developments. These direct selling applications were not approved or rejectedlicense may be partially offset by the pertinent authorities, but did not appear to materially progress. By 2009, the information contained in the most recent application was stale. The Company applied to temporarily withdraw the license application in February 2009 to furnish new information and intends to amend its applicationhigher fixed costs associated with the goal to re-apply in the future.establishment and maintenance of required service centers and branch offices. We are unable to predict whether and when we will be successful in obtaining a direct selling license to operate in China, and if we are successful, when we will be permitted to enhance our e-commerce retail platform withconduct direct selling operations.

Most of the Company’s Hong Kong revenue is derived from the sale of products that are delivered to members in China. After consulting with outside professionals, the Company believes that its Hong Kong e-commerce business does not violate any applicable laws in China even though it is used for the internet purchase of our products by buyers in China. But the government in China could, in the future, officially interpret its lawsoperations and regulations – or adopt new laws and regulations – to prohibit some or all of our e-commerce activities with China and, if our members engage in illegal activities in China, those actions couldwhether such operations would be attributed to us. In addition, other Chinese laws regarding how and when members may assemble and the activities that they may conduct, or the conditions under which the activities may be conducted, in China are subject to interpretations and enforcement attitudes that sometimes vary from province to province, among different levels of government, and from time to time. Members sometimes violate one or more of the laws regulating these activities, notwithstanding training that the Company attempts to provide. Enforcement measures regarding these violations, which can include arrests, raise the uncertainty and perceived risk associated with conducting this business, especially among those who are aware of the enforcement actions but not the specific activities leading to the enforcement. The Company believes that this has led some existing members in China – who are signed up as distributors in Hong Kong - to leave the business or curtail their selling activities and has led some potential members to choose not to participate. Among other things, the Company is combating this with more training and public relations efforts that are designed, among other things, to distinguish the Company from businesses that make no attempt to comply with the law. This environment creates uncertainty about the future of doing this type of business in China generally and under our business model, specifically.See “Item 1A. Risk Factors—Because our Hong Kong operations account for a majority of our overall business….”

profitable.


Income Statement Presentation

We mainly derive revenue from sales of products, enrollment packages, and shipping charges.products. Substantially all of our product sales are to independent distributorsmembers at published wholesale prices. Product sales are recorded when the products are shipped and title passes to independent distributors,members, which generally is upon our delivery to the carrier that completes delivery to the distributors.members. We estimate and accrue a reserve for product returns based on our return policies and historical experience. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.

We bill members for shipping charges and recognize the freight revenue in net sales. Event and training revenue is deferred and recognized as the event or training occurs.

Cost of sales consists primarily of products purchased from third-party manufacturers, freight cost for transporting products to our foreign subsidiaries and shipping products to distributors,members, import duties, packing materials, product royalties, costs of promotional materials sold to the Company’s distributorsour members at or near cost, and provisions for slow moving or obsolete inventories. Cost of sales also includes purchasing costs, receiving costs, inspection costs and warehousing costs.

Distributor


Member commissionsare typically our most significant expense and are classified as an operating expense. Under our compensation plan, distributorsmembers are paid weekly commissions by our subsidiary in which they are enrolled, generally in their home country currency, for product purchases by their down-line distributormember network across all geographic markets, exceptmarkets. Our China where we launchedsubsidiary maintains an e-commerce retail platform and dodoes not pay any commissions. This "seamless"“seamless” compensation plan enables a distributormember located in one country to sponsorenroll other distributorsmembers located in other countries where we are authorized to conduct our business. Currently, there are basically two ways in which our distributorsmembers can earn income:

Through retail markups on sales of products purchased by distributors at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market); and

Through commissions paid on product purchases made by their down-line distributors.


through commissions paid on product purchases made by their down-line members; and

through retail markups on sales of products purchased by members at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market).
Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per weekly sales period. Bonus volume points are essentially a percentage of a product’s wholesale cost.price. As the distributor’smember’s business expands from successfully sponsoringenrolling other distributorsmembers who in turn expand their own businesses by sponsoringselling product to other distributors,members, the distributormember receives higher commissions from purchases made by an expanding down-line network. ToIn some of our markets, to be eligible to receive commissions, a distributormember may be required to make nominal monthly or other periodic purchases of our products. Certain of our subsidiaries do not require these nominal purchases for a distributormember to be eligible to receive commissions. In determining commissions, the number of levels of down-line distributorsmembers included within the distributor'smember’s commissionable group increases as the number of distributorshipsmemberships directly below the distributormember increases. Under our current compensation plan, certain of our commission payouts may be limited to a hard cap in terms ofdollar amount per week or a specific percentage of total product sales. In some markets, commissions may be further limited. In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors,enrolled members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors. Distributorsenrolled members. Members can also earn income, trips and other prizes in specific time-limited promotions and contests we hold from time to time. DistributorMember commissions are dependent on the sales mix and, for each of fiscal 20122016, 2015 and 2013,2014 represented 42%44%, 48% and 46%, respectively, of net sales, respectively. From time to timesales. Occasionally, we make modifications and enhancements to our compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time weWe may also enter into agreements for business or market development, which maycould result in additional compensation to specific distributors.

members.

Selling, general and administrative expenses consist of administrative compensation and benefits, (including stock-based compensation), travel, credit card fees and assessments, professional fees, certain occupancy costs, and other corporate administrative expenses.expenses (including stock-based compensation). In addition, this category includes selling, marketing, and promotion expenses including(including the costs of distributormember training events and conventions whichthat are designed to increase both product awareness and distributor recruitment.member recruitment). Because our various distributormember conventions are not always held at the same time each year, interim period comparisons will be impacted accordingly.

 


The functional currency of our international subsidiaries is generally their local currency. Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at average rates of exchange during the period. Equity accounts are translated at historical rates.  The resulting translation adjustments are recorded directly into a separate component of stockholders’ equity and represent the only component of accumulated other comprehensive income.

Sales by our foreign subsidiaries are transacted in the respective local currencies and are translated into U.S. dollars using average rates of exchange for each monthly accounting period to which they relate.  Most of our product purchases from third-party manufacturers are transacted in U.S. dollars.  Consequently, our sales and net earnings are affected by changes in currency exchange rates, with sales and earnings generally increasing with a weakening U.S. dollar and decreasing with a strengthening U.S. dollar. 

dollar, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” and more specifically under the caption “Foreign Currency Exchange Risk” for further information. 



Results of Operations

The following table sets forth our operating results as a percentage of net sales for the periods indicated.

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Net sales

  100.0%  100.0%

Cost of sales

  25.8   23.9 

Gross profit

  74.2   76.1 

Operating expenses:

        

Distributor commissions

  41.9   45.8 

Selling, general and administrative expenses

  25.1   22.2 

Depreciation and amortization

  0.1   0.1 

Total operating expenses

  67.1   68.1 

Income from operations

  7.1   8.0 

Other expense, net

  (0.1) 

 

Income before income taxes

  7.0   8.0 

Income tax provision (benefit)

 

   0.2 

Net income

  7.0%  7.8%

Net Sales

indicated:

 Year Ended December 31,
 2016 2015 2014
Net sales100.0% 100.0% 100.0 %
Cost of sales19.1
 20.4
 21.7
Gross profit80.9
 79.6
 78.3
Operating expenses:     
Commissions expense43.5
 47.8
 45.7
Selling, general and administrative expenses15.0
 13.6
 15.8
Depreciation and amortization0.1
 0.1
 0.1
Total operating expenses58.6
 61.5
 61.6
Income from operations22.3
 18.1
 16.7
Other expense, net
 
 (0.2)
Income before income taxes22.3
 18.1
 16.5
Income tax provision3.1
 0.2
 0.2
Net income19.2% 17.9% 16.3 %
The following table sets forth revenue by market for the periods indicated (in thousands):

  

Year Ended December 31,

 
  

2012

  

2013

 
                 

North America

 $1,816   4.8% $2,361   4.5%

Hong Kong

  26,235   69.9   40,585   77.3 

China

  1,081   2.9   791   1.5 

Taiwan

  2,074   5.5   3,387   6.4 

South Korea

  285   0.8   702   1.3 

Japan

  168   0.5   106   0.2 

Russia and Kazakhstan

  5,540   14.8   4,354   8.3 

Europe

  315   0.8   241   0.5 

Total

 $37,514   100.0% $52,527   100.0%

 Year Ended December 31,
 2016 2015 2014
North America$5,909
 2.0% $5,992
 2.3% $2,812
 2.3%
Hong Kong1
263,482
 91.6
 245,737
 92.8
 111,028
 89.1
China9,086
 3.2
 4,425
 1.7
 1,538
 1.2
Taiwan6,213
 2.2
 5,965
 2.3
 4,628
 3.7
South Korea691
 0.2
 1,128
 0.4
 1,009
 0.8
Japan86
 
 92
 
 89
 0.1
Singapore169
 0.1
 
 
 
 
Russia, Kazakhstan and Ukraine2
858
 0.3
 1,139
 0.4
 3,113
 2.5
Europe1,234
 0.4
 382
 0.1
 373
 0.3
Total$287,728
 100.0% $264,860
 100.0% $124,590
 100.0%
1Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. See “Item 1A. Risk Factors”.
2We discontinued our Ukraine operations during the second quarter of 2015.

Financial Results of 2016 Compared to 2015

Net Sales
Net sales were $52.5$287.7 million for the year ended December 31, 20132016 compared with $37.5$264.9 million a year ago, an increase of $15.0$22.8 million, or 40%9%.  Hong Kong net sales, substantially all of which were shipped to members residing in China, increased $14.4$17.7 million, or 55%7%, over the prior year. TheHong Kong experienced an increase can be attributableof 7,800 active members, or 8%, during 2016, which contributed to the year-long marketing campaignincrease in product sales volume. We also launched new Wellness products during 2016, which contributed approximately $11.2 million to our top-line growth. However, we believe our net sales increase was adversely impacted by the following:

A primary factor was the special measures the Chinese government implemented in preparation of the G20 Summit in Hangzhou, one of our top markets, in which they relocated city residents, emptied entire districts, blocked urban traffic and in-market activities designed to reward our members with additional cash bonuses, prizesshut down businesses in July, August and advancementearly September 2016.

Also, we did not offer a comparable incentive trip promotion in our international recognition program, which we refer to2016 as the Supreme Bonus program. A similar2015 supplemental incentive programtrip promotion to the U.S., which proved to be appealing and contributed to increased sales in 2015.

Finally, the devaluation of the Chinese yuan, which depreciated 7% against the Hong Kong dollar during 2016, indirectly affected our financial results by increasing the prior year endedproduct pricing in June.

the currency of our Chinese members.

Outside of our Hong Kong business, net sales elsewhere increased $663,000,$5.1 million, or 6%27%, compared with the prior year, driven by a year ago. A decrease105% increase in the Russian market was substantiallyour China e-commerce business and a 223% increase in Europe, offset by increases in Taiwan andthe performance of South Korea, bothwhich decreased 39% and our Commonwealth of Independent States (“CIS”) market, which benefited from additionaldecreased 25%. The $4.7 million net sales and marketing programs offeredincrease in our China e-commerce business was primarily driven by increased sales in our Home product line, which was introduced during 2013.

the fourth quarter of 2015. The $852,000 net sales increase in Europe was primarily driven by our Wellness product line.
 

As of December 31, 2013, the operating subsidiaries of the Company had 27,520 active distributors, compared to 20,680 active distributors at December 31, 2012. Hong Kong experienced an increase of 6,060 active distributors, or 43%, from December 31, 2012 to December 31, 2013.

As of December 31, 2013, the Company had2016, deferred revenue was $4.9 million, which primarily consisted of $2.6$2.2 million of which $1.9 million pertained toin unshipped product orders, $449,000 pertainedand $2.3 million and $430,000 pertaining to auto ship advances and $182,000 pertained to unamortized enrollment package revenue.

revenue, respectively.

Gross Profit

Gross profit was 76.1%80.9% of net sales for the year ended December 31, 20132016 compared with 74.2% of net sales for the year ended December 30, 2012. The margin increase is attributable to lower fees paid to our third-party service provider in Russia and lower importation costs incurred in the Russian market as a percentage of overall net sales, which occurs when sales from the Russian market comprise a lower percentage of our overall net sales. Additionally, the increase is attributable to the introduction of new higher margin products in Hong Kong in late 2012 and early 2013, as well as a price increase onPremium Noni Juice™ effective mid-June 2012 in Hong Kong.

Distributor Commissions

Distributor commissions were 45.8%79.6% of net sales for the year ended December 31, 2013 compared with 41.9%2015. The gross profit margin percentage increase is due to higher event and training revenue, higher product margins and lower logistics costs.

Commissions
Commissions were 43.5% of net sales for the year ended December 31, 2012.2016 compared with 47.8% of net sales for the year ended December 31, 2015.  The increase is due to the 12-month incentive program around our international recognition program, called the Supreme Bonus program. A comparable program in the prior year concluded at the end of the second quarter, which similarly resulted in distributor commissionsdecrease as a percentage of net sales around 44% during that particular period. Without suchresulted primarily from the reduction in our on-going cash and other incentive programs during 2013 orwhich cost 3.0% of net sales for the first halfyear ended December 31, 2016 compared with 6.4% of 2012,net sales for the year-over-year commission rate would have been roughly the same.

year ended December 31, 2015.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $11.6$43.2 million for the year ended December 31, 20132016 compared with $9.4$36.0 million for the year ended December 31, 2012.2015. Selling, general and administrative expenses increased by $2.2$7.2 million, or 24%20%, mainly due to the following:

An aggregate $749,000 increase in employee compensation-related costs primarily resulting from employee incentive programs and new hires in Hong Kong and Russia during the latter half of 2012;

Employee-related travel increased $156,000an increase in event costs, member training costs, professional fees, and an increase in credit card fees and assessments due to higher net sales, offset by a decrease in our employee-related expenses, as compared to more support on incentive trips and at training events;

Severance cost increased $320,000 primarily due to the accrual of salary and benefit continuation per a terminated employment agreement in December 2013;

Credit card fees and assessments increased $404,000 due to higher net sales over the prior year; and

Higher professional fees of $261,000 resulting from the development of the Kazakhstan and Ukraine markets as well as professional fee adjustments recognized in the prior year.

Other Expense, Net

Loss on foreign exchange was $125,000 for the year ended December 31, 2012 due to the impact2015.

Income Taxes
An income tax provision of strengthening currencies (against the U.S. dollar) earlier in the year on inter-company balances, namely the European euro and Russian ruble. The Company took certain steps during the second quarter of 2012 to mitigate its exposure to the European euro going forward. A loss on foreign exchange totaling $32,000$9.0 million was recognized for the year ended December 31, 2013.

2016 compared with $552,000 for the year ended December 31, 2015. The increase is due to greater profitability of our international operations, as well as the repatriation of foreign earnings back to the U.S. during the year. As a result of capital return activities approved by the Board of Directors during the first quarter of 2016 and anticipated future capital return activities, we then determined that a portion of our undistributed foreign earnings were no longer deemed reinvested indefinitely by our non-U.S. subsidiaries. We repatriated $19.8 million to the U.S. during the three months ended March 31, 2016, part of which was offset by U.S. net operating losses. Accordingly, the deferred tax liability previously established for undistributed foreign earnings up to existing U.S. net operating losses was reduced. The excess amount repatriated during the year ended December 31, 2016 was generated from current foreign earnings. In addition, during the three months ended December 31, 2016, we released our remaining valuation allowance against U.S. deferred tax assets as it was determined that it is more likely than not that we will realize the tax benefits of our deferred assets in future periods. We will continue to periodically reassess the needs of our foreign subsidiaries and update our indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, we expect to recognize additional income tax provision at the applicable U.S. corporate tax rate.



Financial Results of 2015 Compared to 2014

Net Sales

Net sales were $264.9 million for the year ended December 31, 2015 compared with $124.6 million a year ago, an increase of $140.3 million, or 113%.  Hong Kong net sales, substantially all of which were shipped to members residing in China, increased $134.7 million, or 121%, over the prior year.  Hong Kong experienced an increase of 54,100 active members, or 116%, during 2015, which is comparable to the increase in net sales. The sales increase in Hong Kong was primarily due to a substantial increase in product sale volumes attributable to the increase in new active members and effectiveness of our leadership development, promotional programs, incentives, events, new products, training, commission plans and services. During 2015, our on-going member cash and incentive programs, including a supplemental incentive trip promotion to the U.S. offered during part of 2015, were more appealing to our members than those offered during the prior year and contributed to increased sales. Additionally, we hosted the largest event in our company’s history in Hong Kong during August 2015, and launched new Wellness products that resulted in additional sales of approximately $7.0 million.
Outside of our Hong Kong business, net sales increased $5.6 million, or 41%, compared with the prior year. Double or triple digit percentage sales increases occurred in North America, Taiwan, South Korea and the China e-commerce business. These increases were offset by the performance of our CIS market, which continued to be negatively impacted by the political unrest in the region, as well as the devaluation of the Russian ruble, and decreased $2.0 million, or 63%, compared with the prior year.
As of December 31, 2015, deferred revenue was $4.0 million, which primarily consisted of $1.8 million in unshipped product orders, and $1.6 million and $331,000 pertaining to auto ship advances and unamortized enrollment package revenue, respectively.
Gross Profit
Gross profit was 79.6% of net sales for the year ended December 31, 2015 compared with 78.3% of net sales for the year ended December 31, 2014. The gross profit margin percentage increase was primarily attributable to higher product margins, lower third party service provider fees in Russia and lower logistics costs in Hong Kong.
Commissions
Commissions were 47.8% of net sales for the year ended December 31, 2015 compared with 45.7% of net sales for the year ended December 31, 2014.  The increase as a percentage of net sales for the year ended December 31, 2015 primarily resulted from an increase in the cost of our on-going member cash and other incentive programs.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $36.0 million for the year ended December 31, 2015 compared with $19.7 million for the year ended December 31, 2014. Selling, general and administrative expenses increased by $16.3 million, or 83%, mainly due to an increase in employee-related costs and incentive program accruals, professional fees, director costs, and facility costs, as well as an increase in credit card fees and assessments due to higher net sales as compared to the year ended December 31, 2014.
Income Taxes

An income tax provision of $102,000$552,000 was recognized for the year ended December 31, 2013 primarily related to our operations outside the United States,2015 compared with an income tax benefit of $24,000$266,000 for the year ended December 31, 2012.2014. The Company did not recognizeincrease was due to greater profitability of our international operations, as well as the repatriation of foreign earnings back to the U.S. during the year. As a result of capital return activities approved by the Board of Directors during the three months ended September 30, 2015, and anticipated future capital return activities intended to take full advantage of existing U.S. net operating losses, we determined that a portion of our undistributed foreign earnings were no longer deemed reinvested indefinitely by our non-U.S. subsidiaries beginning in the quarter ended September 30, 2015. As such, an accumulated deferred tax benefitliability of $9.3 million was recorded against these undistributed earnings, which included the impact of utilization of foreign tax credits. However, because it was anticipated that these earnings would be offset by U.S. net operating losses that had previously been fully offset by a valuation allowance, we also released a similar amount of valuation allowance. Accordingly, there was no significant impact on the income tax provision for the year ended December 31, 2015.


During 2015, $18.4 million in foreign earnings were repatriated back into the U.S. which were offset by U.S. net operating losses. As of December 31, 2015 there was a remaining deferred tax liability of $2.8 million, which was offset by an equivalent amount of net operating loss deferred tax assets. This represented the remaining balance of the U.S. tax purposesimpact of undistributed foreign earnings that was planned to be repatriated to the U.S. as of December 31, 2015. All other undistributed foreign earnings were intended to be permanently reinvested in either 2012 or 2013 duenon-U.S. operations to uncertainty thatfund and expand the benefit will be realized.

non-U.S. subsidiaries as of December 31, 2015.


Liquidity and Capital Resources

At December 31, 2013, the Company’s2016, our cash and cash equivalents totaled $14.6$125.9 million. Total cash and cash equivalents increased by $2.6$21.0 million and $10.3$60.1 million during 20122016 and 2013,2015, respectively.

We consider all highly liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. As of December 31, 2016, we had $73.5 million in available-for-sale investments classified as cash equivalents. In addition, cash and cash equivalents included $120.0 million held in bank accounts overseas, which included $6.8 million held in banks located in China subject to foreign currency controls.

At December 31, 2013,2016, the ratio of current assets to current liabilities was 1.252.47 to 1.00 and the Companywe had $3.4$84.1 million of working capital. Current liabilities included deferred revenue of $2.6 million that consisted of unshipped product orders, auto ship advances and unamortized enrollment package revenues. The ratio of current assets to current liabilities excluding deferred revenue was 1.54 to 1.00. Working capital as of December 31, 20132016 increased $3.9$27.9 million compared to the Company’sour working capital as of December 31, 2012,2015, primarily due to cash generated from operations.


Cash provided by operations during 20132016 was $10.7$53.2 million compared to $2.2$81.3 million during 2012.2015. The increasedecrease in operating cash flows resultsresulted primarily from the timing of increased commission-related payments, the increase of our members' utilization of our eWallet functionality and U.S. income tax payments resulting from the repatriation of overseas profits of $7.4 million, offset by a reduction in our inventory purchases and increased net sales increase year over year, as well as an increase in both unshipped orders and outstanding commission checks, and the timing difference of cash outlays associated with the incentive programs surrounding our international recognition program.

income during 2016.


Cash flows used in investing activities totaled $292,000$905,000 during 2013,2016. Software development costs of which $210,000$666,800 were purchasesincurred during the year ended December 31, 2016 for our Oracle ERP upgrade and enhancement of propertyour back office software platform. Cash flows used in investing activities totaled $3.7 million during the year ended December 31, 2015 and equipment. During November 2013, we began the build outconsisted primarily of our June 2015 funding of a multi-purposed facilitybank deposit amount in Zhongshan, China intendedthe amount of CNY 20 million (USD $3.3 million at June 30, 2015) for our direct selling license application. Such deposit is required by Chinese laws to serve the needs of Chinese consumers. Accumulated build-out costs for the facility totaled $102,000 during 2013, which was completed in January 2014. Also, asestablish a result of increased sales in South Korea during 2013, additionalconsumer protection fund. In August 2015, cash deposits in the amount of $82,000$218,000 were required to be held by areceived from certain South Korean credit card processing company. Cash provided by investing activitiescompanies. Additionally, buildout costs of $608,000 were incurred during 2012 was $397,000, which resulted from a $493,000 decrease2015 for new offices located in restricted cash. In April 2010,California, Hong Kong and Singapore, at the Company’s primary credit card processing company required thatmulti-purpose facility in Zhongshan, China and at the Company gradually increase to and maintain the reserve balance at $500,000. The Company reached the necessary reserve requirement during the second quarter of 2011. One-half of the reserve balance was returned to the Companynew Healthy Lifestyle Center in January 2012 and the remainder was returned in May 2012.

Monterey Park, California.


Cash flows used in financing activities during 2013 was limited2016 totaled $30.6 million. We used $23.7 million to the repurchase shares of our common stock in accordance with the Rule 10b5-1 plans authorized bystock. On January 12, 2016, the Board of Directors authorized an increase to our stock repurchase program first approved on August 13, 2012July 28, 2015 from $15.0 million to $70.0 million. Repurchases are expected to be executed to the extent that our earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, we may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not require us to acquire a specific number of shares, and may be suspended from time to time or discontinued. During February 2016, pursuant to the stock repurchase program, we authorized our broker to proceed with the purchase 100,000of shares of itsour common stock in the open market. During the year ended December 31, 2016, the stock repurchase program resulted in our purchasing a total of 903,031 shares of our common stock for an aggregate purchase price of $23.7 million, plus transaction costs. As of December 31, 2016, $32.0 million of the $70.0 million stock repurchase program approved on behalfJuly 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of its non-officer, overseas employees. Such purchases totaled $52,000. No significantrelated estimated income tax. Cash flows used in financing activities occurred during 2012.

On March 7, 2014,2015 totaled $17.5 million, and consisted primarily of $16.1 million used to repurchase a total of 547,042 shares of our common stock and $1.7 million in cash dividends.



Other financing cash flows during 2016 included the following cash dividend payments (in thousands, except per share amounts) to holders of our common stock:
Declaration Date Per Share Amount Record Date Payment Date
October 23, 2016 (special) $0.35
 $3,941
 November 15, 2016 November 25, 2016
October 23, 2016 0.08
 901
 November 15, 2016 November 25, 2016
July 19, 2016 0.07
 787
 August 16, 2016 August 26, 2016
April 21, 2016 0.06
 686
 May 10, 2016 May 20, 2016
March 1, 2016 0.05
 576
 March 16, 2016 March 24, 2016
Total $0.61
 $6,891
    

Subsequent to December 31, 2016, on January 24, 2017, the Board of Directors declared a dividend on each share of outstanding Series A preferred stock in the amount of $0.81507 per share representing the accrued unpaid dividends from May 4, 2007 through March 7, 2014. Simultaneously, the Board of Directors also declared acash dividend of $0.005$0.09 and a special cash dividend of $0.35 on each share of common stock outstanding. All suchSuch dividends are payable in cashwere paid on April 8, 2014March 3, 2017 to stockholders of record on March 28, 2014.PaymentFebruary 21, 2017. Payment of any future dividends on shares of Series A preferred stock and common stock will be at the discretion of the Company’sour Board of Directors.

The Company believes

We believe that itsour existing internal liquidity, supported by cash on hand and cash flows from operations should be adequate to fund normal business operations and address itsour financial commitments for at least the next 12 months, assuming no significant unforeseen expense or revenue decline. If the Company’s foregoing beliefs or assumptions prove to be incorrect, however, the Company’s business, results of operations and financial condition could be materially adversely affected.See “Item 1A. Risk Factors.”

The Company doesforeseeable future.

We do not have any significant unused sources of liquid assets. Potentially the Company might receive additional external funding if currently outstanding warrants are exercised. Furthermore, ifIf necessary, the Companywe may attempt to generate more funding from the capital markets, but currently doesdo not believe that will be necessary.

On October 19, 2007, the Company issued warrants to purchase 3,141,499 shares of common stock in connection with a convertible debentures financing. The warrants consisted of seven-year warrants to purchase 1,495,952 shares of common stock, one-year warrants to purchase 1,495,952 shares of common stock, and five-year warrants to purchase 149,595 shares of common stock. The term for each of the warrants began six months and one day after their respective issuance and each have an exercise price of $3.52 per share.Such one-year warrants expired unexercised on April 21, 2009 and such five-year warrants expired unexercised on April 21, 2013. Of the seven-year warrants to purchase 1,495,952 shares of common stock, as of February 28, 2014 warrants to purchase 120,0000 shares of common stock were exercised (resulting in gross proceeds of $422,000), leaving warrants to purchase 1,375,952 shares of common stock outstanding. These unexercised warrants expire April 21, 2015 if not previously exercised. Additionally, on May 4, 2013, warrants issued by the Company in a May 2007 private equity placement representing the right to purchase 2,059,307 shares of common stock expired unexercised.



We do not intend to devote material resources to opening any additional foreign markets in the near future.

Our priority is to focus our resources on investing in our most promisingimportant markets, which we consider to be Greater China and certain CIS countries namely Russia, Ukrainewhere our existing members may have the connections to recruit prospects and Kazakhstan. 

sell our products, such as Southeast Asia. We will continue to invest in our Mainland China entity for such purposes as establishing China-based manufacturing capabilities, increasing public awareness of our brand and our products, sourcing more Chinese-made products, building a chain of service stations, opening additional Healthy Lifestyle Centers or branch offices, adding local staffing and other requirements for a China direct selling license application. We have also begun to invest some resources in Central and South America.


Quarterly Results of Operations (Unaudited)

The Companyfollowing table sets forth unaudited quarterly operating results for each of the last eight fiscal quarters. The information for each of these quarters has been prepared on the same basis as the audited annual financial statements included elsewhere in this annual report and, in the opinion of management, includes all adjustments, which includes only normal recurring adjustments, necessary for the fair statement of the results of operations for these periods. This data should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8. Financial Statements and Supplementary Data” of this annual report. These quarterly operating results are not necessarily indicative of our operating results for any future period.
 2016 2015
 
4th
Quarter
 
3rd
Quarter
 
2nd
Quarter
 
1st
Quarter
 4th
Quarter
 3rd
Quarter
 2nd
Quarter
 1st
Quarter
                
 (In Thousands, Except Per Share Data)
Net sales$62,312
 $70,679
 $80,391
 $74,346
 $73,656
 $80,779
 $69,716
 $40,709
Gross profit50,375
 57,052
 65,332
 60,066
 58,583
 64,778
 55,622
 31,779
Income from operations20,014
 15,208
 14,927
 13,987
 13,893
 14,803
 12,263
 6,918
Net income19,048
 12,557
 12,201
 11,280
 13,699
 14,531
 12,273
 6,738
Income per common share:               
Basic1.70
 1.12
 1.08
 0.96
 1.13
 1.19
 0.99
 0.54
Diluted1.70
 1.12
 1.07
 0.95
 1.13
 1.18
 0.98
 0.54


Contractual Obligations

The following table summarizes our contractual obligations as of December 31, 2016 and the expected effect on our cash flow and liquidity in future periods (in thousands):
  Total 2017 2018-2019 2020-2021 Thereafter
Operating leases $3,923
 $1,559
 $1,154
 $510
 $700
Purchase obligations 20,745
 9,725
 11,020
 
 
Long-term incentive 10,064
 1,874
 2,390
 1,963
 3,837
Other commitments 357
 107
 163
 87
 
Total $35,089
 $13,265
 $14,727
 $2,560
 $4,537

We have entered into non-cancelable operating lease agreements for locations within the United States and for itsour international subsidiaries, with expirations through March 2018.

September 2025 totaling $3.9 million.

In May 2013, the Companywe entered into an exclusive distribution agreement with one of itsour suppliers to purchase itstheir product through July 2016.2016 which automatically renews annually unless terminated 90 days prior to the termination date. To maintain exclusivity, the Company iswe are required to purchase a minimum of $40,000 of product per month until the termination date. As of December 31, 2013, the Company was2016, we were in compliance with the exclusivity provision.

In February 2016, we amended a supply agreement with one of our suppliers to maintain worldwide exclusivity in return for purchasing a minimum of $9.4 million of product annually on average over the next three years, plus certain raw material guarantees. If we do not purchase the minimum product as required, then a Cure Payment, as defined, will be due to the supplier. The Company hasterm of the agreement is three years commencing February 2016 and shall automatically renew for successive three year terms unless notice of termination is provided by either party.

In recognition of the achievement of specified performance goals, financial rewards are awarded under our 2014 Long-Term Incentive Plan with cash payments through December 2023. See Note 1 of the Notes to Consolidated Financial Statements in “Item 8. Financial Statements and Supplementary Data” of this report for additional information.

We have evaluated our tax positions and have determined that there are no uncertain tax positions for the current year or years prior.
We have employment agreements with certain members of itsour management team that can be terminated by either the employee or the Companyus upon four weeks’ notice.  The employment agreements entered into with the management team contain provisions that guarantee the payments of specified amounts in the event of a change in control, as defined, or if the employee is terminated without cause, as defined, or terminates employment for good reason, as defined. In addition, the Company has an employment agreement with another employee that can be terminated at will by either the employee or the Company, provided that the Company must pay a specified amount if it terminates the agreement without cause, as defined, or the employee terminates the agreement with good reason, as defined. Accrued severance obligations totaling $296,000 as of December 31, 2013 are expected to be paid during 2014.


Critical Accounting Policies and Estimates

A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in “Item 8. Financial Statements and Supplementary Data” of this report. The Company has identified certain policiespreparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. To the extent that there are important tomaterial differences between the portrayal of its financial conditionestimates and actual results, future results of operations. operations will be affected.
Critical accounting policies and estimates are defined as both those that are material to the portrayal of our financial condition and results of operations and as those that require management’s most subjective judgments.  TheseManagement believes our critical accounting policies and estimates require the application of significant judgment by the Company’s management.

The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill,are those related to revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributormember commissions and income taxes. Various assumptions and other factors prompt the determination of these significant estimates. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. The actual results may differ materially and adversely from the Company’s estimates. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected. The Company’s critical accounting policies at December 31, 2013 include the following:

Inventory Valuation. The Company reviews its inventory carrying value and compares it to the net realizable value of its inventory and any inventory value in excess of net realizable value is written down. In addition, the Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. Also, if actual sales or management plans are less favorable than those originally projected by management, additional inventory reserves or write-downs may be required. At December 31, 2012 and 2013, the Company’s inventory value was $867,000 and $1.8 million, respectively, net of reserves of $72,000 and zero, respectively. No significant provision was recorded during the periods presented.

Valuation of Goodwill.In accordance with accounting principles generally accepted in the United States of America, the Company assesses qualitative factors in order to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a two-step impairment test is performed. The Company’s policy is to test for impairment annually during the fourth quarter. At December 31, 2012 and 2013, goodwill of $1.8 million was reflected on the Company’s balance sheet. No impairment of goodwill was recognized during the periods presented.

Allowance for Sales Returns.An allowance for sales returns is provided during the period the product is shipped.  The allowance is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 3% of sales.  Sales returns were 2% and 1% of sales for the years ended December 31, 2012 and 2013, respectively.  The allowance for sales returns was $181,000 and $504,000 at December 31, 2012 and 2013, respectively.  No material changes in estimates have been recognized during the periods presented.



Revenue Recognition.Product sales are recorded when the products are shipped and title passes to independent distributors.members. Product sales to distributorsmembers are made pursuant to a distributormember agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors,members, which is commonly referred to as “F.O.B. Shipping Point.” The CompanyWe primarily receivesreceive payment by credit card at the time distributorsmembers place orders. The Company’sOur sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. Amounts received for unshipped product are recorded as deferred revenue. Such amounts totaled $384,000$2.2 million and $1.9$1.8 million at December 31, 20122016 and 2013,2015, respectively. Shipping charges billed to distributorsmembers are included in net sales. Costs associated with shipments are included in cost of sales.

Event and training revenue is deferred and recognized as the event or training occurs.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributorsmembers access to both a personalized marketing website and a business management system. No upfront costs are deferred as the amount is nominal. At December 31, 20122016 and 2013,2015, enrollment package revenue totaling $189,000$430,000 and $182,000$331,000 was deferred, respectively. Although the Company haswe have no immediate plans to significantly change the terms or conditions of enrollment packages, any changes in the future could result in additional revenue deferrals or could cause us to recognize the deferred revenue over a longer period of time. Additionally, deferred revenue includes advances for auto ship orders. In certain markets, when a distributor’smember’s cumulative commission income reaches a certain threshold, a percentage of the distributor’smember’s weekly commission is held back as an advance and applied to an auto ship order once the accumulated amount of the advances is sufficient to pay for the pre-selected auto ship package of the distributor.member.  Such advances were $263,000$2.3 million and $449,000$1.6 million at December 31, 20122016 and 2013,2015, respectively.

Distributor

Allowance for Sales Returns. An allowance for sales returns is provided during the period the product is shipped.  The allowance is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 7% of sales.  Sales returns were 2% and 1% of sales for the years ended December 31, 2016 and 2015, respectively.  The allowance for sales returns was $1.6 million at December 31, 2016 and 2015.  No material changes in estimates have been recognized during the periods presented.
Commissions.Independent distributorsmembers earn commissions based on total personal and group bonus volume points per weekly sales period.  Each of our products are designated a specified number of bonus volume points, which is essentially a percentage of the product’s wholesale price.  The Company accruesWe accrue commissions when earned and paysas the related revenue is recognized and pay commissions on product sales generally two weeks following the end of the weekly sales period.

In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors.

Independent distributorsmembers may also earn incentives based on meeting certain qualifications during a designated incentive period, which may range from several weeks to up to a year.  These incentives may be both monetary and non-monetary in nature.  The Company estimatesFor each individual incentive, we estimate the total number of qualifiers as well as the expected per qualifier cost and accrues theaccrue all costs associated with incentives throughout the qualification period. We regularly review and update, if necessary, the estimates of both qualifiers and cost as more information is obtained during the qualification period. Any resulting change in total cost is recognized over the duration of theremaining qualification period based on distributor achievement of the qualification requirements.period. Accrued commissions, including the estimated cost of our international recognition incentive program and other supplemental programs,totaled $1.3$13.6 million and $4.0$19.6 million at December 31, 20122016 and 2013,2015, respectively.

Tax Valuation Allowance.The Company evaluates

Income Taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory rates for the years in which the temporary differences are expected to be recovered or settled. We evaluate the probability of realizing the future benefits of any of itsour deferred tax assets and recordsrecord a valuation allowance when it believeswe believe a portion or all of itsour deferred tax assets may not be realized. The Company increased the valuation allowance to equal its netDeferred tax expense or benefit is a result of changes in deferred tax assets during 2005 dueand liabilities. Based on the technical merits of our tax position, tax benefits may be recognized if we determine it is more likely than not that our position will be sustained on examination by tax authorities. The complex nature of these estimates requires us to anticipate the likely application of tax law and make judgments on the largest benefit that has a greater than fifty percent likelihood of being realized prior to the uncertaintycompletion and filing of future operating results.tax returns for such periods. As of December 31, 2016, we no longer have a valuation allowance against our U.S. deferred tax assets. We maintain a valuation allowance in certain foreign jurisdictions with an overall tax loss. The valuation allowance will be reduced at such time as management believes it is more likely than not that the deferred tax assets will be realized. During 2012 and 2013, no such reduction in the valuation allowance occurred. Any reductions in the valuation allowance will reduce future income tax provisions.

provision.



Provision for income taxes depends on the statutory tax rates in each of the jurisdictions in which we operate. We believeAs a result of capital return activities, we determined that we operate in compliance with all applicable transfer pricing laws and we intend to continue to operate in compliance with such laws. However, there can bea portion of our current undistributed foreign earnings are no assurance that welonger deemed reinvested indefinitely by our non-U.S. subsidiaries. We will continue to be foundperiodically reassess the needs of our foreign subsidiaries and update our indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, we expect to recognize additional income tax provision at the applicable U.S. corporate tax rate. As of December 31, 2016, we recorded a deferred tax liability for earnings that we plans to repatriate out of accumulated earnings in future periods. All undistributed earnings in excess of 50% of current earnings on an annual basis are intended to be operatingreinvested indefinitely as of December 31, 2016.

We estimate what our effective tax rate will be for the full fiscal year at each interim reporting period and record a quarterly tax provision based on that estimated effective tax rate. Throughout the year that estimated rate may change based on variations in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may requireour business, changes in our operating procedures. If the United States Internal Revenue Service or the taxing authorities of any other jurisdiction were to successfully challenge these agreements, plans, or arrangements, or requirecorporate structure, changes in the geographic mix and amount of income, applicable tax laws and regulations, communications with tax authorities, as well as our transfer pricing practices, we could be required to pay higher taxes, interestestimated and penalties, andactual level of annual pre-tax income. We adjust our earnings would be adversely affected.

income tax provision in the reporting period in which the change in our estimated rate occurs so that the year-to-date provision is consistent with the anticipated annual tax rate. 

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable under smaller reporting company disclosure rules.


We have operations both internationally and within the United States, and we are exposed to market risks in the ordinary course of our business. These risks include primarily interest rate, foreign exchange and inflation risks.

Interest Rate Fluctuation Risk

Our cash and cash equivalents consist of cash, available-for-sale securities, comprising municipal notes, bonds and corporate debt, money market funds and time deposits. The primary objective of our investment in available-for-sale securities is to preserve principal while maximizing income without significantly increasing risk. Because our cash and cash equivalents have a relatively short maturity, our portfolio's fair value is relatively insensitive to interest rate changes. In future periods, we will continue to evaluate our investment policy relative to our overall objectives.

Foreign Currency Exchange Risk

We have foreign currency risks related to our revenue and expenses denominated in currencies other than the U.S. dollar. Our most significant foreign exchange exposure, the Hong Kong dollar, is for now pegged to the U.S. dollar. Our foreign currency exchange rate exposure to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble, Kazakhstani tenge, Singaporean dollar, Malaysian ringgit, Canadian dollar, and European euro represented approximately 7%, 6% and 10% of our revenue during the years ended December 31, 2016, 2015 and 2014, respectively. We have experienced and will continue to experience fluctuations in our net income as a result of transaction gains and losses related to translating certain balances denominated in currencies other than the U.S. dollar.

Our foreign currency exchange rate exposure may increase in the near future as we further develop opportunities in Southeast Asia, Canada, Central America, South America and Europe. Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar. We also experience indirect exchange rate exposure due to the recent devaluation of the Chinese yuan, which has depreciated 7% against the Hong Kong dollar and has eroded our Chinese memberspurchasing power. Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition. Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.

Inflation Risk

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we might not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.



Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


NATURAL HEALTH TRENDS CORP.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page

Page

31

32

33

34

35

36

37


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Natural Health Trends Corp.

Dallas, Texas

Rolling Hills Estates, California
We have audited the accompanying consolidated balance sheets of Natural Health Trends Corp. (the “Company”) as of December 31, 20132016 and 2012,2015, and the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the years in the two-yearthree-year period ended December 31, 2013. These consolidated2016. We also have audited the Company’s internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these financial statements, are the responsibilityfor maintaining effective internal control over financial reporting, and for its assessment of the Company’s management.effectiveness of internal control over financial reporting, included in the accompanying “Management's Annual Report on Internal Control over Financial Reporting”. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, or were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration ofmisstatement and whether effective internal control over financial reporting as a basis for designing audit procedures that are appropriatewas maintained in the circumstances, but not for the purpose of expressing an opinion on the effectivenessall material respects. Our audits of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includesstatements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well asand evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinion.

opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Natural Health Trends Corp. as of December 31, 20132016 and 2012,2015, and the results of its operations and its cash flows for each of the years in the two-yearthree-year period ended December 31, 2013,2016, in conformity with accounting principles generally accepted in the United States of America.

Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

/s/ Lane Gorman Trubitt, PLLC

Dallas, Texas

March 7, 2014

LLC
 
Dallas, Texas
March 10, 2017


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

  

December 31,

 
  

2012

  

2013

 
         

ASSETS

        

Current assets:

        

Cash and cash equivalents

 $4,207  $14,550 

Accounts receivable

  122   134 

Inventories, net

  867   1,828 

Other current assets

  641   658 

Total current assets

  5,837   17,170 

Property and equipment, net

  121   265 

Goodwill

  1,764   1,764 

Restricted cash

  239   328 

Other assets

  258   300 

Total assets

 $8,219  $19,827 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        
         

Current liabilities:

        

Accounts payable

 $1,385  $3,058 

Income taxes payable

  10   25 

Accrued distributor commissions

  1,308   3,962 

Other accrued expenses

  1,688   3,146 

Deferred revenue

  836   2,569 

Deferred tax liability

  92   108 

Other current liabilities

  991   882 

Total current liabilities

  6,310   13,750 

Commitments and contingencies

        

Stockholders’ equity:

        

Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,761,900 shares designated Series A convertible preferred stock, 138,400 and 123,693 shares issued and outstanding at December 31, 2012 and 2013, respectively; aggregate liquidation value of $308

  124   111 

Common stock, $0.001 par value; 50,000,000 shares authorized; 11,324,048 and 11,332,771 shares issued and outstanding at December 31, 2012 and 2013, respectively

  11   11 

Additional paid-in capital

  80,584   80,655 

Accumulated deficit

  (78,708)  (74,619)

Accumulated other comprehensive loss:

        

Foreign currency translation adjustments

  (102)  (81)

Total stockholders’ equity

  1,909   6,077 

Total liabilities and stockholders’ equity

 $8,219  $19,827 

 December 31,
 2016 2015
ASSETS   
Current assets:   
Cash and cash equivalents$125,921
 $104,914
Inventories, net11,257
 10,455
Other current assets4,066
 2,343
Total current assets141,244
 117,712
Property and equipment, net1,388
 894
Goodwill1,764
 1,764
Restricted cash2,963
 3,166
Other assets692
 616
Total assets$148,051
 $124,152
LIABILITIES AND STOCKHOLDERS’ EQUITY   
Current liabilities:   
Accounts payable$2,145
 $2,862
Income taxes payable663
 379
Accrued commissions13,611
 19,634
Other accrued expenses14,989
 16,703
Deferred revenue4,948
 4,011
Amounts held in eWallets19,165
 16,414
Other current liabilities1,633
 1,510
Total current liabilities57,154
 61,513
Deferred tax liability268
 60
Long-term incentive8,190
 5,770
Total liabilities65,612
 67,343
Commitments and contingencies

 

Stockholders’ equity:   
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding at December 31, 2016 and 2015
 
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2016 and 201513
 13
Additional paid-in capital86,574
 85,963
Retained earnings (accumulated deficit)38,548
 (9,647)
Accumulated other comprehensive loss(807) (101)
Treasury stock, at cost; 1,692,218 and 840,202 shares at December 31, 2016 and 2015, respectively(41,889) (19,419)
Total stockholders’ equity82,439
 56,809
Total liabilities and stockholders’ equity$148,051

$124,152
See accompanying notes to consolidated financial statements.


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In Thousands, Except Per Share Data)

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Net sales

 $37,514  $52,527 

Cost of sales

  9,685   12,551 

Gross profit

  27,829   39,976 

Operating expenses:

        

Distributor commissions

  15,724   24,053 

Selling, general and administrative expenses (including stock-based compensation expense of $94 and $110 during 2012 and 2013, respectively)

  9,415   11,634 

Depreciation and amortization

  45   66 

Total operating expenses

  25,184   35,753 

Income from operations

  2,645   4,223 

Other expense, net

  (39)  (32)

Income before income taxes

  2,606   4,191 

Income tax provision (benefit)

  (24)  102 

Net income

  2,630   4,089 

Preferred stock dividends

  (17)  (15)

Net income available to common stockholders

 $2,613  $4,074 
         

Income per share of Natural Health Trends – basic

 $0.24  $0.36 

Income per share of Natural Health Trends – diluted

 $0.23  $0.36 
         

Weighted-average number of shares outstanding – basic

  10,944   11,154 

Weighted-average number of shares outstanding – diluted

  11,234   11,331 

 Year Ended December 31,
 2016 2015 2014
Net sales$287,728
 $264,860
 $124,590
Cost of sales54,903
 54,098
 26,981
Gross profit232,825

210,762
 97,609
Operating expenses:     
Commissions expense125,050
 126,598
 56,997
Selling, general and administrative expenses43,245
 36,024
 19,687
Depreciation and amortization394
 263
 105
Total operating expenses168,689
 162,885
 76,789
Income from operations64,136
 47,877
 20,820
Other expense, net(59) (84) (184)
Income before income taxes64,077
 47,793
 20,636
Income tax provision8,991
 552
 266
Net income55,086

47,241
 20,370
Preferred stock dividends
 
 (10)
Net income available to common stockholders$55,086
 $47,241
 $20,360
Income per common share:     
Basic$4.84
 $3.84
 $1.67
Diluted$4.83
 $3.82
 $1.61
Weighted-average number of common shares outstanding:     
Basic11,382
 12,302
 12,131
Diluted11,407
 12,372
 12,600
Cash dividends declared per common share$0.61
 $0.14
 $0.03
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Net income

 $2,630  $4,089 

Other comprehensive income (loss), net of tax:

        

Foreign currency translation adjustments

  (3)  21 

Comprehensive income

 $2,627  $4,110 

 Year Ended December 31,
 2016 2015 2014
Net income$55,086
 $47,241
 $20,370
Other comprehensive income (loss), net of tax:     
Foreign currency translation adjustments(838) (79) 143
Release of cumulative translation adjustment132
 (82) 
Net change in foreign currency translation adjustment(706) (161) 143
Unrealized losses on available-for-sale securities
 (2) 
Comprehensive income$54,380
 $47,078
 $20,513
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In Thousands, Except Share Data)

  Preferred Stock  Common Stock  

Additional

Paid-In

  Accumulated  

Accumulated

Other Comprehensive

     
  

Shares

  

Amount

  

Shares

  

Amount

  Capital  Deficit  Loss  Total 
                                 

BALANCE, December 31, 2011

  138,400  $124   11,326,323  $11  $80,493  $(81,338) $(99) $(809)

Net income

 

  

  

  

  

   2,630  

   2,630 

Repurchase of common stock

 

  

   (2,275) 

   (3) 

  

   (3)

Foreign currency translation adjustments

 

  

  

  

  

  

   (3)  (3)

Stock-based compensation

 

  

  

  

   94  

  

   94 

BALANCE, December 31, 2012

  138,400   124   11,324,048   11   80,584   (78,708)  (102)  1,909 

Net income

 

  

  

  

  

   4,089  

   4,089 

Conversion of Series A preferred stock

  (14,707)  (13)  14,707  

   13  

  

  

 

Repurchase of common stock

 

  

   (32,660) 

   (52) 

  

   (52)

Issuance of common stock

 

  

   26,676  

  

  

  

  

 

Foreign currency translation adjustments

 

  

  

  

  

  

   21   21 

Stock-based compensation

 

  

  

  

   110  

  

   110 

BALANCE, December 31, 2013

  123,693  $111   11,332,771  $11  $80,655  $(74,619) $(81) $6,077 

 Preferred Stock Common Stock 
Additional
Paid-In
Capital
 
Retained Earnings
(Accumulated Deficit)
 
Accumulated
Other
Comprehensive
(Loss) Income
 Treasury Stock  
 Shares Amount Shares Amount    Shares Amount Total
BALANCE, December 31, 2013123,693
 $111
 11,359,769
 $11
 $80,690
 $(74,619) $(81) (26,998) $(35) $6,077
Net income
 
 
 
 
 20,370
 
 
 
 20,370
Conversion of Series A preferred stock(123,693) 
(111
) 123,693
 
 111
 
 
 
 
 
Exercise of warrants
 
 1,407,855
 2
 4,946
 
 
 
 
 4,948
Repurchase of common stock
 
 
 
 
 
 
 (382,564) (4,661) (4,661)
Common stock issued
 
 
 
 (46) (74) 
 25,342
 120
 
Dividends declared
 
 
 
 
 (476) 
 
 
 (476)
Foreign currency translation adjustments
 
 
 
 
 
 143
 
 
 143
Stock-based compensation
 
 
 
 49
 
 
 
 
 49
BALANCE, December 31, 2014
 
 12,891,317
 13
 85,750
 (54,799) 62
 (384,220) (4,576) 26,450
Net income
 
 
 
 
 47,241
 
 
 
 47,241
Exercise of warrants
 
 88,097
 
 309
 
 
 
 
 309
Repurchase of common stock
 
 
 
 
 
 
 (547,042) (16,071) (16,071)
Common stock issued
 
 
 
 (182) (380) 
 91,060
 1,228
 666
Dividends declared
 
 
 
 
 (1,709) 
 
 
 (1,709)
Elimination of CTA upon dissolution
 
 
 
 
 
 (82) 
 
 (82)
Foreign currency translation adjustments
 
 
 
 
 
 (79) 
 
 (79)
Unrealized loss on available-for-sale securities
 
 
 
 
 
 (2) 
 
 (2)
Stock-based compensation
 
 
 
 86
 
 
 
 
 86
BALANCE, December 31, 2015
 
 12,979,414
 13
 85,963
 (9,647) (101) (840,202) (19,419) 56,809
Net income
 
 
 
 
 55,086
 
 
 
 55,086
Repurchase of common stock
 
 
 
 
 
 
 (903,031) (23,704) (23,704)
Common stock issued
 
 
 
 507
 
 
 51,015
 1,234
 1,741
Dividends declared
 
 
 
 
 (6,891) 
 
 
 (6,891)
Elimination of CTA upon dissolution
 
 
 
 
 
 132
 
 
 132
Foreign currency translation adjustments
 
 
 
 
 
 (838) 
 
 (838)
Stock-based compensation
 
 
 
 104
 
 
 
 
 104
BALANCE, December 31, 2016
 $
 12,979,414
 $13
 $86,574
 $38,548
 $(807) (1,692,218) $(41,889) $82,439
See accompanying notes to consolidated financial statements. 


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

  

Year Ended December 31,

 
  

2012

  

2013

 
         

CASH FLOWS FROM OPERATING ACTIVITIES:

        

Net income

 $2,630  $4,089 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

  45   66 

Stock-based compensation

  94   110 

Deferred income taxes

  (56)  16 

Changes in assets and liabilities:

        

Accounts receivable

  (24)  (17)

Inventories, net

  236   (974)

Other current assets

  (95)  (35)

Other assets

  (5)  (38)

Accounts payable

  (826)  1,673 

Income taxes payable

  (1)  16 

Accrued distributor commissions

  117   2,679 

Other accrued expenses

  203   1,467 

Deferred revenue

  (140)  1,738 

Other current liabilities

  36   (104)

Net cash provided by operating activities

  2,214   10,686 
         

CASH FLOWS FROM INVESTING ACTIVITIES:

        

Purchases of property and equipment

  (96)  (210)

Decrease (increase) in restricted cash

  493   (82)

Net cash provided by (used in) investing activities

  397   (292)
         

CASH FLOWS FROM FINANCING ACTIVITIES:

        

Repurchase of common stock

  (3)  (52)

Net cash used in financing activities

  (3)  (52)
         

Effect of exchange rates on cash and cash equivalents

  (18)  1 

Net increase in cash and cash equivalents

  2,590   10,343 

CASH AND CASH EQUIVALENTS, beginning of period

  1,617   4,207 

CASH AND CASH EQUIVALENTS, end of period

 $4,207  $14,550 

 Year Ended December 31,
 2016 2015 2014
CASH FLOWS FROM OPERATING ACTIVITIES:     
Net income$55,086
 $47,241
 $20,370
Adjustments to reconcile net income to net cash provided by operating activities:     
Depreciation and amortization394
 263
 105
Stock-based compensation104
 86
 49
Cumulative translation adjustment realized in net income132
 (82) 
Deferred income taxes217
 (15) (43)
Changes in assets and liabilities:     
Inventories, net(851) (6,762) (2,029)
Other current assets(1,681) (1,025) (501)
Other assets(90) (267) (85)
Accounts payable(714) 637
 (822)
Income taxes payable303
 (115) 243
Accrued commissions(6,031) 10,840
 5,077
Other accrued expenses51
 10,714
 3,706
Deferred revenue947
 1,331
 147
Amounts held in eWallets2,752
 14,350
 2,065
Other current liabilities135
 25
 666
Long-term incentive2,420
 4,105
 1,665
Net cash provided by operating activities53,174
 81,326
 30,613
CASH FLOWS FROM INVESTING ACTIVITIES:     
Purchases of property and equipment(905) (710) (339)
Increase in restricted cash
 (3,028) 
Net cash used in investing activities(905) (3,738) (339)
CASH FLOWS FROM FINANCING ACTIVITIES:     
Proceeds from exercise of warrants
 309
 4,948
Repurchase of common stock(23,704) (16,071) (4,661)
Dividends paid(6,891) (1,709) (476)
Net cash used in financing activities(30,595) (17,471) (189)
Effect of exchange rates on cash and cash equivalents(667) (19) 181
Net increase in cash and cash equivalents21,007

60,098
 30,266
CASH AND CASH EQUIVALENTS, beginning of period104,914
 44,816
 14,550
CASH AND CASH EQUIVALENTS, end of period$125,921
 $104,914
 $44,816
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.     NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Natural Health Trends Corp. (the “Company”), a Delaware corporation (whether or not including its subsidiaries, the “Company”), is an international direct-selling and e-commerce company headquartered in Dallas, Texas.company. Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers.

Our

The Company’s wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of ItalyEurope. The Company also operates in Russia and Slovenia. In June 2013, we opened a marketing center in Almaty, Kazakhstan through ourits engagement with our Russiana local service provider. The center also opened for sales and distribution purposes in

 In September 2013. A similar fully-operational facility opened in Odessa, Ukraine in February 2014.

2015, the Company relocated its corporate headquarters from Dallas, Texas to Rolling Hills Estates, California.


Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.


The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributor commissions and income taxes. Various assumptions and other factors prompt the determination of these significant estimates. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. The actual results may differ materially and adversely from the Company’s estimates. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.

Reclassification
Certain accounts receivable balances have been reclassified in the prior year consolidated financial statements to conform to current year presentation. No change in total current assets occurred. Additionally, deferred tax liability balances have been reclassified from current to long-term in the prior year consolidated financial statements to conform to the early adoption of ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes.

Cash and Cash Equivalents

As of December 31, 2016, cash and cash equivalents include $6.8 million held in banks located within China subject to foreign currency controls. The Company includes credit card receivables due from certain of its credit card processors in its cash and cash equivalents as the cash proceeds are received within two to five days.


Additionally, as of December 31, 2016, cash and cash equivalents include the Company's investments in debt securities, comprising municipal notes, bonds and corporate debt, money market funds and time deposits. The Company considers all highly liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities. As such, the Company determined its investments in debt securities held at December 31, 2016 should be classified as available-for-sale and are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income in stockholders' equity. The Company includescost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is included in its cashother income. Realized gains and losses, as well as interest income, are also included in other income. The fair values of securities are based on quoted market prices.
Cash and cash equivalents credit card receivables due from its major credit card processor, which servesat the Hong Kong, North America, Europe, and Japan markets,end of each period were as the cash proceeds from credit card receivables are received within two to five days.

follows (in thousands):

 December 31,
 2016 2015
Cash$52,453
 $47,431
Cash equivalents73,468
 57,483
Total cash and cash equivalents$125,921
 $104,914

The Company maintains certain cash balances at several institutions located in the United States, Hong Kong and Malaysia which at times may exceed insured limits.  The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk.


Restricted Cash
 

In June 2015, the Company funded a bank deposit account in the amount of CNY 20 million (USD 2.9 million at December 31, 2016) in anticipation of submitting a direct selling license application in China. Such deposit is required by Chinese laws to establish a consumer protection fund.

Restricted Cash

The Company periodically maintains a cash reserve with certain credit card processing companies to provide for potential uncollectible amounts and chargebacks. Those cash reserves held by credit card processing companies located in South Korea are reflected in noncurrent assets since those cardsthey require the Company to provide 100% collateral before processing transactions, which must be maintained indefinitely.

Inventories

Inventories consist primarily of finished goods and are stated at the lower of cost or market, using the first-in, first-out method. The Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. At December 31, 2012,2016 and 2015, the reserve for obsolescence totaled $72,000. No such reserve existed at December 31, 2013.

$82,000, and $29,000, respectively.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to five years for office equipment and office software and five to seven years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the assets. Expenditures for maintenance and repairs are charged to expense as incurred.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparison of its carrying amounts to future undiscounted cash flows the assets are expected to generate. If property and equipment are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair value.


Goodwill

In accordance with accounting principles generally accepted in the United States of America, the

The Company assesses qualitative factors in order to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a two-step impairment test is performed. The Company’s policy is to test for impairment annually during the fourth quarter. Considerable management judgment is necessary to measure fair value. WeThe Company did not recognize any impairment charges for goodwill during the periods presented.

Income Taxes

The Company recognizes income taxes under the liability method of accounting for income taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the temporary differences are expected to reverse.be recovered or settled. Deferred tax expense or benefit is a result of changes in deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.realized based on the more likely than not recognition criteria. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company has evaluated its tax positions and determined that there are no uncertain tax positions for the current year or years prior. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested.


Amounts Held in eWallets
Commencing in October 2014, the Company requires commission payments of certain members in Hong Kong to be first deposited into an electronic wallet (eWallet) account in lieu of being paid out directly to members. The CompanyeWallet functionality allows members to place new product orders utilizing eWallet available funds and/or request commission payout via multiple payment methods. Amounts held in eWallets are reflected on the balance sheet as a current liability.

Long-Term Incentive
Financial rewards earned under the 2014 Long-Term Incentive Plan (the “LTI Plan”) are recognized over the performance period as specified performance or other goals are achieved or exceeded. In accordance with the LTI Plan, fifty percent of any cash payment earned is payable in thirty-five equal consecutive monthly installments commencing in February of the calendar year immediately following the conclusion of the performance period and its subsidiaries file income tax returnsthe remaining fifty percent of the payment earned is payable in thirty-five equal consecutive monthly installments commencing in February 2021 and ending in December 2023. As such, certain installments to be paid are reflected on the balance sheet as a non-current liability, and the current portion of the installments is reflected in other accrued expenses.

At the sole discretion of the Compensation Committee of the Company’s Board of Directors, distributions under the LTI Plan are made in cash, or alternatively awarded in the United States, various states, and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years prior to 2010, and is no longer subject to state income tax examinations for years prior to 2009. No jurisdictions are currently examining any income tax returnsform of common stock or other common stock rights having an equivalent cash value under the terms of the Company or its subsidiaries.

Natural Health Trends Corp. 2016 Equity Incentive Plan. A determination of the form of distribution, if any, is made by the Compensation Committee subsequent to the end of each calendar year. As such, amounts earned are considered non-equity awards. See Note 5 for grant information of distributions settled in common stock.
 

Foreign Currency

The functional currency of the Company’s international subsidiaries is generally their local currency. Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at average rates of exchange during the period. Equity accounts are translated at historical rates.  The resulting translation adjustments are recorded directly into a separate component of stockholders’ equity and represents the only component of accumulated other comprehensive income.

Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Loss on foreign exchange totaling $125,000$333,000, $204,000 and $32,000$202,000 was recognized during 20122016, 2015 and 2013,2014, respectively.


Revenue Recognition

Product sales are recorded when the products are shipped and title passes to independent distributors.members. Product sales to distributorsmembers are made pursuant to a distributormember agreement that provides for transfer of both title and risk of loss upon ourthe Company’s delivery to the carrier that completes delivery to the distributors,members, which is commonly referred to as “F.O.B. Shipping Point.” The Company primarily receives payment by credit card at the time distributorsmembers place orders. Amounts received for unshipped product are recorded as deferred revenue. The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.

Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributorsmembers access to both a personalized marketing website and a business management system. No upfront costs are deferred as theamountthe amount is nominal.

Shipping charges billed to distributorsmembers are included in net sales. Costs associated with shipments are included in cost of sales.

Event and training revenue is deferred and recognized as the event or training occurs. Costs of events and member training are included within selling, general and administrative expenses.

Various taxes on the sale of products and enrollment packages to distributorsmembers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.

Distributor

Commissions

Independent distributorsmembers earn commissions based on total personal and group bonus volume points per weekly sales period.  Each of ourthe Company’s products are designated a specified number of bonus volume points, which is essentially a percentage of the product’s wholesale price.  The Company accrues commissions when earned and pays commissions on product sales generally two weeks following the end of the weekly sales period.

In some markets, wethe Company also paypays certain bonuses on purchases by up to three generations of personally sponsored distributors,enrolled members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors.enrolled members. Independent distributorsmembers may also earn incentives based on meeting certain qualifications during a designated incentive period, which may range from several weeks to up to a year.  These incentives may be both monetary and non-monetary in nature.  The Company estimates and accrues all costs associated with the incentives as the distributorsmembers meet the qualification requirements.

From time to time we makethe Company makes modifications and enhancements to ourthe Company’s compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time wethe Company also enterenters into agreements for business or market development, which may result in additional compensation to specific distributors.

members.

Operating Leases

The Company leases its physical properties under operating leases. Certain lease agreements include rent holidays. The Company recognizes rent holiday periods on a straight-line basis over the lease term beginning when the Company has the right to the leased space.

Stock-Based Compensation
 

Stock-Based Compensation

Stock-based compensation expense is determined based on the grant date fair value of each award, net of estimated forfeitures which are derived from historical experience, and is recognized on a straight-line basis over the requisite service period for the award.


Income Per Share

Basic income per share isfor 2014 was computed via the “two-class” method by dividing net income allocated to common stockholders by the weighted-average number of common shares outstanding during the period. Net income available to common stockholders is allocated to both common stock and participating securities as if all of the income for the period had been distributed. The Company’s Series A convertible preferred stock iswas a participating security due to its participation rights related to dividends declared by the Company. If dividends arewere distributed to common stockholders, the Company iswas also required to pay dividends to the holders of the preferred stock in an amount equal to the greater of (1) the amount of dividends then accrued and not previously paid on such shares of preferred stock or (2) the amount payable if dividends were distributed to the common stockholders on an as-converted basis.

Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. TheFor 2014, the dilutive effect of the Company’s Series A convertible preferred stock iswas calculated using the more dilutive of the “two-class” method and the “if-converted” method, which assumes that the preferred stock was converted into common stock at the beginning of each period presented.


 All shares of the Company’s Series A convertible preferred stock were converted into shares of common stock in December 2014. Warrants to purchase 88,097 shares of common stock were still outstanding at December 31, 2014. Such warrants were exercised during April 2015.

The following table illustrates the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):

  

Year Ended December 31,

 
  

2012

  

2013

 
  

Income

(Numerator)

  

Shares

(Denominator)

  

Per Share

Amount

  

Income

(Numerator)

  

Shares

(Denominator)

  

Per Share

Amount

 

Basic EPS:

                        

Net income available to common stockholders

 $2,613          $4,074         

Less: undistributed earnings to participating securities

  (16)          (31)        

Net income allocated to common stockholders

 $2,597   10,944  $0.24  $4,043   11,154  $0.36 
                         

Effect of dilutive securities:

                        

Non-vested restricted stock

 

   290      

   177     
                         

Diluted EPS:

                        

Net income allocated to common stockholders plus assumed conversions

 $2,597   11,234  $0.23  $4,043   11,331  $0.36 

 Year Ended December 31,
 2016 2015 2014
 Income Shares Per Share Income Shares Per Share Income Shares Per Share
Basic EPS:                 
Net income available to common stockholders$55,086
  
  
 $47,241
  
  
 $20,360
  
  
Less: undistributed earnings to participating securities
  
  
 
  
  
 (127)  
  
Net income allocated to common stockholders$55,086

11,382
 $4.84
 $47,241
 12,302
 $3.84
 $20,233
 12,131
 $1.67
Effect of dilutive securities:                 
Warrants to purchase common stock
 
  
 
 21
  
 
 421
  
Non-vested restricted stock
 25
  
 
 49
  
 
 48
  
Plus: reallocation of undistributed earnings to participating securities
  
  
 
  
  
 5
  
  
Diluted EPS:                 
Net income allocated to common stockholders plus assumed conversions$55,086
 11,407
 $4.83
 $47,241
 12,372
 $3.82
 $20,238
 12,600
 $1.61

Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested. Other commonFor the year ended December 31, 2016, 345 shares of non-vested restricted stock equivalents are also anti-dilutive since the applicable exercise price exceeds the average market price of the related common stock for the period.


The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Warrants to purchase common stock

  3,704,854   2,234,994 

Non-vested restricted stock

  100,000  

 

Warrants to purchase 1,495,952 shares of common stock were still outstanding at December 31, 2013. Such warrants expire April 21, 2015.

anti-dilutive.



Certain Risks and Concentrations

A substantial portion of the Company’s sales are generated in Hong Kong (see Note 10). MostSubstantially all of the Company’s Hong Kong revenues are derived from the sale of products that are delivered to members in China. In contrast to the Company’s operations in other parts of the world, the Company has not implemented a direct sales model in China. The Chinese government permits direct selling only by organizations that have a license, thatwhich the Company does not have,has applied for, and has also adopted anti-multilevel marketing legislation. The Company operates an e-commerce direct selling model in Hong Kong and recognizes the revenue derived from sales to both Hong Kong and Chinese members as being generated in Hong Kong. Products purchased by members in China are delivered by the Company to one or more third parties that act as the importers of record under agreements to pay applicable duties. In addition, through a Chinese entity, the Company sells products in China using an e-commerce retail model. The Chinese entity operates separately from the Hong Kong entity, althoughand a Chinese member may elect to participate separately or in both.


The Company believes that theits e-commerce direct selling model in Hong Kong does not violate any applicable laws and regulations in China, regarding direct selling and multi-level marketing are not specifically applicable toeven though it is used for the Company’s Hong Kong basedinternet purchase of the Company's products by members in China. The Company also believes that its Chinese entity, including its e-commerce activity, and that the Company’s Chinese entityretail platform, is operating in compliance with applicable Chinese laws. However, there can be no assurance that the Chinese authorities will agree with the Company’s interpretations of applicable laws and regulations or that China will not adopt new laws or regulations. Should the Chinese government determine that the Company’s e-commerce activity violatesactivities violate China’s direct selling or anti-multilevel marketing legislation, or should new laws or regulations be adopted, there could be a material adverse effect on the Company’s business, financial condition and results of operations.

Although the Company attempts to work closely with both national and local Chinese governmental agencies in conducting the Company’sits business, the Company’s efforts to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violations of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, Chinese nationals collaborating with short traders to damage the Company's business and activities by individual distributorsmembers that may violate laws notwithstanding the Company’s strict policies prohibiting such activities. Any determination that the Company’s operations or activities, or the activities of the Company’sits individual distributorsmembers or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on the Company’s future ability to obtain business licenses or expand into new locations, changes to the Company’sits business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm the Company’s business, financial condition and results of operations.

The Company’sPremium Noni Juice™Juice andAlura™Enhanced Essential Probiotics®products each account for a significant portionmore than 10% of the Company’s total revenue and, together, account for a majority of our total revenue. The Company currently sources each such product from a single suppliers.supplier. If demand for these products decreases significantly, government regulation restricts thetheir sale, of these products, the Company is unable to adequately source or deliver thesethe products, or the Company ceases offering any of thesethe products for any reason without a suitable replacement,replacements, the Company’s business, financial condition and results of operations could be materially and adversely affected.


Sales are made to the Company’s members and no single customer accounted for 10% or more of its net sales. However, the Company’s business model can result in a concentration of sales to several different members and their network of members. Although no single member accounted for 10% or more of net sales, the loss of a key member or that member’s network could have an adverse effect on the Company’s net sales and financial results.
Fair Value of Financial Instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.

The Company’s cash equivalents are valued based on level 1 inputs which consist of quoted prices in active markets.
 

Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.  The Company has elected to not fair value existing eligible items.



Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands):
 December 31, 2016 December 31, 2015
 Adjusted Cost Gross Unrealized Gains/Losses Fair Value Adjusted Cost Gross Unrealized Gains/Losses Fair Value
Municipal bonds and notes$43,490
 $
 $43,490
 $35,222
 $2
 $35,224
Corporate debt securities1,673
 (2) 1,671
 5,029
 (5) 5,024
Financial institution instruments28,307
 
 28,307
 17,235
 
 17,235
Total available-for-sale investments$73,470
 $(2) $73,468
 $57,486
 $(3) $57,483

Financial institution instruments include instruments issued or managed by financial institutions such as money market fund deposits and time deposits.

Recently Issued and Adopted Accounting Pronouncements


In February 2013,November 2016, the FASBFinancial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU"(“ASU”) No. 2013-02, Comprehensive Income (Topic 220) —Reporting2016-18, Statement of Amounts Reclassified Out of Accumulated Other Comprehensive IncomeCash Flows - Restricted Cash, to require an entity to provide information aboutthat requires amounts generally described as restricted cash or restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, eithershown on the facestatement of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") tocash flows. The new standard will be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.  ASU 2013-02 is effective prospectively for reporting periods, including interim periods,fiscal years beginning after December 15, 2012.2017, including interim periods within those fiscal years, and early adoption is permitted. The Company’s adoption of this guidance is not expected to have a material impact on the standard on January 1, 2013 did not result in any additional disclosures in itsCompany’s consolidated financial statements for the year ended December 31, 2013.

statements.


In March 2013,2016, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830) —Parent’s2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, that simplifies several aspects of the accounting for share-based payment transactions, including the Cumulative Translation Adjustment upon Derecognitionincome tax consequences, classification of Certain Subsidiariesawards as either equity or Groupsliabilities, and classification on the statement of Assets within a Foreign Entity or of an Investment in a Foreign Entity, to clarify the guidancecash flows. The new standard will be effective for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.  ASU 2013-05 is effective prospectively for reporting periods, including interim periods,fiscal years beginning after December 15, 2013.  Early2016, including interim periods within those annual years, and early adoption is permitted. The Company is currently evaluatingassessing the impact of adopting ASU 2013-05.

that this standard will have on its consolidated financial statements.


In July 2013,February 2016, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740) — Presentation of an Unrecognized Tax Benefit When A Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists2016-02, Leases, that requires organizations that lease assets, referred to as “lessees”, to provide explicit guidancerecognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 will also require disclosures to help investors and other financial statement presentationusers better understand the amount, timing, and uncertainty of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists.cash flows arising from leases and will include qualitative and quantitative requirements. The amendments in this update arenew standard will be effective for fiscal years, and interim periods within those years beginning after December 15, 20132018, including interim periods within those annual years, and should be applied prospectively to all tax benefits that exist at the effective date. Retrospectiveearly application is permitted. The Company is currently evaluatingassessing the impact that this standard will have on its consolidated financial statements.
In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of adoptingDeferred Taxes. Under this guidance, entities are required to present deferred tax tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. This guidance is effective for annual and interim periods beginning after December 15, 2016, with early adoption permitted. Entities are permitted to adopt this guidance either prospectively or retrospectively. The Company elected to early adopt this guidance prospectively as of the quarter ended December 31, 2016.

In July 2015, the FASB issued ASU 2013-11.

No. 2015-11, Inventory: Simplifying the Measurement of Inventory. Under this guidance, inventory not measured using either the last in, first out (LIFO) or the retail inventory method to be measured at the lower of cost and net realizable value.  Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal, and transportation.  The new standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, and will be applied prospectively.  Early adoption is permitted. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.



In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers, that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  It also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract.  Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard.  In July 2015, the FASB approved the deferral of the effective date for annual reporting periods that begin after December 15, 2017, including interim reporting periods. Early adoption is permitted to the original effective date of December 15, 2016, including interim reporting periods. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

2.     BALANCE SHEET COMPONENTS

The components of certain balance sheet amounts are as follows (in thousands):

  

December 31,

 
  

2012

  

2013

 
         

Property and equipment:

        

Office equipment

 $544  $354 

Office software

  523   533 

Furniture and fixtures

  49   62 

Leasehold improvements

  294   256 
Construction in progress    102 

Property and equipment, at cost

  1,410   1,307 

Accumulated depreciation and amortization

  (1,289)  (1,042)
  $121  $265 
         

Other accrued expenses:

        

Sales returns

 $181  $504 

Employee-related expense

  1,034   1,860 

Warehousing and inventory-related expense

  301   595 

Other

  172   187 
  $1,688  $3,146 
         

Deferred revenue:

        

Unshipped product

 $384  $1,938 
Auto ship advances  263   449 

Enrollment package revenue

  189   182 
  $836  $2,569 
         

Other current liabilities:

        

Unclaimed checks

 $761  $674 

Other

  230   208 
  $991  $882 

 December 31,
 2016 2015
Property and equipment:   
Office equipment$517
 $495
Office software672
 536
Machinery28
 24
Furniture and fixtures241
 222
Leasehold improvements840
 730
Construction in progress (including internal use software development costs)157
 10
Property and equipment, at cost2,455
 2,017
Accumulated depreciation and amortization(1,067) (1,123)
 $1,388
 $894
Other accrued expenses:   
Sales returns$1,632
 $1,552
Employee-related expense10,541
 11,064
Warehousing, inventory-related and other2,816
 4,087
 $14,989
 $16,703
Deferred revenue: 
  
Unshipped product$2,191
 $1,783
Auto ship advances2,327
 1,597
Enrollment package revenue430
 331
Market development fees
 300
 $4,948
 $4,011


3.     COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company has entered into non-cancelable operating lease agreements for locations within the United States and for its international subsidiaries, with expirations through March 2018.September 2025. Rent expense in connection with operating leases was $740,000$1.8 million, $1.5 million and $787,000$777,000 during 20122016, 2015 and 2013,2014, respectively.


Future minimum lease obligations as of December 31, 2013,2016 are as follows (in thousands):

2014

$617

2015

 253

2016

 40

2017

 40

2018

 10

Total minimum lease obligations

$960

2017$1,559
2018752
2019402
2020314
2021196
Thereafter700
Total minimum lease obligations$3,923



Purchase Commitment

Commitments


In May 2013, the Company entered into an exclusive distribution agreement with one of its suppliers to purchase its product through July 2016.2016 which automatically renews annually unless terminated 90 days prior to the termination date. To maintain exclusivity, the Company is required to purchase a minimum of $40,000 of product per month until the termination date. As of December 31, 2013,2016, the Company was in compliance with the exclusivity provision.

In February 2016, the Company amended a supply agreement with one of its suppliers to maintain worldwide exclusivity in return for purchasing a minimum of $9.4 million of product annually on average over the next three years, plus certain raw material guarantees. If the Company does not purchase the minimum product as required, then a Cure Payment, as defined, will be due to the supplier. The term of the agreement is three years commencing February 2016 and shall automatically renew for successive three year terms unless notice of termination is provided by either party.

Employment Agreements

The Company has employment agreements with certain members of its management team that can be terminated by either the employee or the Company upon four weeks’ notice.  The employment agreements entered into with the management team contain provisions that guarantee the payments of specified amounts in the event of a change in control, as defined, or if the employee is terminated without cause, as defined, or terminates employment for good reason, as defined. In addition, the Company has an employment agreement with another employee that can be terminated at will by either the employee or the Company, provided that the Company must pay a specified amount if it terminates the agreement without cause, as defined, or the employee terminates the agreement with good reason, as defined. Accrued severance obligations totaling $296,000 as of December 31, 2013 are expected to be paid during 2014.

Consumer Indemnity

As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative & Consumer (the “Cooperative”). The contract secures payment to distributorsmembers in the event that the Company is unable to provide refunds to distributors.members. Typically, requests for refunds are paid directly by the Company according to the Company’s normal Korean refund policy, which requires that refund requests be submitted within three months. Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience. Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract. The maximum potential amount of future payments the Company could be required to make to address actual distributormember claims under the contract is equivalent to three months of rolling sales. At December 31, 2013,2016, non-current other assets include KRW 144223 million (USD $137,000)$185,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributormember claims. The Company believes that the likelihood of utilizing these funds to provide for distributorsmembers claims is remote.

Registration Payment Arrangements

Pursuant



Securities Class Action

In January 2016, two putative securities class action complaints were filed against the Company and its top executives. On March 29, 2016, the court consolidated these actions, appointed two Lead Plaintiffs, Messrs. Dao and Juan, and appointed the Rosen Law Firm and Levi & Korsinsky LLP as co-Lead Counsel for the purported class. Plaintiffs filed a consolidated complaint on April 29, 2016. The consolidated complaint purports to a Registration Rights Agreement withassert claims on behalf of all persons who purchased or otherwise acquired our common stock between March 6, 2015 and March 15, 2016 under (i) Section 10(b) of the investorsSecurities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder against Natural Health Trends Corp., Chris T. Sharng, and Timothy S. Davidson, and (ii) Section 20(a) of the Securities Exchange Act of 1934 against Chris T. Sharng, Timothy S. Davidson, and George K. Broady. The consolidated complaint alleges, inter alia, that the Company made materially false and misleading statements regarding the legality of its business operations in the Company’s October 2007 financing of variable rate convertible debentures havingChina, including running an aggregate faceallegedly illegal multi-level marketing business. The consolidated complaint seeks an indeterminate amount of $4,250,000, seven-year warrants to purchase 1,495,952 shares of the Company’s common stock,damages, plus interest and one-year warrants to purchase 1,495,952 shares of the Company’s common stock, the Company was obligated to (i) file a registration statement covering the resale of the maximum number of Registrable Securities (as defined) that is permitted by SEC Guidance (as defined) prior to November 18, 2007, (ii) cause the registration statement to be declared effective within certain specified periods of time and (iii) maintain the effectiveness of the registration statement until all Registrable Securities have been sold, or may be sold without volume restrictions pursuant to Rule 144(k) under the Securities Act.  The Company timely filed that registration statement covering the shares of common stock underlying the debentures, which have been redeemed, and the one-year warrants, which have expired. At the time, the 1,495,952 shares of common stock underlying the seven-year warrants were not deemed Registrable Securities and were not included in the Registration Statement. If they are subsequently deemed Registrable Securities at a time when a registration statement covering them is required to be effective under the Registration Rights Agreement, and such registration statement is not then effective, then the warrants may be exercised by means of a cashless exercise. The maximum number of shares that could be required to be issued upon exercise of the warrants (whether on a cashless basis or otherwise) is limited to the number of shares indicated on the face of the warrants.costs. The Company filed a registration statementmotion to dismiss the consolidated complaint on NovemberJune 15, 2016 and a reply in support of its motion to dismiss on August 22, 2013 covering2016. On December 5, 2016, the maximum number of sharesCourt denied the Company’s motion to dismiss. On February 17, 2017, the Company filed an answer to the consolidated complaint. The Company believes that could be requiredthese claims are without merit and intends to be issued upon exercisevigorously defend against them.

Shareholder Derivative Claims

In February 2016, a purported shareholder derivative complaint was filed in the Superior Court of the warrants,State of California, County of Los Angeles: Zhou v. Sharng. In March 2016, a purported shareholder derivative complaint was filed in the United States District Court for the Central District of California: Kleinfeldt v. Sharng (collectively the “Derivative Complaints”). The Derivative Complaints purport to assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and such registration statementcorporate waste against certain of the Company’s officers and directors. The Derivative Complaints also purport to assert fiduciary duty claims based on alleged insider selling and conspiring to enter into several stock repurchase agreements, which allegedly harmed the Company and its assets. The Derivative Complaints allege, inter alia, that the Company made materially false and misleading statements regarding the legality of its business operations in China, including running an allegedly illegal multi-level marketing business, and that certain officers and directors sold common stock on the basis of this allegedly material, adverse non-public information. The Derivative Complaints seek an indeterminate amount of damages, plus interest and costs, as well as various equitable remedies. On February 1, 2017, pursuant to a stipulation among the parties, the Los Angeles Superior Court entered a stay of the Zhou action pending conclusion of the related federal class action in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. A nearly identical stipulated stay was declared effectiveentered in the Kleinfeldt case on December 5, 2013.  AsFebruary 8, 2017. The Company believes that these claims are without merit and intend to vigorously defend against them.

The consolidated class action and the Derivative Complaints, or others filed alleging similar facts, could result in monetary or other penalties that may materially affect the Company’s operating results and financial condition.

Other Claims

The Company is currently involved in a legal matter with one of December 31, 2013, no contingent obligations have been recognized under registration payment arrangements.

its vendors and an outside party. Per the royalty agreement with the vendor, the Company believes that it is fully indemnified in the event of an unfavorable outcome and any potential settlement costs related to the matter would be fully covered by the Company’s vendor.


4.     STOCKHOLDERS’ EQUITY

Authorized Shares

The Company is authorized to issue two classes of capital stock consisting of up to 5,000,000 shares of preferred stock, $0.001$0.001 par value, and 50,000,000 shares of common stock, $0.001$0.001 par value. On May 4, 2007, the Board of Directors designated up to 1,761,900 shares of preferred stock as Series A preferred stock with the following rights and preferences:


Priority – the Series A preferred stock shall rank, in all respects, including the payment of dividends and upon liquidation, senior and prior to the common stock and other equity of the Company not expressly made senior or pari passu with the Series A preferred stock (collectively, “Junior Securities”).



Dividends –dividends at the rate per annum of $0.119$0.119 per share shall accrue from the date of issuance of any shares of Series A preferred stock, payable upon declaration by the Board of Directors. Accruing dividends shall be cumulative; provided, however, that except as set forth below for the liquidation preference, the Company shall be under no obligation to pay such dividends. No dividends shall be declared on Junior Securities (other than dividends on shares of common stock payable in shares of common stock) unless the holders of the Series A preferred stock then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A preferred stock in an amount at least equal to the greater of (i) the amount of the aggregate accrued dividends on such share of Series A preferred stock and not previously paid and (ii) in the case of a dividend on common stock or any class or series of Junior Securities that is convertible into common stock, that dividend per share of Series A preferred stock as would equal the product of (1) the dividend payable on each share as if all shares of such class or series had been converted into common stock and (2) the number of shares of common stock issuable upon conversion of a share of Series A preferred stock.


Liquidation preference – in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, then, before any distribution or payment shall be made to the holders of any Junior Securities, the holders of the Series A preferred stock then outstanding shall be entitled to be paid in cash out of the assets of the Company available for distribution to its stockholders (on a pari passu basis with the holders of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock) an amount per share equal to the sum of the Series A Original Issue Price plus any dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon. If the assets of the Company are insufficient to pay the aggregate liquidation preference and the liquidation preference of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock, the holders of the Series A preferred stock and the holders of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock shall share ratably with one another in any such distribution or payment in proportion to the full amounts to which they would otherwise be respectively entitled before any distribution shall be made to the holders of the Junior Securities. The “Series A Original Issue Price” shall mean $1.70$1.70 per share, subject to adjustment.


Voting rights – the holders of shares of Series A preferred stock shall be entitled to vote with the holders of the common stock, and with the holders of any other series of preferred stock, voting together as a single class, upon all matters submitted to a vote of stockholders of the Company. Each holder of shares of Series A preferred stock shall be entitled to the number of votes equal to the product (rounded down to the nearest number of whole shares) of 0.729 times the largest number of shares of common stock into which all shares of Series A preferred stock held of record by such holder could then be converted.


Conversion – each share of Series A preferred stock shall be convertible, subject to adjustment only in the event of stock splits, stock dividends, recapitalizations and similar events that would affect all of stockholders,, at the option of the holder thereof, at any time and from time to time, into such number of fully paid and nonassessable shares of common stock as determined by dividing the Series A Original Issue Price by the Series A Conversion Price (as defined) in effect at the time of conversion. The “Series A Conversion Price” shall initially be equal to $1.70.$1.70. Each share of Series A preferred stock shall automatically be converted into shares of common stock at the then effective conversion price immediately upon such date as the average closing price of the common stock over a consecutive, trailing 6-month period equals or exceeds $10.00$10.00 per share.

As


On December 3, 2014, the Company filed a Certificate of December 31, 2013, 123,693Elimination of the Series A Convertible Preferred Stock (the “Certificate”) with the Secretary of State of the State of Delaware. The Certificate, which was effective upon filing, canceled the Company’s Series A preferred stock. At the time of filing the Certificate, no shares of Series A preferred stock were outstanding. Cumulative unpaid dividends andremained outstanding as a result of the liquidation preference relatingautomatic conversion of all outstanding shares into the Company’s common stock due to the outstanding Series A preferredfact that the average closing price of the Company’s common stock at December 31, 2013 was $98,000 and $308,000, respectively.

equaled or exceeded $10.00 per share over a consecutive, trailing 6-month period that ended November 18, 2014.
 

Common Stock Purchase Warrants

On May 4, 2007, the Company issued warrants to purchase 2,059,307 shares of common stock as a component of a private equity placement. The warrants were exercisable at any time during the period beginning November 4, 2007 (six months after their issuance) and ending May 4, 2013 (six years after their issuance).The exercise price of the warrants was $5.00 per share. Such warrants expired unexercised onMay 4, 2013.

On October 19, 2007, the Company issued warrants to purchase 3,141,499 shares of common stock in connection with a convertible debentures financing. The warrants consisted of seven-year warrants to purchase 1,495,952 shares of common stock, one-year warrants to purchase 1,495,952 shares of common stock, and five-year warrants to purchase 149,595 shares of common stock. The term for each of the warrants began six months and one day after their respective issuance and each have an exercise price of $3.52 per share. The exercise price and the number of shares underlying the warrants are subject to adjustment for stock dividends and splits, combinations, and reclassifications, certain rights offerings and distributions to common stockholders, and mergers, consolidations, sales of all or substantially all assets, tender offers, exchange offers, reclassifications or compulsory share exchanges. In addition, subject to certain exceptions, the exercise price and number of shares underlying the warrants are subject to anti-dilution adjustments from time to time if the Company issues its common stock or equivalent securities at below the exercise price for the warrants. If, at any time after the earlier of October 19, 2008 and the completion of the then applicable holding period under Rule 144, there is no effective registration statement for the underlying shares of common stock that are then required to be registered, the warrants may be exercised by means of a cashless exercise. Such one-year warrants expired unexercised on April 21, 2009 and such five-year warrants expired unexercised on April 21, 2013. TheSeven-year warrants to purchase 1,407,855 shares of common stock were exercised during 2014 at exercise prices ranging from $3.5108 to $3.52 per share for total proceeds of $4.9 million. As a result of the cash dividends declared on each share of outstanding common stock and in accordance with the terms of the related warrant agreement, the exercise price per share for each warrant was adjusted from $3.52 per share to $3.5082 per share. In April 2015, the remaining warrants to purchase 1,495,95288,097 shares of common stock expire April 21,were exercised at $3.5043 per share for total proceeds of $309,000.
Dividends
The following tables summarize the Company’s cash dividend activity during 2016, 2015 ifand 2014 (in thousands, except per share data):

Declaration Date Per Common Share Amount Payment Date
October 23, 2016 (special) $0.35
 $3,941
 
November 25, 2016
October 23, 2016 0.08
 901
 
November 25, 2016
July 19, 2016 0.07
 787
 
August 26, 2016
April 21, 2016 0.06
 686
 
May 20, 2016
March 1, 2016 0.05
 576
 
March 24, 2016
Total $0.61
 $6,891
  
Declaration Date Per Common Share Amount Payment Date
October 21, 2015 $0.05
 $598
 
November 20, 2015
July 28, 2015 0.04
 489
 
August 28, 2015
May 4, 2015 0.03
 372
 
May 29, 2015
February 27, 2015 0.02
 250
 
March 27, 2015
Total $0.14
 $1,709
  

  Dividends Per Share    
Declaration Date Preferred Common Amount Payment Date
November 4, 2014 $0.032
 $0.010
 $128
 
December 3, 2014
July 29, 2014 0.027
 0.010
 127
 
August 27, 2014
May 6, 2014 0.020
 0.005
 62
 
June 4, 2014
March 7, 2014 0.815
 0.005
 159
 
April 8, 2014
Total $0.894
 $0.030
 $476
  

Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.


Treasury Stock

On January 12, 2016, the Board of Directors authorized an increase to the Company’s stock repurchase program first approved on July 28, 2015 from $15.0 million to $70.0 million. Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not previously exercised.

5.     STOCK-BASED COMPENSATION

require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued.


During February 2016, pursuant to the stock repurchase program, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market. During the year ended December 31, 2016, the Company purchased a total of 903,031 shares of its common stock for an aggregate purchase price of $23.7 million, plus transaction costs. As of December 31, 2016, $32.0 million of the $70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax.

On August 18, 2006,July 28, 2015, the Compensation Committee of Company’s Board of Directors approved subjecta stock repurchase program of up to stockholder approval,$15.0 million of the Natural Health Trends Corp. 2007 Equity Incentive Plan (the “2007 Plan”). UnderCompany’s outstanding shares of common stock. Repurchases are expected to be executed to the 2007 Plan,extent that the Company’s earnings and cash-on-hand allow, are anticipated to be conducted through December 2016, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act.  For all or a portion of the authorized repurchase amount, the Company may grant (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock, (iv) restricted stock units, (v) stock appreciation rights either in tandementer into one or more plans that are compliant with an option or alone and unrelated to an option, or SARs, (vi) performance shares, (vii) award shares, or (viii) stock awards. The 2007 Plan was approved by the Company’s stockholders on November 17, 2006.

The purposeRule 10b5-1 of the 2007 Plan isExchange Act that are designed to enablefacilitate these purchases.  The repurchase program does not require the Company to attractacquire a specific number of shares, and retain employees, officers, directors, consultantsmay be suspended from time to time or discontinued. In connection therewith, the Company was advised that George K. Broady, a director of the Company and advisors;owner of more than 5% of its outstanding shares of common stock, would participate in the stock repurchase program on a basis roughly proportional to providehis family’s ownership interest. See Note 8.


During August 2015, pursuant to the foregoing stock repurchase program, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.5 million. The open market repurchases were completed on August 4, 2015. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, resulted in the Company purchasing a total of 162,442 shares of its common stock for an incentiveaggregate purchase price of $5.0 million, plus transaction costs. During October 2015, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for thema total purchase price of $3.6 million. The open market repurchases were completed on October 30, 2015. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, resulted in the Company purchasing a total of 106,264 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs.

On May 4, 2015, the Board of Directors approved a separate, prior stock repurchase program of up to assist$5.0 million of the Company’s outstanding shares of common stock.  In connection therewith, the Company was advised by Mr. Broady that he would participate in achieving long-range performance goals;the stock repurchase program on a basis roughly proportional to his family’s ownership interest (see Note 8). As such, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.5 million in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, was completed on May 13, 2015, and resulted in the Company purchasing a total of 186,519 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs. 

On January 22, 2015, the Company entered into a stock repurchase agreement with Mr. Broady that provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased (see Note 8). The shares were purchased at a per share price equal to enable themthe closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock is publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of $1.1 million.

On November 4, 2014, the Board of Directors approved a special stock repurchase program of up to $5.0 million of the Company’s outstanding shares of common stock (the “Repurchase Plan”). In connection therewith, the Company was advised that Mr. Broady desired to participate in the long-term growthRepurchase Plan on a basis roughly proportional to his family’s ownership interest, with an estimate of generating approximately $1.5 million through the sale of a portion of the Company. The termsshares of any particular grant are determinedthe Company’s common stock held by him (see Note 8). After noting Mr. Broady’s participation interest, the Board of Directors or a committee appointed byCompany authorized its broker to proceed with the Board of Directors. Generally, the grants of restricted stock vest quarterly on a pro rata basis over a three-year period. The maximum numberpurchase of shares availableof the Company’s common stock in the open market for issuancea total purchase price of $3.0 million in accordance with Rules 10b5-1 and 10b-18 under the 2007Exchange Act. The Repurchase Plan was 1,550,000 shares. At the Company’s Annual Meeting of Stockholders heldcompleted on December 30, 2008,17, 2014. The Repurchase Plan, which included both open market purchases and the Company’s stockholders approved an increasepurchase of shares from Mr. Broady, resulted in the maximum numberCompany purchasing a total of 359,840 shares availableof its common stock for issuance under the 2007 Plan by 500,000 shares. As such, the maximuman aggregate numberpurchase price of shares available for issuance under the 2007 Plan totals 2,050,000 shares.As of December 31, 2013, 1,083 shares remain available to be granted under the 2007 Plan.

Valuation and Expense Information under FASB ASC Topic 718

Stock-based compensation expense totaled approximately $94,000 and $110,000 for 2012 and 2013, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.     

$4.5 million, plus transaction costs. 
 

A following table summarizes the Company’s restricted stock activity under the 2007 Plan:

  

Shares

  

Wtd. Avg.

Price at

Date of

Issuance

 
         

Nonvested at December 31, 2011

  473,688  $0.37 

Vested

  (212,030)  0.36 

Nonvested at December 31, 2012

  261,658   0.37 

Vested

  (206,672)  0.37 

Nonvested at December 31, 2013

  54,986   0.37 

The restricted stock vests quarterly on a pro rata basis over a three-year period. As of December 31, 2013, total unrecognized stock-based compensation expense related to non-vested restricted stock was approximately $18,000, which is expected to be recognized over a weighted-average period of 0.3 years.

On August 13, 2012, the Company’s Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company'sCompany’s policies regarding stock transactions.  Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing shares in December 2012. The latest 10b5-1 plan terminated in November 2014 and the Company, as Trustee, has not entered into a new 10b5-1 plan. See Note 5.


5.     STOCK-BASED COMPENSATION
Stock-based compensation expense totaled approximately $104,000, $86,000 and $49,000 for 2016, 2015 and 2014, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets. During March 2016, the Company modified the vesting feature of an award granted to a director who decided to not stand for re-election at the Company’s 2016 annual meeting of stockholders. The modification of the award resulted in an additional $64,000 in stock-based compensation expense for the three months ended March 31, 2016.

At the Company’s annual meeting of stockholders held on April 7, 2016, the Company’s stockholders approved the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “2016 Plan”) to replace its 2007 Equity Incentive Plan. The 2016 Plan allows for the grant of various equity awards including incentive stock options, non-statutory options, stock, stock units stock appreciation rights and other similar equity-based awards to the Company’s employees, officers, non-employee directors, contractors, consultants and advisors of the Company. Up to 2,500,000 shares of the Company’s common stock (subject to adjustment under certain circumstances) may be issued pursuant to awards granted.

On April 8, 2016, the Company initially granted 51,015 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of further aligning their interest with those of its stockholders and settling fiscal 2015 performance incentives. The shares vest on a quarterly basis over three years and are subject to forfeiture in the event of the employee’s termination of service to the Company under specified circumstances.

The following table summarizes the Company’s restricted stock activity under the 2016 Plan:
 Shares Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2015
 $
Granted51,015
 34.13
Vested(12,759) 34.13
Nonvested at December 31, 201638,256
 34.13

On January 20, 2015, the Company’s Board of Directors granted 60,960 shares of restricted common stock to certain employees and its then-existing outside directors for the purpose of further aligning their interest with those of its stockholders and as to the employee shares, settling fiscal 2014 performance incentives. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances. On February 11, 2015, the Board of Directors granted an additional 6,116 shares of restricted common stock to its newly-elected outside directors subject to the same conditions.


The following table summarizes the Company’s other restricted stock activity:
 Shares Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2014
 $
Granted67,076
 12.15
Vested(22,364) 12.15
Nonvested at December 31, 201544,712
 12.15
Granted
 
Vested(22,364) 12.15
Nonvested at December 31, 201622,348
 12.15

As of December 31, 2016, total unrecognized stock-based compensation expense related to non-vested restricted stock was $38,000, which is expected to be recognized over a weighted-average period of one year.

On August 13, 2012, the Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company’s policies regarding stock transactions.  Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing in December 2012. The currentlatest 10b5-1 plan for the purchase of up to 2,100 shares per month will expire onterminated in November 11, 2014, unless terminated earlier, and the Company, as Trustee, intends at or after that time todid not enter into a new 10b5-1 plan or plans to complete the purchases authorized. The Company may terminate the plan at any time.plan. The employees will receivereceived the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they arewere employees of the Company on the date of the distribution. Any common stock that iswas forfeited by an employee whose employment terminates will beterminated was delivered to the Company and held as treasury stock.

  

Shares

  

Wtd. Avg.

Grant-Date

Fair Value

 
         
Nonvested at December 31, 2011  -  $- 
Granted  100,000   1.37 

Nonvested at December 31, 2012

  100,000   1.37 

Vested

  (26,676)  1.37 

Forfeited

  (20,000)  1.37 

Nonvested at December 31, 2013

  53,324   1.37 

As of December 31, 2013, total unrecognized stock-based compensation expense related to these stock awards was $64,000, which is expected to be recognized over a weighted-average period of 2.0 years.

 Shares Wtd. Avg. Grant-Date Fair Value
Nonvested at December 31, 201353,324
 $1.37
Vested(25,342) 1.37
Forfeited(3,998) 1.37
Nonvested at December 31, 201423,984
 1.37
Vested(23,984) 1.37
Forfeited
 
Nonvested at December 31, 2015
 


6.     INCOME TAXES

The components of income before income taxes consist of the following (in thousands):

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Domestic

 $(2,824) $194 

Foreign

  5,430   3,997 

Income before income taxes

 $2,606  $4,191 

 Year Ended December 31,
 2016 2015 2014
Domestic$(3,106) $(7,820) $4,502
Foreign67,183
 55,613
 16,134
Income before income taxes$64,077
 $47,793
 $20,636

 

The components of the income tax provision (benefit) consist of the following (in thousands):

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Current:

        

Federal

 $  $10 

Foreign

  32   76 

Total current taxes

  32   86 

Deferred foreign taxes

  (56)  16 

Income tax provision (benefit)

 $(24) $102 

 Year Ended December 31,
 2016 2015 2014
Current:     
Federal$7,151
 $12
 $104
State(81) 100
 11
Foreign1,648
 456
 194
Total current taxes8,718
 568
 309
Deferred taxes273
 (16) (43)
Income tax provision$8,991
 $552
 $266


A reconciliation of the reported income tax provision (benefit) to the provision that would result from applying the domestic federal statutory tax rate to pretax income is as follows (in thousands):

  

Year Ended December 31,

 
  

2012

  

2013

 
         

Income tax at federal statutory rate

 $886  $1,425 

Effect of permanent differences

  8   7 

Increase in valuation allowance

  672   430 

Foreign rate differential

  (1,576)  (1,218)

True up of foreign tax balances

  1   (597)

Other reconciling items

  (15)  55 

Income tax provision (benefit)

 $(24) $102 

 Year Ended December 31,
 2016 2015 2014
Income tax at federal statutory rate$22,427
 $16,250
 $7,016
Effect of permanent differences12,496
 370
 9
Change in valuation allowance(3,877) 2,017
 (2,070)
Foreign rate differential(21,713) (18,099) (5,240)
Other reconciling items(342) 14
 551
Income tax provision$8,991
 $552
 $266

Income before income taxes and the statutory tax rate for each country that materially contributed to the foreign rate differential presented above is as follows (in thousands):
   Year Ended December 31,
 Statutory Tax Rate 2016 2015 2014
Cayman Islands% $58,169
 $50,993
 $16,267
Hong Kong16.5% 3,992
 2,645
 1,129
China25.0% 3,855
 1,493
 153



Deferred income taxes consist of the following (in thousands):

  

December 31,

 
  

2012

  

2013

 
         

Deferred tax assets:

        

Net operating losses

 $15,081  $13,115 

Stock-based compensation

  352  

 

Accrued expenses

  104   268 

Tax credits

  501   512 

Impairment of long-lived assets

  76   88 

Other

  75   1 

Total deferred tax assets

  16,189   13,984 

Valuation allowance

  (16,141)  (13,927)
   48   57 
         

Deferred tax liabilities:

        

Intangible assets

  (43)  (43)

Accrued expenses

  (91)  (107)

Prepaids

 

   (11)

Other

  (6)  (4)

Total deferred tax liabilities

  (140)  (165)

Net deferred tax liability

 $(92) $(108)

The

 December 31,
 2016 2015
Deferred tax assets:   
Net operating losses$235
 $3,197
Stock-based compensation623
 
Accrued expenses3,174
 3,367
Tax credits
 418
Other
 32
Total deferred tax assets4,032
 7,014
Valuation allowance(235) (4,112)
Net deferred tax assets3,797
 2,902
Deferred tax liabilities:   
Foreign earnings(3,650) (2,789)
Other(415) (173)
Total deferred tax liabilities(4,065) (2,962)
Net deferred tax liability$(268) $(60)


As of December 31, 2016, the Company has recordedreleased its valuation allowance against its U.S. deferred tax assets. In addition to having a net deferred tax liability and no indefinite lived intangibles, the Company analyzed all sources of available income and determined that they are more likely than not to realize the tax benefits of their deferred assets in future periods or carryback years.

As of December 31, 2016, the Company has a valuation allowance to equal its netagainst certain foreign deferred tax assets due to the uncertainty of future operating results.assets. The Company is recording a valuation allowance in foreign jurisdictions with an overall deferred tax loss. The valuation allowance will be reduced at such time as management believes it is more likely than not that the deferred tax assets will be realized. Any reductions in the valuation allowance will reduce future income tax provisions.


Atprovision. As of December 31, 2013,2016, the Company has no U.S. federal net operating loss or credit carryforwards of $33.0 million that beginas any remaining attributes are expected to expirebe fully utilized to offset tax in 2021, if not utilized. Thethe current year.


At December 31, 2016, the Company also has foreign net operating loss carryforwards totaling $7.3of approximately $1.3 million in various jurisdictions with various expirations, including $4.2 million in China with expirations from 2014 to 2017.expirations.

As a result of capital return activities approved by the Board of Directors during the first quarter of 2016 and anticipated future capital return activities, the Company determined that a portion of its current undistributed foreign earnings are no longer deemed reinvested indefinitely by its non-U.S. subsidiaries. The Company has not providedrepatriated $19.8 million to the U.S. during the three months ended March 31, 2016, part of which was offset by U.S. net operating losses. Accordingly, the deferred tax liability previously established for undistributed foreign earnings up to its existing U.S. federal andnet operating losses was reduced. The excess amount repatriated during the year ended December 31, 2016 was generated from current foreign withholding taxes onearnings. The Company will continue to periodically reassess the undistributed earningsneeds of its foreign subsidiaries and update its indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, the Company expects to recognize additional income tax provision at the applicable U.S. corporate tax rate. As of December 31, 2013. Such2016, the Company has recorded a deferred tax liability for earnings that the Company plans to repatriate out of accumulated earnings in future periods. All undistributed earnings in excess of 50% of current earnings on an annual basis are intended to be reinvested indefinitely. Generally, such earnings becomeindefinitely as of December 31, 2016.

The Company and its subsidiaries file tax returns in the United States, California and Texas and various foreign jurisdictions. For federal income tax purposes, fiscal years 2007 through 2015 remain open for examination by tax authorities as a result of net operating loss carryovers from older years being used to offset income in recent tax years. The Company is no longer subject to U.S.state income tax uponexaminations for years prior to 2011. No jurisdictions are currently examining any income tax returns of the remittance of dividends and under certain other circumstances. At December 31, 2013, it is not practicable to estimate the amount of deferred tax liability on such undistributed earnings.

Company or its subsidiaries.



7.     SUPPLEMENTAL CASH FLOW INFORMATION

  

Year Ended December 31,

 
  

2012

  

2013

 
  

(In Thousands)

 

Cash paid during the year for:

        

Income taxes, net of refunds

 $34  $71 

Interest

 

  

 
         
Non-cash financing activity:        
Conversion of preferred stock    13 

 Year Ended December 31,
 2016 2015 2014
      
Cash paid during the year for:(In Thousands)
Income taxes, net of refunds$8,791
 $707
 $60
Interest9
 
 1
Non-cash financing activity: 
  
  
Conversion of preferred stock
 
 111
Issuance of treasury stock1,741
 666
 

8.     RELATED PARTY TRANSACTIONS

In February 2013,

Product Royalties
On April 29, 2015, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C., a Texas limited liability company, (“BHS”) regarding the manufacture and sale of a new product called ReStor™Soothe. The Company began selling this product in the fourth quarter of 2012 with the permission of BHS. Mr. Broady is owner of BHS. Under thisthe agreement, the Company has agreed to pay BHS a royalty of 2.5% of sales revenue in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide. Further, the Company agreed to pay BHS $11,700 as royalties for 2011the period it began selling the product in the fourth quarter of 2012 through 2014. The Company recognized royalties of $3,400, $7,000 and subsequent years$6,400 during 2016, 2015 and 2014, respectively. The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice. Otherwise, the agreement terminates March 31, 2020.

In February 2013, the Company entered into a Royalty Agreement and License with BHS regarding the manufacture and sale of a product called ReStor™.  Under this agreement, the Company agreed to pay BHS a royalty of 2.5% of sales revenue in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States. George Broady, a director ofOn April 29, 2015, the Company and owner of more than 5% of its outstanding common stock, is owner of BHS.  During 2011 and 2012, BHS permitted the Company to manufacture (or have manufactured), market and sell the ReStor™ product. In April 2012, the Company reimbursed BHS $42,000 in expenses incurred in 2011 to promote the ReStor™ product on the Company’s behalf. To permit the Company to continue selling ReStor™and obtain certain exclusive rights outside of the United States, BHS requested that the Company enter intoamended the Royalty and Agreement and License.License to change the royalty to a price per unit instead of 2.5% of sales revenue. This agreementprovision was reviewed, considered, authorizedeffective retroactive to January 1, 2015.  The Company recognized royalties of $475,000, $555,000 and approved by the sole disinterested, non-employee member of the Board of Directors under appointment by the full Board of Directors as an ad hoc committee for this purpose. Upon signing this agreement, the Company paid BHS $12,000$144,000 during 2016, 2015 and $25,000 as royalties for 2011 and 2012,2014, respectively. Royalties accrued for 2013 were $48,000.  The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice.

Otherwise, the agreement terminates March 31, 2020.

Stock RepurchaseAgreements
On October 28, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4066 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on July 28, 2015. The Company’s purchases from Mr. Broady concluded on November 2, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company’s broker in its open-market purchases, and resulted in an aggregate purchase price of $1.4 million. See Note 4.

On July 31, 2015, the Company is considering enteringentered into another royalty agreementa Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4085 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on July 28, 2015. The Company’s purchases from Mr. Broady concluded on August 6, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company’s broker in its open-market purchases, and licenseresulted in an aggregate purchase price of $1.5 million. See Note 4.


On May 7, 2015, the Company entered into a Stock Repurchase Agreement with BHS regardingMr. Broady that provided for the manufactureCompany’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4286 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on May 4, 2015. The Company’s purchases from Mr. Broady concluded on May 13, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company's broker in its open-market purchases, and saleresulted in an aggregate purchase price of $1.5 million. See Note 4.

On January 22, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a new product called Soothe™,total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased. The shares were purchased at a per share price equal to the closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock was publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of $1.1 million. See Note 4.

On November 14, 2014, the Company began sellingentered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase from Mr. Broady of one-half of the number of shares of common stock purchased by the Company’s broker in the fourth quarteropen market under the Repurchase Plan approved by the Company’s Board of 2012Directors on November 4, 2014. The Stock Repurchase Agreement with the permission of BHS. To continue selling this product, BHS has requestedMr. Broady required that the Company payreport to Mr. Broady on a royalty of 2.5% of sales revenue for this product for 2012weekly basis information regarding the broker’s open market purchases, and subsequent years.  The Company is considering that proposal and discussing the terms of a definitive agreement.  At a royalty of 2.5% of net sales, the Company calculates that royalties for 2012purchase from Mr. Broady on a weekly basis at a per share purchase price equal to the weighted average price per share paid by the Company’s broker to purchase shares in the open market. The Company’s purchases concluded on December 17, 2014, totaled 119,947 shares of its common stock and 2013 would total $5,000.

resulted in an aggregate purchase price of $1.5 million. See Note 4.

9.     EMPLOYEE BENEFIT PLANS

     The Company has a 401(k) defined contribution plan which permits participating employees in the United States to defer up to a maximum of 90% of their compensation, subject to limitations established by the Internal Revenue Service. Employees age 21 and older are eligible to contribute to the plan starting the first day of the following month of employment.  Participating employees are eligible to receive discretionary matching contributions and profit sharing, subject to certain conditions, from the Company.  In 20122016, 2015 and 2013,2014, the Company matched employee deferral contributions up to 4.5% of salary, which vested 100% immediately. No profit sharing has been paid under the plan. The Company recorded compensation expense of $61,000$134,000, $115,000 and $62,000$60,000 for 20122016, 2015 and 2013,2014, respectively, related to its matching contributions to the plan. Certain of the Company’s employees located outside the United States participate in employee benefit plans that are statutory in nature.



10.    SEGMENT INFORMATION

The Company sells products to a distributormember network that operates in a seamless manner from market to market, except for the Chinese market. Themarket where it sells to consumers through an e-commerce retail platform. Outside of the China e-commerce retail platform, the Company believes that eachall of its other operating segments should be aggregated into a single reportable segment as they have similar economic characteristics.characteristics, except for its operations located within the Commonwealth of Independent States (“CIS”). In making this determination, the Company believes that each of theits operating segments are similar in the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.

The Company’s e-commerce retail business launchedengagement of a third-party service provider in China during June 2007 does not requirethe CIS market results in a direct selling license and allows for discounts on volume purchases. Theredifferent economic structure than its other markets.


However, there is no separate segment manager who is held accountable by ourthe Company’s chief operating decision-makers, or anyone else, for operations, operating results and planning for the either Chinese marketor the CIS markets on a stand-alone basis. Accordingly, we consider ourselves tobasis, and neither market is material for the two years presented. As such, the Company believes that all operating segments should be inaggregated into a single reportingreportable segment and operating unit structure.

for disclosure purposes.


The Company’s net sales by geographic area are as follows (in thousands):

  

Year Ended December 31,

 
  

2012

  

2013

 

Net sales from external customers:

        

United States

 $1,737  $2,289 

Hong Kong

  26,235   40,585 

China

  1,081   791 

Taiwan

  2,074   3,387 

South Korea

  285   702 

Russia and Kazakhstan

  5,540   4,354 

Other foreign countries

  562   419 

Total net sales

 $37,514  $52,527 

 Year Ended December 31,
 2016 2015 2014
Net sales from external customers:     
United States$4,100
 $3,246
 $1,438
Canada1,809
 2,746
 1,374
Hong Kong263,482
 245,737
 111,028
China9,086
 4,425
 1,538
Taiwan6,213
 5,965
 4,628
South Korea691
 1,129
 1,009
Commonwealth of Independent States (Russia, Kazakhstan and Ukraine)1
858
 1,139
 3,113
Europe1,234
 382
 373
Other foreign countries255
 91
 89
Total net sales$287,728
 $264,860
 $124,590

1The Companydiscontinued its Ukraine operations during the second quarter of 2015.
The Company’s net sales by product and service are as follows (in thousands):

  

December 31,

 
  

2012

  

2013

 

Net sales by product and service:

        

Product sales

 $36,174  $50,385 

Enrollment package revenue, freight and other

  2,225   2,955 

Less: sales returns

  (885)  (813)

Total net sales

 $37,514  $52,527 

 Year Ended December 31,
 2016 2015 2014
Net sales by product and service:     
Product sales$269,731
 $253,041
 $118,843
Enrollment package revenue, freight and other25,616
 17,623
 7,927
Less: sales returns(7,619) (5,804) (2,180)
Total net sales$287,728
 $264,860
 $124,590

Due to system constraints, it is impracticable for the Company to separately disclose sales by product category for the years presented.

The Company’s long-lived assets by geographic area are as follows (in thousands):

  

December 31,

 
  

2012

  

2013

 

Long-lived assets:

        

United States

 $38  $35 
China  63   137 

Other foreign countries

  20   93 

Total long-lived assets

 $121  $265 

 December 31,
 2016 2015
Long-lived assets:   
United States$763
 $283
Hong Kong140
 204
China199
 252
Other foreign countries286
 155
Total long-lived assets$1,388
 $894

11.     SUBSEQUENT EVENTS

  In February 2014, warrants to purchase 120,000 shares of common stock were exercised at $3.52 per share for total proceeds of $422,000.


On March 7, 2014,January 24, 2017, the Board of Directors declared a dividend on each share of outstanding Series A preferred stock in the amount of $0.81507 per share representing the accrued and cumulative dividends from May 4, 2007 through March 7, 2014. Simultaneously, the Board of Directors also declared acash dividend of $0.005$0.09 and a special cash dividend of $0.35 on each share of common stock outstanding. All suchSuch dividends are payable in cashwere paid on April 8, 2014March 3, 2017 to stockholders of record on March 28, 2014.

February 21, 2017. Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.

On January 24, 2017, the Company granted 56,260 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of settling fiscal 2016 performance incentives. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances.


Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


Not applicable.

Item 9A. CONTROLS AND PROCEDURES


Disclosure Controls and Procedures

Management, with the participation of the Company’sour principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’sour disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”))Act) as of December 31, 2013. The Company’s2016. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by the Companyus in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to management, including the Company’sour principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of December 31, 2013, the Company’s2016, our disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the Company’sour principal executive and principal financial officers and effected by the Company’sour Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
 Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management evaluates the effectiveness of the Company’sour internal control over financial reporting by using the criteria established in Internal Control – Integrated Framework (1992)(2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO ”)COSO”).  Based on this criteria, management concluded that the Company’sour internal control over financial reporting as of December 31, 20132016 was effective.

This Annual

Attestation Report does not include an attestation report of the Company’sCompany's Independent Registered Public Accounting Firm

The effectiveness of our internal control over financial reporting as of December 31, 2016, has been audited by Lane Gorman Trubitt, LLC, an independent registered public accounting firm, regarding internal control over financial reporting. Management’s report was not subject toas stated in their attestation by the Company’s independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in “Item 8. Financial Statements and Supplementary Data” of this Annual Report.

Report on Form 10-K.

Changes in Internal Control over Financial Reporting

There were no changes in internal control over financial reporting that occurred during the fiscal quarter ended December 31, 20132016 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting, except that Gary C. Wallace resigned as General Counsel, Chief Compliance Officer and Secretary of the Company effective December 31, 2013. On January 1, 2014, the Board of Directors appointed Timothy S. Davidson as the Company’s Secretary and assigned him the duties of chief compliance officer until a Chief Compliance Officer is appointed.

reporting.


Item 9B.OTHER INFORMATION


None.

 

Part III

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors


The biographical information for each director of the Companyrequired by this Item is set forth below:

Randall A. Mason.Mr. Mason, age 55, has been a director of the Company since May 2003 and has served as Chairman of the Board of Directors since March 2006. Mr. Mason founded and has served as President and Chief Executive Officer of Marden Rehabilitation Associates, Inc. since 1989. Marden Rehabilitation Associates, Inc. is a private, Midwest U.S. ancillary provider of rehabilitative therapy services and home healthcare. Mr. Mason has a bachelor degree in chemical engineeringincorporated by reference from the University of Pittsburgh.

Mr. Mason is an experienced businessman with valued insight into management, operations, finances and governance issues.  As a long-time member of the Company’s Board of Directors, Mr. Mason understands the business of the Company and potential risks and pitfalls. 

George Broady.Mr. Broady, age 75, has served as a director of the Company since October 2008. He has been active in business for more than 40 years, and he is currently the principal owner and chairman of several privately held companies in the fields of telecommunications, enterprise software applications for time and attendance and security access control. He founded Network Security Corporation, Interactive Technologies Inc. and Ultrak Inc., and brought each of them public on The NASDAQ Stock Market. He was chairman of all three organizations and CEO of both Network Security and Ultrak. All three companies were involved in electronic security, including CCTV and access control. Earlier in his career, Mr. Broady was an investment analyst with both a private investment firm, Campbell Henderson & Co., anddefinitive proxy statement to be filed with the First National Bank in Dallas. Mr. Broady served twice in the U.S. Army and holds a Bachelor of Science degree from Iowa State University.

Mr. Broady is an experienced investor and businessman who also brings welcome insight into management, operations, and finances.  As a long-time investor in the Company, and incumbent director, Mr. Broady also understands the business of the Company and its industry. He is owner of Broady Health Sciences, a leader in dietary supplements invigorating the production of Ca2+ATPase, an enzyme found in every cell of the body, and Soothe, a formula that helps to restore and repair dry skin.

Chris T. Sharng.Mr. Sharng, age 50, has served as a director since March 2012. He has served as President of the Company since February 2007 and as Executive Vice President and Chief Financial Officer of the Company from August 2004 to February 2007. Mr. Sharng also performed the functions of the principal executive officer of the Company from April 2006 to August 2006. From March 2006 to August 2006, Mr. Sharng served as a member of the Company’s Executive Management Committee, which was charged with managing the Company’s day-to-day operations while a search was conducted for a new chief executive officer for the Company. From March 2004 through July 2004, Mr. Sharng was the Chief Financial Officer of NorthPole Limited, a privately held Hong Kong-based manufacturer and distributor of outdoor recreational equipment. From October 2000 through February 2004, Mr. Sharng was the Senior Vice President and Chief Financial Officer of Ultrak Inc., which changed its name to American Building Control Inc. in 2002, a Texas-based, publicly traded company listed on The NASDAQ Stock Market that designed and manufactured security systems and products. From March 1989 through July 2000, Mr. Sharng worked at Mattel, Inc., most recently as the Vice President of International Finance. Mr. Sharng has an MBA from Columbia University and received his bachelor degree from National Taiwan University.

As the Company’s President since 2007, and as the Chief Financial Officer prior to that, Mr. Sharng has developed a deep understanding of our business globally. His leadership has been integral to the success of several of our key initiatives in recent years.

Executive Officers

The biographical information for Mr. Sharng is set out above in the biographical information for directors. Biographical information regarding the Company’s current other executive officer is as follows:

Timothy S. Davidson. Mr. Davidson, age 43, has served as the Company’s Senior Vice President and Chief Financial Officer since February 2007. He previously served as the Company’s Chief Accounting Officer from September 2004 to February 2007. From March 2001 to September 2004, Mr. Davidson was Corporate Controller for a telecommunications company, Celion Networks, Inc., located in Richardson, Texas. From February 2000 to February 2001, Mr. Davidson was Manager of Financial Reporting for another Dallas-based telecommunications company, IP Communications, Inc. FromSEC within 120 days after December 1994 through January 2000, Mr. Davidson was employed by Arthur Andersen, LLP, most recently as an Audit Manager. Mr. Davidson has a master degree in professional accounting from the University of Texas at Austin and received his bachelor degree from Texas A&M University at Commerce.

31, 2016.
 

Section 16(A) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors, executive officers, and persons who own more than 10% of a registered class of the Company’s equity securities, to file with the Securities and Exchange Commission (the “SEC”) initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than 10% shareholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file.

Based solely on a review of the copies of such reports furnished to the Company, during the fiscal year ended December 31, 2013 and thereafter, all Section 16(a) filing requirements applicable to its officers, directors and greater than 10% beneficial owners were complied with, except that Mr. Broady filed six late Form 4s in 2013 reporting 73 late transactions and failed to file reports with respect to an additional 33 late transactions from 2013.

Code of Ethics

The Company has a Code of Business Conduct that applies to our employees, officers (including our principal executive officer, principal financial officer and principal accounting officer or controller) and directors and a Code of Ethics for Senior Financial Officers (collectively, the “Codes”). The Codes are intended to establish standards necessary to deter wrongdoing and to promote compliance with applicable governmental laws, rules and regulations and honest and ethical conduct. The Codes cover all areas of professional conduct, including conflicts of interest, fair dealing, financial reporting and disclosure, protection of Company assets and confidentiality. Employees have an obligation to promptly report any known or suspected violation of the Codes without fear of retaliation. Waiver of any provision of the Codes for executive officers may only be granted by the Board of Directors or one of its committees and any such waiver or modification of the Codes relating to such individuals will be disclosed by the Company on its website. The Codes are available on the Company’s website,www.naturalhealthtrendscorp.com.

Audit Committee Matters

On March 30, 2012, the Board of Directors adopted resolutions by unanimous consent dissolving the Audit Committee and no longer has a standing Audit Committee. Instead, the entire Board of Directors acts as the Audit Committee, although Mr. Sharng, as an employee director, does not participate in executive sessions that the Board of Directors has with the Company’s outside auditors. The Board of Directors has determined that Mr. Mason meets the SEC criteria of an “audit committee financial expert.”


Item 11. EXECUTIVE COMPENSATION


The following table provides information concerningrequired by this Item is incorporated by reference from the compensation fordefinitive proxy statement to be filed with the years endedSEC within 120 days after December 31, 2012 and 2013, for our principal executive officer and two other executive officers (collectively, the “Named Executive Officers”):

Summary Compensation Table

 
                  

Name and Principal Position

Year

 

Salary

($)

  

Bonus

($)

  

All Other

Compensation

($)

  

Total

($)

 
                  

Chris T. Sharng, President

2012

 $400,000  $138,462  $33,278(1)  $571,740 
 

2013

  403,846   144,231   40,609(2)  588,686 
                  

Timothy S. Davidson, Senior Vice President and

2012

  235,000   46,154   24,734(3)  305,888 

Chief Financial Officer

2013

  236,346   52,500   29,092(4)  317,938 
                  

Gary C. Wallace, former General Counsel(5)

2012

  250,000   22,154   25,102(6)  297,256 
 

2013

  250,000   28,385   29,706(7)  308,091 

(1)

Represents $11,250 in employer matching contributions under the Company’s defined contribution plan and $22,028 in tax gross-up payments.

(2)

Represents $11,475 in employer matching contributions under the Company’s defined contribution plan and $29,134 in tax gross-up payments.

(3)

Represents $10,575 in employer matching contributions under the Company’s defined contribution plan and $14,159 in tax gross-up payments.

(4)

Represents $10,636 in employer matching contributions under the Company’s defined contribution plan and $18,456 in tax gross-up payments.

(5)

Mr. Wallace’s employment with the Company terminated effective December 31, 2013.

(6)

Represents $11,250 in employer matching contributions under the Company’s defined contribution plan and $13,852 in tax gross-up payments.

(7)

Represents $11,250 in employer matching contributions under the Company’s defined contribution plan and $18,456 in tax gross-up payments.

The following tables summarize all outstanding equity awards held by our Named Executive Officers as of December 31, 2013:

Outstanding Equity Awards at December 31, 2013

  

Number of Shares

or Units of Stock

That Have Not

Vested (#)

  

Market Value of

Shares or Units of

Stock That Have

Not Vested ($)(1)

 

Equity Incentive

Plan Awards:

Number of

Unearned Shares,

Units or Other

Rights That Have

Not Vested
(#)

 

Equity Incentive

Plan Awards:

Market or Payout

Value of Unearned

Shares, Units or

Other Rights That

Have Not Vested
($)

             

Chris T. Sharng

  10,413 (2) $33,322  $
             

Timothy S. Davidson

  6,250 (2)  20,000 

  

             

Gary C. Wallace(3)

  6,250 (2)  20,000 

  

(1)

Market value is computed by multiplying the closing market price of the Company’s stock as of December 31, 2013 of $3.20 per share by the number of shares of stock that have not vested.

(2)

One-twelfth of the original grant of will vest quarterly on March 15, June 15, September 15, and December 15 through March 15, 2014.

(3)

Mr. Wallace’s employment with the Company terminated effective December 31, 2013.

2016.
 

Named Executive Officer Compensation Arrangements

Chris T. Sharng.On April 23, 2007, we entered into an employment agreement with Mr. Sharng that provides for a base annual salary and also entitles Mr. Sharng to participate in our annual incentive plan, equity incentive plan and other standard U.S. employee benefit programs. Additionally, Mr. Sharng is entitled to receive certain gross-up payments on federal taxes due upon vesting of restricted stock grants on or after September 15, 2011.Mr. Sharng’s base annual salary was raised to $400,000 effective August 1, 2011 and to $500,000 effective December 1, 2013. Mr. Sharng was awarded a discretionary bonus in each of 2012 and 2013 of $150,000 (see description below). Mr. Sharng has also served on the Company’s Board of Directors since March 30, 2012, but does not receive any additional compensation for his service in that capacity.

Timothy S. Davidson.On April 23, 2007, we entered into an employment agreement with Mr. Davidson that provides for a base annual salary and also entitles Mr. Davidson to participate in our annual incentive plan, equity incentive plan and other standard U.S. employee benefit programs. Additionally, Mr. Davidson is entitled to receive certain gross-up payments on federal taxes due upon vesting of restricted stock grants on or after September 15, 2011.Mr. Davidson’s base annual salary was raised to $235,000 effective August 1, 2011 and to $270,000 effective December 1, 2013. Mr. Davidson was awarded a discretionary bonus in 2012 and 2013 of $50,000 and $55,000, respectively (see description below).

Gary C. Wallace.On April 23, 2007, we entered into an employment agreement with Mr. Wallace that provided for a base annual salary of $190,000. Mr. Wallace was also entitled to participate in our annual incentive plan, equity incentive plan and other standard U.S. employee benefit programs. Additionally, Mr. Wallace was entitled to receive certain gross-up payments on federal taxes due upon vesting of restricted stock grants on or after September 15, 2011.Mr. Wallace’s base annual salary was raised to $250,000 effective August 1, 2011. Mr. Wallace was awarded a discretionary bonus in 2012 and 2013 of $24,000 and $30,000, respectively (see description below). On December 31, 2013, the Company and Mr. Wallace agreed to terminate Mr. Wallace’s employment agreement dated April 23, 2007.

On and after September 15, 2011, the aggregate amount of all tax gross-up payments to executive officers and directors may not exceed $30,000 per quarter, provided that the unused portion of each quarter’s cap is rolled over to future quarters.

The discretionary bonuses to Messrs. Sharng, Davidson and Wallace in 2012 and 2013 were awarded by the Board of Directors (or a committee thereof) in January 2012 and 2013, respectively. These bonuses were payable over 12 months, and each payment was contingent upon the award recipient being employed at the time of payment.  The unpaid portion of any bonus at the time that employment is terminated was to be forfeited.  As such, unpaid bonus in the amount of $3,231 was forfeited upon Mr. Wallace’s termination effective December 31, 2013. In awarding these bonuses, the Board of Directors (or a committee thereof) awarded discretionary amounts after finding that the estimated financial results for fiscal 2011 and 2012 achieved the revenue and earnings performance goals for that particular year.

In January 2014, the Board of Directors awarded bonuses of $320,000 to Mr. Sharng and $75,000 to Mr. Davidson. These bonuses are payable over 12 months beginning in February 2014, and each payment is contingent upon the award recipient being employed at the time of payment.  The unpaid portion of any bonus at the time that employment is terminated is forfeited.  In awarding these bonuses, the Board of Directors awarded discretionary amounts after finding that the estimated financial results for fiscal 2013 achieved the Board’s revenue and earnings performance goals for 2013.

Severance and Post-Termination Payment Arrangements

We have entered into employment agreements with each of our Named Executive Officers. Under these agreements, we may be required to provide compensation to these officers in the event of the termination of the executive’s employment. Details for each Named Executive Officer are set forth below.

Chris T. Sharng.Our current employment agreement with Mr. Sharng, entered into on April 23, 2007, provides that if Mr. Sharng’s employment with us is terminated voluntarily by him for “good reason” as defined in the employment agreement that has not been cured by us within 30 days of such notice, or is terminated by us without cause, other than in connection with a “change of control”, then Mr. Sharng will be entitled to the continuation of the payment of his salary, plus health and medical insurance coverage, for a period of up to one year following the termination date, or until the earlier date upon which he becomes engaged in any “competitive activity” as defined in the Non-Competition Agreement or otherwise breaches the terms and conditions of his Non-Competition Agreement with us.


If Mr. Sharng’s employment with us is terminated by us without cause during the period commencing on the date that is 30 days prior to a change of control through and including a date that is 18 months following the change of control, he is entitled to the continuation of the payment of his salary, plus health and medical insurance coverage for a period of up to two years, plus health and medical insurance coverage for the same two year period following the termination date. This payment is due in a lump sum 30 days after the termination date.

In order to be entitled to receive the severance amount in either of the above scenarios, Mr. Sharng must execute a full general release of all claims against us and our affiliates within 90 days from the date of termination.

A “change of control” is defined as: (i) when any “person” as defined in Section 3(a)(9) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and as used in Section 13(d) and 14(d) thereof including a “group” as defined in Section 13(d) of the Exchange Act, but excluding the Company or any subsidiary or any affiliate of the Company or any employee benefit plan sponsored or maintained by the Company or any subsidiary of the Company (including any trustee of such plan acting as trustee), becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities; or (ii) when, during any period of 24 consecutive months, the individuals who, at the beginning of such period constituted the Board of Directors (the “Incumbent Directors”) cease for any reason other than death to constitute at least a majority thereof, provided, however, that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24 month period) or through the operation of this provision; or (iii) the occurrence of a transaction requiring stockholder approval under applicable state law for the acquisition of the Company by an entity other than the Company or a subsidiary or an affiliated company of the Company through purchase of assets, or by merger, or otherwise; provided however, that none of the foregoing shall constitute a change of control if such transaction, event or occurrence is approved by, or consented to, by Mr. Sharng.

Mr. Sharng will be subject to a covenant not to compete for one year, and a non-solicitation covenant for two years, following his termination and thereafter as long as his severance payments continue (other than severance in connection with a change of control).

Timothy S. Davidson.Our employment agreement with Mr. Davidson entered into on April 23, 2007, contains the same severance and change of control provisions as those set out in our agreement with Mr. Sharng dated April 23, 2007, subject to the terms and conditions of his Non-Competition Agreement with us.

Gary C. Wallace.Our employment agreement with Mr. Wallace entered into on April 23, 2007, contained the same severance, change of control, non-competition and non-solicitation provisions as those set out in our agreement with Mr. Sharng dated April 23, 2007. On December 31, 2013, the Company and Mr. Wallace agreed to terminate Mr. Wallace’s employment agreement. As such, Mr. Wallace isentitled to the continuation of the payment of his salary, plus health and medical insurance coverage, for a period of up to one year following the termination date, or until the earlier date upon which he becomes engaged in any “competitive activity” or breaches the terms and conditions of his Non-Competition Agreement with us.

Director Compensation

During 2013, each non-employee member of our Board of Directors earned a cash retainer of $3,333 per month, plus the reimbursement of their respective out-of-pocket expenses incurred in connection with the performance of their duties as directors.  In addition, Mr. Mason earned an additional retainer of $4,000 per month as Chairman of the Board of Directors in 2013.  Effective December 1, 2013, an annual director compensation pool of $120,000 was established to be allocated evenly between the non-employee directors. As such, additional compensation earned in December 2013 was $5,000 for each of the existing two directors.

Starting in 2011, directors are also entitled to receive certain gross-up payments on federal taxes due upon vesting of restricted stock grants to them.  In addition, as additional compensation for his services as the Chairman of the Board, Mr. Mason is entitled to receive $54,000 as a gross-up payment for federal taxes incurred with respect to restricted stock granted in 2007, payable in quarterly installments of $4,500 beginning September 15, 2011.  On and after September 15, 2011, the aggregate amount of all tax gross-up payments to executive officers and directors may not exceed $30,000 per quarter, provided that the unused portion of each quarter’s cap is rolled over to future quarters.


The following table shows the 2013 compensation earned by each non-employee member of the Company’s Board of Directors:

2013 Non-Employee Director Compensation

 
                 

 

Name

 

Fees Earned or

Paid in Cash ($)

  

Stock Awards

($)(1)

  

All Other

Compensation ($)

  

 

Total ($)

 
                 

Randall A. Mason

 $93,000  $  $38,463(2)  $131,463 

George K. Broady

  45,000  

   20,463(3)   65,463 

(1)

The aggregate number of stock awards outstanding to each of Messrs. Mason and Broady as of December 31, 2013 was 4,163 shares.

(2)

Represents $18,000 in tax gross-up payments for restricted stock granted in 2007 and $20,463 in tax gross-up payments for 2013.

(3)

Represents tax gross-up payments for 2013.

Item 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The following table showsinformation required by this Item is incorporated by reference from the amount of the Company’s common stock beneficially owned (unless otherwise indicated) as of February 28, 2014 by (i) each stockholder known to usdefinitive proxy statement to be the beneficial owner of more than 5% of the Company’s common stock, (ii) each director or director nominee, (iii) each of the Named Executive Officers and (iv) all executive officers and directors as a group. Beneficial ownership is determined in accordancefiled with the rules and regulations of the SEC and generally includes those persons who have voting or investment power with respect to the securities. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of the Company’s common stock beneficially owned by them.

 

 

Name and Address of Beneficial Owner(1)

 

Amount and Nature

of Beneficial

Ownership(2)

 

 

Percent of

Class(2)

     

Executive Officers and Directors:

    

Chris T. Sharng

 

413,311

(3)

3.6%

Timothy S. Davidson

 

204,150

(4)

1.8%

Gary C. Wallace(5)

 

163,542

(6)

1.4%

Randall A. Mason

 

262,400

(7)

2.3%

George K. Broady

 

4,023,967

(8)

34.7%

All executive officers and directors as a group (5 persons)

 

5,067,370

(9)

43.7%

     

5% or More Stockholders:

    

Robert L. Frome

 

672,311

(10)

5.9%

Park Avenue Tower

    

65 East 55th Street

    

New York, NY 10022

    
     

(1)

Unless otherwise indicated, the address of each beneficial owner is c/o Natural Health Trends Corp., 4514 Cole Avenue, Suite 1400, Dallas, Texas 75205.

(2)

Any securities not outstanding that are subject to conversion privileges exercisable within 60 days of February 28, 2014 are deemed outstanding for the purpose of computing the percentage of outstanding securities of the class owned by any person holding such securities, but are not deemed outstanding for the purpose of computing the percentage of the class owned by any other person in accordance with Item 403 of Regulation S-K of the Exchange Act and Rules 13(d)-3 of the Exchange Act, and based upon 11,448,571 shares of common stock outstanding as of February 28, 2014.

(3)

Includes 10,413 shares of restricted stock subject to vesting. Mr. Sharng shares voting and investment power over 15,500 of the shares with his wife.

(4)

Includes 6,250 shares of restricted stock subject to vesting.

(5)

Mr. Wallace’s employment with the Company terminated effective December 31, 2013.

(6)

Includes 6,250 shares of restricted stock subject to vesting.

(7)

Includes (i) 27,399 shares owned by Marden Rehabilitation Associates, Inc., an entity controlled by Mr. Mason, and (ii) 4,163 shares of restricted stock subject to vesting.

(8)

Includes (i) 61,693 shares of common stock issuable upon the conversion of shares of Series A preferred stock, (ii) 87,997 shares of common stock issuable upon the exercise of warrants held by Mr. Broady, and (iii) 4,163 shares of restricted stock subject to vesting.

(9)

Includes (i) 61,693 shares of common stock issuable upon the conversion of shares of Series A preferred stock held by Mr. Broady, (ii) 87,997 shares of common stock issuable upon the exercise of warrants held by Mr. Broady, and (ii) 31,239 shares of restricted stock held by our directors and executive officers that are subject to vesting.

(10)

Includes (i) 100,000 shares owned by Frome & Co., a family partnership, which Mr. Frome is the general partner; (ii) 30,000 shares held by the Jennifer Frome Trust, which Mr. Frome is the trustee; and (iii) 30,000 shares owned by his wife. Information is based in part on the Schedule 13G filed by Mr. Frome with the SEC on February 14, 2014.

within 120 days after December 31, 2016.
 

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Certain Relationships and Related Transactions

In February 2013,

The information required by this Item is incorporated by reference from the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C., a Texas limited liability company, (“BHS”) regarding the manufacture and sale of a new product called ReStor™. Under this agreement, the Company has agreeddefinitive proxy statement to pay BHS a royalty of 2.5% of sales revenue for this product for 2011 and subsequent years in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States. George Broady, a director of the Company and owner of more than 5% of its outstanding common stock, is owner of BHS.  During 2011 and 2012, BHS permitted the Company to manufacture (or have manufactured), market and sell the ReStor™ product. In April 2012, the Company reimbursed BHS $42,000 in expenses incurred in 2011 to promote the ReStor™ product on the Company’s behalf. To permit the Company to continue selling ReStor™and obtain certain exclusive rights outside of the United States, BHS requested that the Company enter into the Royalty Agreement and License. This agreement was reviewed, considered, authorized and approved by the sole disinterested, non-employee member of the Board of Directors under appointment by the full Board of Directors as an ad hoc committee for this purpose. Upon signing this agreement, the Company paid BHS $12,000 and $25,000 as royalties for 2011 and 2012, respectively. Royalties accrued for 2013 were $48,000.  The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice.

The Company is considering entering into another royalty agreement and license with BHS regarding the manufacture and sale of a new product called Soothe™, which the Company began selling in the fourth quarter of 2012filed with the permission of BHS. To continue selling this product, BHS has requested that the Company pay a royalty of 2.5% of sales revenue for this product for 2012 and subsequent years.  The Company is considering that proposal and discussing the terms of a definitive agreement.  At a royalty of 2.5% of net sales, the Company calculates that royalties for 2012 and 2013 would total $5,000.

Director Independence

The Board of Directors has adopted the requirements in Nasdaq Marketplace Rule 4200(a)(15) as its standard in determining the “independence” of members of its Board of Directors. The Board of Directors has determined that Randall A. Mason, who served as a director of the Company during all of 2012 and 2013, qualifies as an “independent director” under these standards.

Messrs. Mason and Broady are the only current non-employee members of the Board of Directors of the Company, and each of them served as a member of the Company’s Audit Committee and Compensation Committee until those committees were dissolved on March 30, 2012.  Mr. Mason was the Chairman of both of those committees until they were dissolved, and was the Chairman and only member of the Nominating Committee until that committee was dissolved on March 30, 2012. Mr. Sharng is the only other member of the Board of Directors and also serves as President of the Company.

SEC within 120 days after December 31, 2016.
 

Item 14. PRINCIPAL ACCOUNTINGACCOUNTANT FEES AND SERVICES

During 2012 and 2013, approximate fees billed


The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the Company for services provided by Lane Gorman Trubitt, PLLC (“Lane Gorman”), were as follows:

Audit Fees.Fees billed to the Company by Lane Gorman for the audit of our annual financial statements and review of our quarterly financial statements during the years endedSEC within 120 days after December 31, 2012 and 2013 totaled $105,000 and $132,280, respectively.

Audit-Related Fees. No audit-related fees were billed to the Company by Lane Gorman for services rendered during the years ended December 31, 2012 or 2013.

Tax Fees. There were no fees billed to the Company by Lane Gorman for services rendered in connection with tax compliance, planning and advice during the years ended December 31, 2012 or 2013.

All Other Fees. There were no fees billed by Lane Gorman for services other than audit fees, audit-related fees or tax fees during the years ended December 31, 2012 or 2013.

Pre-approval Policies and Procedures for Audit and Non-Audit Services

All audit and permitted non-audit services required pre-approval by the Audit Committee until its dissolution on March 30, 2012 and, since then, by the entire Board of Directors. All audit and permitted non-audit services performed by Lane Gorman during 2012 and 2013 were pre-approved.

2016.

Part IV

Item 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES


Documents filed as part of this Form 10-K:

1.

Financial Statements. See Index to Consolidated Financial Statements under Item 8“Item 8. Financial Statements and Supplementary Data” of Part II.

this report.

2.

Financial Statement Schedules. Financial statement schedules have been omitted because they are not required, not applicable, or because the required information is shown in the financial statements or notes thereto.

3.

Exhibits. The exhibits listed on the accompanying Exhibit Index are filed as a part of, and are incorporated by reference into, this report.

We will furnish any of the exhibits referenced in the accompanying Exhibit Index to a requesting shareholder upon payment of a fee equal to our reasonable expenses in furnishing such exhibit(s).


Item 16. FORM 10-K SUMMARY

None.


SIGNATURES
 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

NATURAL HEALTH TRENDS CORP.

Date: March 7, 2014

/s/ Chris T. Sharng

Chris T. Sharng

President

  

Date: March 10, 2017/s/ Chris T. Sharng
Chris T. Sharng
President
(Principal Executive Officer)

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS that each of Natural Health Trends Corp., a Delaware corporation, and the undersigned directors and officers of Natural Health Trends Corp., hereby constitutes and appoints Chris T. Sharng and Timothy S. Davidson, or any one of them, its, his or her true and lawful attorney-in-fact and agent, for it, him or her and in its, his or her name, place and stead, in any and all capacities, with full power to act alone, to sign any and all amendments to this report, and to file each such amendment to the report, with all exhibits thereto, and any and all other documents in connection therewith, with the Securities and Exchange Commission, hereby granting unto said attorney-in-fact and agent full power and authority to do and perform any and all acts and things requisite and necessary to be done in and about the premises as fully to all intents and purposes as it, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

 

Title

 

Date

     

/s/ Chris T. Sharng

 

President and Director

 March 7, 201410, 2017

Chris T. Sharng

 

(Principal Executive Officer)

 

     

/s/ Timothy S. Davidson

 

Senior Vice President and Chief Financial Officer

 March 7, 201410, 2017

Timothy S. Davidson

 

(Principal Financial and Accounting Officer)

 

    
/s/ Randall A. Mason Chairman of the Board and Director March 7, 201410, 2017

Randall A. Mason

 

 

     

/s/ George K. Broady

 Director March 7, 201410, 2017

George K. Broady

 

 

/s/ Kin Y. ChungDirectorMarch 10, 2017
Kin Y. Chung
/s/ Yiu T. ChanDirectorMarch 10, 2017
Yiu T. Chan


EXHIBIT INDEX

(Pursuant to Item 601 of Regulation S-K)

Exhibit

Number

Exhibit Description

3.1 

Exhibit
Number
Exhibit Description
3.1Certificate of Incorporation of Natural Health Trends Corp. (incorporated by reference to Exhibit 3.01 to Current Report on Form 8-K filed on July 12, 2005).

3.2

3.3
 

Certificate of Designations, Rights and Preferences of the Series A Convertible Preferred Stock of the Company (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on May 9, 2007).

3.3 

By-Laws of Natural Health Trends Corp. (incorporated by reference to Exhibit 3.02 to Current Report on Form 8-K filed on July 12, 2005).

4.1

Specimen Certificate for shares of common stock, $.001 par value per share, of Natural Health Trends Corp. (incorporated by reference to Exhibit 4.01 to Annual Report on Form 10-K filed on May 8, 2006).

+10.1

 

Natural Health Trends Corp. 2016 Equity Incentive Plan (incorporated by reference to Appendix C to Definitive Proxy Statement filed on March 4, 2016).

+10.2Form of Seven Year Warrants to Purchase Shares of CommonRestricted Stock ofAward Agreement under the Company issued by the Company to certain purchasers2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.410.2 to CurrentAnnual Report on Form 8-K10-K filed on October 22, 2007)March 4, 2016).

+10.2

10.3
 

2007Natural Health Trends Corp. Annual Incentive Plan (Restated as of January 1, 2016) (incorporated by reference to Appendix A to Definitive Proxy Statement filed on October 20, 2006)March 4, 2016).

+10.3

10.4
 

2007 EquityNatural Health Trends Corp. 2014 Long-Term Incentive Plan as amended and restated(Restated as of November 13, 2008January 1, 2016) (incorporated by reference to Appendix AB to Definitive Proxy Statement filed on November 25, 2008)March 4, 2016).

+10.4

10.5
 

Form of Notice of Restricted Stock Grant and Restricted Stock Agreement underFirst Amendment to the Company’s 2007 EquityNatural Health Trends Corp. 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.5 to Quarterly Report on Form 10-Q filed on May 11, 2007)(Restated as of January 1, 2016) (filed herewith).

+10.5

10.6
 

Employment Agreement (including form of Non-Competition and Proprietary Rights Assignment Agreement) for Chris T. Sharng, dated April 23, 2007 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on April 26, 2007).

+10.6

10.7
 

Employment Agreement (including form of Non-Competition and Proprietary Rights Assignment Agreement) for Timothy S. Davidson dated April 23, 2007 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed on April 26, 2007).

+10.7

10.8
 

EmploymentForm of Restricted Stock Notice of Grant and Award Agreement (including formfor shares of Non-Competitionrestricted stock granted on (1) January 20, 2015 to each of Chris T. Sharng, Timothy S. Davidson, Randall A. Mason and Proprietary Rights Assignment Agreement) for Gary C. Wallace dated April 23, 2007George K. Broady, and (2) February 11, 2015 to each of Christopher R. O’Brien and Kin Y. Chung (incorporated by reference to Exhibit 10.310.9 to CurrentAnnual Report on Form 8-K10-K filed on April 26, 2007)March 6, 2015).

+10.8

10.9
 

Form of Indemnification Agreement dated December 13, 2005,February 11, 2015, between Natural Health Trends Corp. and each of its directors (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on December 13, 2005)February 12, 2015).

14.1

10.10
 

Stock Repurchase Agreement dated January 22, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed January 26, 2015).

10.11Stock Repurchase Agreement dated May 7, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed May 7, 2015).
10.12Stock Repurchase Agreement dated July 31, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed July 31, 2015).
10.13Stock Repurchase Agreement dated October 28, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed October 28, 2015).
14.1Worldwide Code of Business Conduct, as revised on November 5, 2015 (incorporated by reference to Exhibit 14.1 to AnnualCurrent Report on Form 10-K8-K filed on March 28, 2007)February 12, 2015).

14.2

21.1
 

CodeSubsidiaries of Ethics of Senior Financial Officers (incorporated by reference to Exhibit 14.2 to Annual Report on Form 10-K filed on March 31, 2005)Natural Health Trends Corp. (filed herewith).

21.1

Subsidiaries of the Company (filed herewith).

23.1

 

Consent of Lane Gorman Trubitt, PLLCLLC (filed herewith).

24.1

 

Power of Attorney (see signature page).

31.1

 

Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2

 

Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1

 

Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

101.INS

XBRL Instance

101.SCH

XBRL Taxonomy Extension Schema

101.CAL

XBRL Taxonomy Extension Calculation

101.DEF

XBRL Taxonomy Extension Definition

101.LAB

XBRL Taxonomy Extension Labels

101.PRE

XBRL Taxonomy Extension Presentation

  

  


101.INSInstance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema
101.CALXBRL Taxonomy Extension Calculation
101.DEFXBRL Taxonomy Extension Definition
101.LABXBRL Taxonomy Extension Labels
101.PREXBRL Taxonomy Extension Presentation
+ Management contract or compensatory plan